pharmacognostical O O
and O O
analytical O O
evaluation O O
of O O
karpasa S-Dg S-Dg
root O O
gossypium O O
herbaceum O O
linn O O
known O O
as O O
karpasa S-Dg S-Dg
belongs O O
to O O
the O O
family O O
malvaceae O O
is O O
used O O
in O O
ayurveda O O
to O O
treat O O
various O O
diseases O O
and O O
for O O
processing O O
various O O
formulations O O
in O O
rasashastra O O
and O O
bhaishajyakalpana O S-Dg
in O O
the O O
present O O
study O O
transverse O O
section O O
of O O
fresh O O
roots O O
of O O
karpasa S-Dg S-Dg
showed O O
cortex O O
with O O
pericyclic O O
fibres O O
prismatic O O
crystals O O
of O O
calcium O O
oxalate O O
and O O
starch O O
grains O O
vascular O O
bundle O O
shows O O
the O O
phloem O O
above O O
the O O
xylem O O
xylem O O
radially O O
arranged O O
with O O
biseriate O O
to O O
multiseriate O O
medullary O O
rays O O
presence O O
of O O
lysigenous O O
cavity O O
in O O
the O O
medullary O O
ray O O
is O O
a O O
special O O
character O O
the O O
physico O O
chemical O O
parameters O O
like O O
of O O
karpasa S-Dg S-Dg
root O O
was O O
the O O
loss O O
on O O
drying O O
was O O
and O O
the O O
alcohol O O
soluble O O
extractive O O
was O O
tlc O O
profile O O
of O O
karpasa S-Dg S-Dg
root O O
showed O O
at O O
frequency O O
and O O
at O O
respectively O O

effect B-Dg O
of O O
mamsyadi O B-Dg
kwatha E-Dg E-Dg
and O O
yoga O O
therapy O O
in O O
the O O
management O O
of O O
anavasthita B-Ds B-Ds
chittatva E-Ds E-Ds
anavasthita B-Ds E-Ds
chittatva E-Ds E-Ds
is O O
a O O
vataja B-Ds B-Ds
nanatmaja I-Ds B-Ds
vikara E-Ds E-Ds
nearly O O
relates O O
with O O
anxiety O O
based O O
on O O
its O O
pathogenesis O O
among O O
three O O
modalities O O
of O O
chikitsa O O
viz O O
daivavyapashraya O O
chikitsa O O
yuktivyapashraya O O
chikitsa O O
and O O
satvavajaya O O
chikitsa O O
two O O
forms O O
are O O
implemented O O
in O O
the O O
present O O
study O O
mamsyadi B-Dg B-Dg
kwatha E-Dg E-Dg
a O O
combination O O
of O O
jatamamsi S-Dg S-Dg
ashwagandha S-Dg S-Dg
and O O
parasika B-Dg B-Dg
yavani E-Dg E-Dg
hyoscyamus O E-Dg
niger O O
in O O
ratio O O
was O O
administered O O
in O O
yuktivyapashraya O O
chikitsa O O
in O O
satvavajaya O O
chikitsa O O
yogic O O
practices O O
like O O
surya O O
namaskaras O O
kriyas O O
and O O
pranayamas O O
were O O
advised O O
patients O O
of O O
anavasthita B-Ds B-Ds
chittatva E-Ds E-Ds
were O O
selected O O
and O O
divided O O
randomly O O
into O O
groups O O
viz O O
patients O O
in O O
control O O
group O O
patients O O
in O O
yuktivyapashraya O O
chikitsa O O
group O O
patients O O
in O O
satvavajaya O O
chikitsa O O
group O O
and O O
patients O O
in O O
combined O O
therapy O O
group O O
the O O
treatment O O
was O O
given O O
for O O
days O O
all O O
the O O
groups O O
viz O O
yuktivyapashraya O B-Dg
chikitsa O O
satvavajaya O O
chikitsa O O
and O O
combined O O
therapy O O
group O O
showed O O
statistically O O
highly O O
significant O O
improvement O O
in O O
total O O
anxiety O O
rating O O
scale O O
and O O
respectively O O
the O O
results O O
revealed O O
that O O
satvavajaya O B-Dg
chikitsa O E-Dg
group O O
has O O
an O O
edge O O
over O O
yuktivyapashraya O O
chikitsa O O
and O O
combined O O
therapy O O
group O O
in O O
alleviating O O
the O O
symptoms O O
of O O
anavasthita B-Ds B-Ds
chittatva E-Ds E-Ds

preliminary O O
analytical O O
study O O
of O O
gandarvahasthadi B-Dg B-Dg
kwatha E-Dg E-Dg
an O O
ayurvedic O O
polyherbal O O
formulation O O
gandarvahasthadi B-Dg B-Dg
kwatha E-Dg E-Dg
is O O
a O O
purely O O
herbal O O
product O O
used O O
commonly O O
for O O
the O O
management O O
of O O
vataja B-Ds B-Ds
rogas E-Ds E-Ds
like O O
grudhrasi S-Ds S-Ds
kati B-Ds I-Dg
graha E-Ds E-Dg
etc O O
the O O
gandarvahasthadi B-Dg B-Dg
kwatha E-Dg E-Dg
is O O
an O O
orally O O
administrable O O
pharmaceutical O O
drug O O
combination O O
of O O
ingredients O O
namely O O
gandarahastha S-Dg S-Dg
chiruvilwa S-Dg S-Dg
hutaswa S-Dg S-Dg
vishwam S-Dg S-Dg
pathya S-Dg S-Dg
terminalia O S-Dg
chebula O O
retz O O
punarnava S-Dg S-Dg
boerhavia O O
diffusa O O
linn O O
yavashaka S-Dg S-Dg
tragia O O
involucrata O O
linn O O
and O O
bhumithalam S-Dg S-Dg
asparagus O O
adscendens O O
lack O O
of O O
standardization O O
of O O
herbal O O
formulations O O
creates O O
difficulty O O
in O O
validating O O
the O O
efficacy O O
and O O
maintaining O O
quality O O
of O O
the O O
product O O
hence O O
an O O
attempt O O
has O O
been O O
made O O
to O O
study O O
gandarvahasthadi B-Dg B-Dg
kwatha E-Dg E-Dg
by O O
analyzing O O
through O O
qualitative O O
and O O
quantitative O O
analysis O O
of O O
parameters O O
and O O
to O O
develop O O
fingerprints O O
of O O
thin O O
layer O O
chromatography O O
study O O
hptlc O O
four O O
peak O O
values O O
at O O
areas O O
at O O
and O O
were O O
found O O
in O O
the O O
hptlc O O
graph O O
the O O
data O O
evolved O O
in O O
the O O
present O O
study O O
will O O
help O O
to O O
maintain O O
the O O
quality O O
of O O
the O O
formulation O O

therapeutic S-Fn O
potentials O O
of O O
kantakari S-Dg S-Dg
the O O
medicinal O O
plants O O
are O O
widely O O
used O O
by O O
the O O
traditional O O
medical O O
practitioners O O
for O O
curing O O
various O O
diseases O O
kantakari S-Dg S-Dg
solanum O O
xanthocarpum O O
schrad O O
wendl O O
of O O
the O O
family O O
solanaceae O O
is O O
one O O
of O O
the O O
dasamoola O O
and O O
commonly O O
used O O
drug O O
in O O
ayurveda O O
in O O
traditional O O
systems O O
of O O
medicine O O
different O O
parts O O
like O O
leaves O O
stem O O
flower O O
root O O
seeds O O
of O O
solanum O O
xanthocarpum O O
and O O
the O O
plant O O
as O O
a O O
whole O O
are O O
used O O
the O O
drug O O
is O O
used O O
as O O
asthmatic S-Ds S-Ds
hypoglycaemic S-Ds S-Ds
anti O B-Ds
inflammatory O E-Ds
antitumor S-Ds S-Ds
anti O S-Ds
tussive O S-Ds
antipyretic S-Ds S-Ds
antispasmodic S-Ds S-Ds
anti O S-Ds
histaminic S-Ds S-Ds
hypotensive S-Ds S-Ds
and O O
cytotoxic S-Ds S-Ds
activity O O
focus O O
on O O
plant O O
research O O
has O O
increased O O
all O O
over O O
the O O
world O O
and O O
a O O
large O O
body O O
of O O
evidence O O
has O O
been O O
collected O O
to O O
show O O
immense O O
potential O O
of O O
the O O
drug O O
kantakari S-Dg S-Dg
used O O
for O O
various O O
respiratory O O
disorders O O
in O O
the O O
ayurvedic O O
systems O O
of O O
medicine O O
to O O
facilitate O O
the O O
readers O O
to O O
look O O
at O O
more O O
easily O O
the O O
datas O O
in O O
the O O
present O O
review O O
have O O
been O O
organized O O
in O O
various O O
sections O O
according O O
to O O
ayurvedic O O
view O O
and O O
with O O
recent O O
researches O O
carried O O
out O O
on O O
the O O
drug O O

uses O O
of O O
langali S-Dg S-Dg
an O O
ethnomedicinal O O
perspective O O
langali S-Dg S-Dg
botanically O O
identified O O
as O O
gloriosa O O
superba O O
of O O
family O O
liliaceae O O
a O O
native O O
of O O
tropical O O
asia O O
and O O
africa O O
is O O
one O O
of O O
the O O
drugs O O
reported O O
for O O
its O O
uses O O
by O O
the O O
tribal O O
people O O
of O O
india O O
here O O
an O O
attempt O O
has O O
been O O
made O O
to O O
compile O O
those O O
scattered O O
reporting O O
from O O
various O O
published O O
research O O
articles O O
and O O
books O O
related O O
to O O
ethnobotany O O
total O O
research O O
articles O O
highlighting O O
the O O
ethnomedicinal O O
aspect O O
of O O
gloriosa O O
superba O O
linn O O
were O O
traced O O
out O O
with O O
regards O O
to O O
its O O
reported O O
clinical O O
efficacy O O
in O O
india O O
the O O
plant O O
is O O
being O O
used O O
in O O
states O O
viz O O
assam O O
chhattisgarh O O
jharkhand O O
karnataka O O
kerala O O
madhya O O
pradesh O O
maharashtra O O
odisha O O
rajasthan O O
tamil O O
nadu O O
uttar O O
pradesh O O
and O O
west O O
bengal O O
and O O
by O O
various O O
parts O O
such O O
as O O
leaf O O
rhizome O O
and O O
seed O O
of O O
the O O
plant O O
are O O
claimed O O
as O O
useful O O
parts O O
by O O
and O O
tribes O O
respectively O O
it O O
is O O
being O O
used O O
in O O
disease O O
conditions O O
like O O
leprosy S-Ds S-Ds
tribes O O
lice S-Ds O
wound O O
along O O
with O O
ulcers S-Ds S-Ds
and O O
sores S-Ds S-Ds
rheumatism S-Ds S-Ds
snakebite S-Ds S-Ds
scorpion B-Ds B-Ds
bite E-Ds E-Ds
gout S-Ds S-Ds
abdominal B-Ds B-Ds
pain E-Ds E-Ds
and O O
useful O O
as O O
abortifacient S-Ds S-Ds
anthelmintic S-Ds S-Ds
etc O O

management O O
of O O
corneal B-Ds B-Ds
erosions E-Ds E-Ds
due O O
to O O
chemical O O
burn O O
by O O
durvadi B-Dg B-Dg
ghritam E-Dg E-Dg
a O O
case O O
study O O
the O O
tremendous O O
treatment O O
approach O O
in O O
wound O B-Ds
healing O E-Ds
is O O
aimed O O
at O O
its O O
cosmetic O O
correction O O
and O O
remains O O
as O O
same O O
even O O
when O O
it O O
occurs O O
in O O
a O O
delicate O O
structure O O
like O O
cornea O O
the O O
aseptic O O
ayurvedic O O
healing O O
of O O
a O O
wound O O
in O O
an O O
eye O O
especially O O
in O O
the O O
cornea O O
stills O O
remains O O
as O O
a O O
challenge O O
owing O O
to O O
several O O
reasons O O
this O O
article O O
explores O O
safe O O
and O O
effective O O
management O O
of O O
corneal B-Ds B-Ds
erosions E-Ds E-Ds
in O O
a O O
short O O
period O O
of O O
time O O
this O O
study O O
explains O O
a O O
case O O
of O O
a O O
yrs O O
old O O
patient O O
having O O
corneal B-Ds B-Ds
superficial I-Ds I-Ds
epithelial I-Ds I-Ds
erosions E-Ds E-Ds
due O O
to O O
chemical O O
burn O O
successfully O O
treated O O
with O O
simple O O
and O O
cost O O
effective O O
combination O O
of O O
durvadi B-Dg B-Dg
ghritam E-Dg E-Dg
and O O
honey O O
following O O
eye O O
pad O O
and O O
bandage O O
for O O
four O O
days O O
the O O
results O O
confirmed O O
that O O
the O O
drug O O
under O O
trial O O
not O O
only O O
prevents O O
infection O O
but O O
it O O
promotes O O
epithelization O O
and O O
complete O O
healing O O
in O O
shorter O O
duration O O

randomized O O
controlled O O
trial O O
on O O
candanaadi B-Dg B-Dg
lepa E-Dg E-Dg
versus O O
triphala B-Dg B-Dg
lepa E-Dg E-Dg
in O O
paaduka B-Ds B-Ds
visha E-Ds E-Ds
to O O
allergic B-Ds B-Ds
contact I-Ds B-Ds
paaduka B-Ds B-Ds
visha I-Ds B-Ds
dermatitis E-Ds E-Ds
represents O O
a O O
distinct O O
and O O
common O O
group O O
among O O
the O O
types O O
of O O
contact B-Ds B-Ds
dermatitis E-Ds E-Ds
cases O O
seen O O
in O O
india O O
this O O
ailment O O
however O O
often O O
remains O O
undiagnosed O O
misdiagnosed O O
or O O
empirically O O
diagnosed O O
without O O
pinpointing O O
the O O
contributory O O
allergens O O
the O O
main O O
objective O O
of O O
the O O
present O O
study O O
was O O
to O O
evaluate O O
the O O
comparative O O
effect O O
of O O
candanaadi B-Dg B-Dg
lepa E-Dg E-Dg
with O O
triphala B-Dg B-Dg
lepa E-Dg E-Dg
in O O
reducing O O
the O O
cardinal O O
signs O O
and O O
symptoms O O
due O O
to O O
paaduka B-Ds B-Ds
visha E-Ds E-Ds
viz O S-Ds
swelling S-Ds S-Ds
vesicles S-Ds S-Ds
oozing S-Ds S-Ds
and O O
numbness S-Ds S-Ds
with O O
itching S-Ds S-Ds
as O O
an O O
associated O O
symptom O O
a O O
total O O
number O O
of O O
cases O O
with O O
footwear B-Ds B-Ds
dermatitis E-Ds E-Ds
were O O
selected O O
and O O
divided O O
randomly O O
into O O
two O O
groups O O
criteria O O
for O O
selection O O
were O O
those O O
having O O
exclusively O O
feet B-Ds B-Ds
dermatitis E-Ds E-Ds
and O O
positive O O
patch O O
test O O
reactions O O
to O O
standard O O
footwear O O
allergens O O
with O O
significant O O
clinico O O
allergological O O
correlation O O
both O O
the O O
drugs O O
candanaadi B-Dg B-Dg
lepa E-Dg E-Dg
and O O
triphala B-Dg B-Dg
lepa E-Dg E-Dg
were O O
significant O O
in O O
reducing O B-Ds
swelling O E-Ds
and O O
respectively O O
both O O
the O O
drugs O O
were O O
significant O O
in O O
relieving O O
discharge O O
vesicles O O
and O O
itching S-Ds S-Ds
though O O
both O O
the O O
drugs O O
were O O
highly O O
significant O O
on O O
account O O
of O O
percentage O O
of O O
relief O O
obtained O O
it O O
was O O
found O O
that O O
candanaadi B-Dg B-Dg
lepa E-Dg E-Dg
was O O
more O O
effective O O
in O O
the O O
management O O
of O O
footwear B-Ds B-Ds
dermatitis E-Ds E-Ds
as O O
compared O O
to O O
triphala B-Dg B-Dg
lepa E-Dg E-Dg

selection O O
of O O
bhallataka S-Dg S-Dg
fruits O O
for O O
therapeutic O O
uses O O
a O O
scientific O O
approach O O
ayurveda O O
emphasizes O O
selection O O
of O O
genuine O O
and O O
quality O O
drugs O O
for O O
therapeutic B-Fn O
uses E-Fn O
selection O O
criteria O O
of O O
the O O
individual O O
herbal O O
drugs O O
differ O O
from O O
drug O O
to O O
drug O O
in O O
ancient O O
times O O
special O O
parameters O O
were O O
followed O O
to O O
fix O O
the O O
grade O O
of O O
the O O
drugs O O
it O O
is O O
reported O O
that O O
bhallataka S-Dg S-Dg
semecarpus O O
anacardium O O
linn O O
fruits O O
which O O
sink O O
in O O
water O O
should O O
be O O
selected O O
for O O
the O O
therapeutic B-Fn O
uses E-Fn O
the O O
reason O O
behind O O
this O O
logic O O
is O O
not O O
explored O O
scientifically O O
an O O
attempt O O
has O O
been O O
made O O
to O O
find O O
out O O
the O O
reason O O
for O O
the O O
selection O O
of O O
the O O
sunken O B-Dg
bhallataka S-Dg S-Dg
fruits O O
pharmacognostically O O
and O O
phytochemically O O
following O O
standard O O
parameters O O
macroscopically O O
the O O
floated O O
fruits O O
were O O
elongated O O
instead O O
of O O
heart O O
shape O O
laterally O O
flattened O O
obliquely O O
ovoid O O
and O O
some O O
ruptured O O
the O O
values O O
were O O
and O O
for O O
sunken O O
and O O
floated O O
respectively O O
though O O
in O O
both O O
the O O
samples O O
spots O O
were O O
observed O O
the O O
difference O O
in O O
value O O
proves O O
the O O
difference O O
of O O
poly O O
phenols O O
in O O
sunken O O
and O O
floated O O
bhallataka S-Dg S-Dg
fruits O O

the O O
concept O O
of O O
vyadhikshamatva O S-Dg
in O O
ayurveda O O
in O O
ayurveda O O
the O O
superior O O
vital O O
essence O O
of O O
all O O
bodily O O
tissues O O
is O O
called O O
ojas O O
overall O O
it O O
is O O
responsible O O
for O O
the O O
defence O O
of O O
human O O
body O O
against O O
diseases O O
and O O
infirmity O O
in O O
conditions O O
like O O
diabetes B-Ds B-Ds
mellitus E-Ds E-Ds
immunodeficiency B-Ds B-Ds
disorders E-Ds E-Ds
and O O
malnutrition S-Ds S-Ds
where O O
loss O O
of O O
ojas O O
or O O
bala O O
is O O
a O O
constant O O
feature O O
people O O
are O O
known O O
to O O
be O O
susceptible O O
to O O
various O O
other O O
diseases O O
or O O
recurrent O O
infections O O
according O O
to O O
the O O
concept O O
of O O
ojas O O
or O O
vyadhikshamatva O O
or O O
bala O O
the O O
resistance O O
is O O
of O O
tremendous O O
importance O O
in O O
the O O
daily O O
welfare O O
of O O
living O O
beings O O
not O O
only O O
for O O
disease O O
prevention O O
but O O
also O O
for O O
rapid O O
recovery O O
after O O
disease O O
affliction O O
ayurveda O O
propounds O O
that O O
prevention O O
is O O
an O O
equally O O
important O O
aspect O O
of O O
disease O O
management O O
as O O
cure O O
and O O
thus O O
strengthening O O
the O O
immune O O
system O O
is O O
a O O
natural O O
way O O
to O O
help O O
the O O
body O O
fight O O
against O O
the O O
disease O O
causing O O
pathogens O O
acharyas O O
promoted O O
the O O
use O O
of O O
rasayana S-Dg S-Dg
rejuvenation O O
to O O
enhance O O
ojas O O
and O O
vyadhikshamatva O S-Dg
immunity O O
rasayanas S-Dg S-Dg
are O O
health O O
promoting O O
and O O
rejuvenating O O
agents O O
which O O
by O O
their O O
empirical O O
effects O O
produce O O
resistance O O
against O O
disease O O
both O O
physically O O
and O O
mentally O O
ojas O O
is O O
responsible O O
for O O
good O O
health O O
better O O
immunity O O
longevity O O
intelligence O O
and O O
thought O O
process O O
for O O
this O O
purpose O O
use O O
of O O
different O O
types O O
of O O
ojas O O
promoting O O
herbs O O
have O O
been O O
described O O
in O O
ayurveda O O
which O O
can O O
be O O
immensely O O
helpful O O
in O O
the O O
management O O
of O O
immunodeficiency B-Ds B-Ds
disorders E-Ds E-Ds

normal O O
dietetics O O
and O O
mode O O
of O O
life O O
for O O
pregnant O O
woman O O
to O O
garbhini B-Dg B-Dg
paricharya E-Dg E-Dg
woman O O
reproductive O O
period O O
bears O O
a O O
lot O O
of O O
importance O O
because O O
it O O
is O O
very O O
much O O
near O O
to O O
disease O O
pregnancy O O
is O O
not O O
a O O
disease O O
condition O O
but O O
a O O
state O O
of O O
physical B-Ds O
and O O
mental B-Ds B-Ds
stress E-Ds E-Ds
during O O
pre O O
and O O
post O O
natal O O
period O O
common O O
problems O O
challenged O O
by O O
the O O
woman O O
are O O
nausea S-Ds S-Ds
vomiting S-Ds S-Ds
anaemia S-Ds S-Ds
constipation S-Ds S-Ds
abortion S-Ds S-Ds
low B-Ds B-Ds
birth I-Ds E-Ds
weight I-Ds B-Ds
baby E-Ds B-Ds
still B-Ds B-Ds
birth E-Ds E-Ds
eclampsia S-Ds S-Ds
pre O O
eclampsia O S-Ds
etc O O
every O O
woman O O
should O O
be O O
ensured O O
free O O
from O O
complication O O
during O O
gestation O O
period O O
and O O
then O O
everyone O O
can O O
have O O
a O O
safe O O
delivery O O
and O O
get O O
a O O
healthy O O
offspring O O
ayurveda O O
is O O
a O O
science O O
which O O
offers O O
a O O
peculiar O O
routine O O
for O O
a O O
pregnant O O
woman O O
which O O
is O O
known O O
as O O
garbhini O B-Dg
paricharya O E-Dg
it O O
reschedules O O
the O O
pattern O O
of O O
woman O O
s O O
life O O
to O O
ensure O O
proper O O
diet O O
and O O
nutrition O O

probable O O
rasanirdharna O S-Dg
model O O
in O O
ayurveda O O
for O O
crude O O
drugs O O
a O O
preliminary O O
study O O
the O O
acharyas O O
of O O
ayurveda O O
like O O
charaka O O
have O O
described O O
the O O
method O O
of O O
perceiving O O
rasa O O
pradhana O O
rasa O O
main O O
taste O O
is O O
considered O O
as O O
one O O
which O O
is O O
perceived O O
shortly O O
after O O
the O O
material O O
comes O O
in O O
contact O O
with O O
tongue O O
and O O
the O O
rasa O O
which O O
is O O
felt O O
later O O
is O O
called O O
anurasa O O
dhayni O O
suggested O O
the O O
threshold O O
method O O
for O O
tara O B-Dg
tamatva O E-Dg
this O O
threshold O O
was O O
further O O
discriminated O O
with O O
better O O
understating O O
by O O
mathematical O O
calculations O O
it O O
was O O
found O O
that O O
the O O
ratio O O
of O O
dilution O O
for O O
perception O O
is O O
getting O O
decreased O O
the O O
compound O O
drug O O
preparation O O
can O O
be O O
analyzed O O
easily O O
by O O
taste O O
with O O
the O O
tongue O O
method O O
sensory O O
evaluation O O
of O O
food O O
principles O O
and O O
practices O O
by O O
harry O O
lawless O O
and O O
hildegarde O O
heymann O O
edition O O
published O O
by O O
springer O O
and O O
applied O O
mathematics O O
for O O
odor O O
testing O O
by O O
michal O B-Dg
amcginely O O
was O O
referred O O
for O O
the O O
measurement O O
of O O
taste O O
threshold O O
as O O
well O O
as O O
for O O
calculation O O
of O O
equations O O
as O O
per O O
the O O
scholars O O
knowledge O O
this O O
is O O
the O O
first O O
attempt O O
tried O O
on O O
taste O O
threshold O O
for O O
its O O
discriminative O O
aspect O O
as O O
well O O
as O O
mathematical O O
calculation O O
of O O
taste O O
threshold O O
on O O
any O O
ayurvedic O O
drug O O

effect O O
of O O
gandharvahasthadi B-Dg B-Dg
kwatha E-Dg E-Dg
in O O
the O O
management O O
of O O
grudhrasi S-Ds S-Ds
a O O
prospective O O
open O O
controlled O O
clinical O O
trial O O
grudhrasi S-Ds S-Ds
is O O
a O O
painful O O
condition O O
chiefly O O
affecting O O
the O O
lower O O
back O O
area O O
which O O
radiates O O
downwards O O
to O O
one O O
leg O O
or O O
both O O
the O O
legs O O
gandarvahasthadi B-Dg B-Dg
kwatha E-Dg E-Dg
is O O
a O O
potent O O
orally O O
administrable O O
pharmaceutical O O
drug O O
combination O O
of O O
gandarahastha S-Dg S-Dg
chiruvilwa S-Dg S-Dg
hutaswa S-Dg S-Dg
vishwam S-Dg S-Dg
pathya S-Dg S-Dg
punamava S-Dg S-Dg
yavashaka S-Dg S-Dg
bhumithalam S-Dg S-Dg
commonly O O
used O O
in O O
the O O
treatment O O
of O O
various O O
vata B-Ds B-Ds
vyadhi E-Ds E-Ds
s O O
the O O
main O O
objective O O
of O O
the O O
study O O
was O O
to O O
assess O O
the O O
efficacy O O
of O O
gandharvahasthadi B-Dg B-Dg
kwatha E-Dg E-Dg
as O O
a O O
trial O O
drug O O
in O O
the O O
management O O
of O O
grudhrasi S-Ds S-Ds
the O O
sample O O
size O O
of O O
the O O
study O O
was O O
results O O
of O O
patients O O
with O O
grudhrasi S-Ds S-Ds
in O O
study O O
group O O
were O O
analyzed O O
the O O
results O O
were O O
statistically O O
analyzed O O
before O O
after O O
treatment O O
and O O
follow O O
up O O
with O O
help O O
of O O
student O O
t O O
test O O
in O O
all O O
the O O
symptoms O O
the O O
paired O O
t O O
test O O
had O O
denoted O O
that O O
the O O
treatment O O
is O O
highly O O
significant O O
which O O
implies O O
that O O
gandharvahasthadi B-Dg B-Dg
kwatha E-Dg E-Dg
is O O
effective O O
in O O
the O O
treatment O O
of O O
grudhrasi S-Ds S-Ds

a O O
conceptual O O
note O O
on O O
the O O
understanding O O
and O O
significance O O
of O O
agadatantra S-Dg S-Dg
in O O
ayurveda O O
the O O
term O O
personalized O O
medicine O O
is O O
an O O
integral O O
part O O
of O O
cikitsa O S-Dg
or O O
management O O
in O O
ayurveda O O
it O O
signifies O O
the O O
need O O
of O O
a O O
very O O
comprehensive O O
approach O O
very O O
much O O
specific O O
to O O
the O O
individual O O
this O O
is O O
because O O
each O O
individual O O
is O O
unique O O
thus O O
one O O
man O O
s O O
food O O
may O O
become O O
another O O
man O O
s O O
poison O O
there O O
is O O
plethora O O
of O O
factors O O
which O O
determines O O
the O O
positive O O
or O O
negative O O
impact O O
of O O
a O O
particular O O
substance O O
these O O
factors O O
are O O
finally O O
related O O
to O O
guna O O
and O O
karma O B-Dg
karma O E-Dg
reflects O O
the O O
latent O O
guna O O
which O O
forms O O
the O O
absolute O O
constituent O O
of O O
dravya O O
thus O O
health O O
and O O
disease O O
depends O O
upon O O
the O O
saatmya S-Ds O
congenial O O
and O O
asaatmya S-Ds O
non O O
congenial O O
nature O O
among O O
the O O
trio O O
respectively O O
agada O O
which O O
literally O O
means O O
absence O O
of O O
disease O O
or O O
non O O
congenial O O
factors O O
thus O O
meaning O O
a O O
healthy O O
state O O
forms O O
a O O
vital O O
part O O
of O O
ayurveda O O
the O O
depth O O
of O O
agadatantra S-Dg S-Dg
is O O
unfathomed O O
by O O
mere O O
translations O O
not O O
understanding O O
its O O
core O O
principles O O
this O O
has O O
led O O
to O O
stunted O O
growth O O
in O O
terms O O
of O O
its O O
practice O O
the O O
true O O
potential O O
of O O
agadatantra S-Dg S-Dg
is O O
realized O O
by O O
the O O
term O O
agadaveda O O
as O O
quoted O O
by O O
acharya O O
caraka O O
in O O
short O O
agadatantra S-Dg O
is O O
synonymous O O
with O O
ayurveda O O
itself O O
as O O
it O O
is O O
denoted O O
as O O
agadaveda O O

role O O
of O O
abhyanga S-Dg S-Dg
to O O
lead O O
a O O
healthy O O
life O O
ayurvedic O O
system O O
of O O
medicine O O
approaches O O
in O O
a O O
particular O O
way O O
to O O
prevent O O
and O O
promote O O
a O O
healthy O O
life O O
by O O
following O O
certain O O
methods O O
and O O
therapies O O
in O O
day O O
today O O
activities O O
which O O
could O O
be O O
considered O O
as O O
a O O
part O O
of O O
a O O
health O O
promotion O O
among O O
the O O
fast O O
moving O O
people O O
of O O
this O O
century O O
abhyanga S-Dg S-Dg
oil O O
massage O O
which O O
is O O
one O O
among O O
the O O
dinacharyas O S-Dg
is O O
an O O
ancient O O
indian O O
approach O O
adopted O O
for O O
healing O O
relaxation O O
and O O
treating O O
various O O
diseases O O
it O O
is O O
one O O
of O O
the O O
most O O
important O O
day O O
today O O
activities O O
of O O
life O O
as O O
how O O
early O O
to O O
bed O O
and O O
early O O
to O O
rise O O
then O O
brushing O O
of O O
tooth O O
etc O O
are O O
important O O
in O O
ayurveda O O
it O O
is O O
clearly O O
mentioned O O
that O O
the O O
abhyanga S-Dg S-Dg
controls O O
vata O O
dosha O O
and O O
the O O
person O O
develops O O
strength O O
both O O
physically O O
and O O
mentally O O
here O O
an O O
attempt O O
has O O
been O O
made O O
to O O
compile O O
the O O
importance O O
and O O
role O O
of O O
abhyanga S-Dg S-Dg
in O O
day O O
today O O
life O O
which O O
reduces O O
the O O
stress S-Ds O
and O O
keeps O O
the O O
society O O
healthy O O

effect O O
of O O
kampillaka B-Dg B-Dg
churna E-Dg E-Dg
on O O
intestinal B-Ds B-Ds
worms E-Ds E-Ds
the O O
descriptions O O
about O O
worms S-Ds O
have O O
been O O
discussed O O
in O O
sushruta O O
samhita O O
and O O
charaka O O
samhita O O
in O O
detail O O
according O O
to O O
modern O O
counterpart O O
it O O
was O O
found O O
that O O
worms S-Ds O
are O O
commonly O O
found O O
in O O
patients O O
belonging O O
to O O
backward O O
areas O O
because O O
of O O
improper O O
maintenance O O
of O O
hygiene O O
hence O O
mortality O O
associated O O
with O O
worm O O
s O O
manifestation O O
is O O
rarely O O
found O O
but O O
it O O
is O O
still O O
a O O
challenge O O
for O O
health O O
care O O
system O O
the O O
present O O
study O O
is O O
an O O
attempt O O
to O O
look O O
into O O
the O O
magnitude O O
of O O
this O O
problem O O
in O O
our O O
communities O O
where O O
hygiene O O
can O O
not O O
be O O
maintained O O
specially O O
in O O
backward O O
areas O O
a O O
subtotal O O
of O O
patients O O
was O O
studied O O
out O O
of O O
patients O O
patients O O
have O O
ascaris O O
lumbricoids O O
ten O O
patients O O
have O O
hook B-Ds B-Ds
worm I-Ds I-Ds
infection E-Ds E-Ds
and O O
fifteen O O
have O O
entamoeba B-Ds B-Ds
hystolytica E-Ds E-Ds
in O O
stool O O
examination O O
it O O
was O O
observed O O
that O O
the O O
overall O O
prevalence O O
of O O
ascaris O O
lumbricoids O O
manifestation O O
is O O
that O O
is O O
chances O O
of O O
ascaris O O
lumbricoids O O
are O O
greatest O O
and O O
these O O
patients O O
were O O
treated O O
by O O
kampillaka B-Dg B-Dg
churna E-Dg E-Dg
powder O O
of O O
fruit O O
hairs O O
for O O
four O O
weeks O O
out O O
of O O
patients O O
forty O O
two O O
patients O O
were O O
benefited O O
by O O
kampillaka B-Dg B-Dg
churna E-Dg E-Dg
while O O
in O O
other O O
two O O
categories O O
hook B-Ds B-Ds
worm E-Ds E-Ds
and O O
entamoeba B-Ds B-Ds
hystolytica E-Ds E-Ds
effects O O
of O O
this O O
churna O E-Dg
was O O
found O O
to O O
lesser O O
extent O O

pharmaceutical O O
study O O
of O O
avartita B-Dg B-Dg
hingusauvarchaladi I-Dg B-Dg
ghrita E-Dg E-Dg
the O O
concept O O
of O O
avarthana O S-Dg
has O O
a O O
great O O
role O O
in O O
minimising O O
the O O
dose O O
of O O
sneha S-Dg S-Dg
based O O
formulations O O
internally O O
screening O O
of O O
ayurvedic O O
classics O O
reveals O O
avarthana O O
potentiates O O
the O O
product O O
moreover O O
the O O
dose O O
can O O
be O O
minimized O O
and O O
can O O
be O O
encapsulated O O
to O O
meet O O
the O O
trend O O
of O O
the O O
fast O O
moving O O
people O O
of O O
the O O
present O O
era O O
hingusauvarchaladi B-Dg B-Dg
ghrita E-Dg E-Dg
is O O
a O O
compound O O
formulation O O
indicated O O
for O O
apasmara S-Ds S-Ds
epilepsy S-Ds S-Ds
considering O O
the O O
concept O O
of O O
avarthana O O
the O O
pharmaceutical O O
procedure O O
of O O
hingusauvarchaladi B-Dg B-Dg
ghrita E-Dg E-Dg
was O O
repeated O O
for O O
times O O
saptavartita O O
and O O
analysed O O
the O O
pharmaceutical O O
study O O
proves O O
that O O
the O O
peroxide O O
value O O
acid O O
value O O
saponification O O
value O O
and O O
ester O O
value O O
of O O
saptavartita O B-Dg
hingusauvarchaladi B-Dg B-Dg
ghrita E-Dg E-Dg
is O O
less O O
when O O
compared O O
to O O
hingusauvarchaladi B-Dg B-Dg
ghrita E-Dg E-Dg

a O O
contemporary O O
study O O
of O O
yavagu S-Dg S-Dg
as O O
pathyakalpana S-Ds S-Dg
the O O
goal O O
of O O
ayurveda O O
is O O
to O O
achieve O O
healthy O O
life O O
by O O
its O O
preventive O O
and O O
curable O O
measures O O
ayurvedic O O
texts O O
like O O
carak O O
samhita O O
susruta O O
samhita O O
and O O
astanga O O
hridaya O O
the O O
whole O O
dravyas O O
are O O
classified O O
into O O
two O O
categories O O
viz O O
ausadha O O
drugs O O
and O O
aahara O S-Dg
food O O
items O O
the O O
second O O
part O O
which O O
is O O
known O O
as O O
pathya B-Ds B-Ds
kalpana E-Ds E-Ds
is O O
very O O
important O O
while O O
dealing O O
with O O
the O O
patients O O
and O O
disease O O
yavagu S-Dg S-Dg
is O O
one O O
of O O
the O O
common O O
types O O
of O O
pathya B-Ds B-Ds
kalpana E-Ds E-Ds
its O O
basic O O
ingredient O O
is O O
rice O O
which O O
is O O
easily O O
digestible O O
and O O
having O O
lot O O
of O O
nutrients O O
it O O
is O O
having O O
the O O
medicinal B-Fn O
uses E-Fn O
also O O

brief O O
review O O
on O O
therapeutic O O
potentials O O
of O O
kakamachi S-Dg S-Dg
kakamachi S-Dg S-Dg
solanaceae O O
family O O
is O O
a O O
prominent O O
herb O O
in O O
ayurveda O O
which O O
is O O
used O O
as O O
food O O
and O O
medicine O O
since O O
long O O
ago O O
this O O
article O O
reviews O O
the O O
various O O
references O O
of O O
kakamachi S-Dg S-Dg
in O O
ayurvedic O O
texts O O
regarding O O
its O O
therapeutic B-Fn O
uses E-Fn O
and O O
different O O
formulations O O
the O O
review O O
also O O
encompasses O O
the O O
pharmacological O O
activities O O
and O O
various O O
folklore O O
uses O O
of O O
this O O
plant O O
it O O
is O O
found O O
that O O
this O O
herb O O
is O O
used O O
since O O
vedic O O
period O O
and O O
widely O O
used O O
as O O
shakadravya S-Dg S-Dg
vegetable O O
it O O
is O O
used O O
successfully O O
in O O
the O O
treatment O O
of O O
various O O
ailments O S-Ds
like O O
measles S-Ds S-Ds
malaria S-Ds S-Ds
cancer S-Ds S-Ds
etc O O
by O O
different O O
folks O O
till O O
date O O
this O O
plant O O
has O O
been O O
screened O O
out O O
for O O
activities O O
like O O
anti O B-Ds
oxidant O S-Ds
hepatoprotective S-Ds S-Ds
anti B-Ds S-Ds
ulcerogenic E-Ds S-Ds
immunomodulatory S-Ds S-Ds
etc O O
and O O
many O O
more O O
the O O
present O O
exercise O O
will O O
help O O
the O O
researchers O O
to O O
widen O O
their O O
horizons O O
in O O
the O O
assessment O O
of O O
other O O
activities O O
which O O
are O O
not O O
screened O O
out O O
yet O O

effect O O
of O O
formulations O O
of O O
vasa S-Dg S-Dg
in O O
the O O
management O O
of O O
tamakashwasa S-Ds S-Dg
different O O
dosage O O
forms O O
of O O
vasa O S-Dg
are O O
recommended O O
to O O
treat O O
tamaka B-Ds B-Dg
shwasa E-Ds E-Dg
these O O
formulations O O
were O O
prepared O O
by O O
keeping O O
the O O
ingredients O O
same O O
to O O
evaluate O O
their O O
efficacy O O
in O O
tamaka B-Ds B-Dg
shwasa E-Ds E-Dg
with O O
this O O
aim O O
a O O
clinical O O
study O O
was O O
undertaken O O
on O O
vasa B-Dg B-Dg
avaleha E-Dg E-Dg
vasa B-Dg B-Dg
arishta E-Dg E-Dg
and O O
vasa B-Dg B-Dg
ghrita E-Dg E-Dg
all O O
these O O
drugs O O
were O O
given O O
two O O
times O O
a O O
day O O
orally O O
for O O
days O O
it O O
is O O
an O O
open O O
trail O O
with O O
days O O
follow O O
up O O
the O O
present O O
study O O
reveals O O
that O O
vasa B-Dg B-Dg
avaleha E-Dg E-Dg
and O O
vasa B-Dg B-Dg
arishta E-Dg E-Dg
showed O O
highly O O
significant O O
results O O
in O O
frequency O O
and O O
intensity O O
of O O
dyspnoea S-Ds S-Ds
while O O
vasa B-Dg B-Dg
ghrita E-Dg E-Dg
showed O O
statistically O O
insignificant O O
results O O
vasa B-Dg B-Dg
avaleha E-Dg E-Dg
and O O
vasa B-Dg B-Dg
arishta E-Dg E-Dg
showed O O
statistically O O
significant O O
and O O
respectively O O
results O O
in O O
sakapha B-Ds B-Ds
kasa E-Ds E-Ds
productive B-Ds B-Ds
cough E-Ds E-Ds
on O O
analyzing O O
the O O
overall O O
effect O O
it O O
was O O
observed O O
that O O
in O O
avaleha O O
group O O
patient O O
showed O O
moderate O O
improvement O O
while O O
marked O O
improvement O O
is O O
seen O O
in O O
patient O O
followed O O
by O O
vasa B-Dg B-Dg
arishta E-Dg E-Dg

role O O
of O O
amalaki B-Dg B-Dg
churna E-Dg E-Dg
in O O
iron B-Ds B-Ds
deficiency I-Ds I-Ds
anemia E-Ds E-Ds
in O O
pregnant O O
women O O
iron B-Ds B-Ds
deficiency I-Ds I-Ds
anemia E-Ds E-Ds
is O O
prevalent O O
in O O
tropical O O
countries O O
among O O
women O O
of O O
child O O
bearing O O
age O O
because O O
demand O O
of O O
iron O O
during O O
pregnancy O O
is O O
markedly O O
increased O O
and O O
simultaneously O O
pregnancy O O
depresses O O
the O O
erythropoietic O O
function O O
of O O
bone O O
marrow O O
maternal O O
mortality O O
is O O
due O O
to O O
anemia S-Ds S-Ds
pregnant O O
women O O
require O O
about O O
iron O O
every O O
day O O
and O O
she O O
must O O
consume O O
of O O
dietary O O
iron O O
everyday O O
whereas O O
normal O O
vegetarian O O
diet O O
supply O O
more O O
than O O
normally O O
elemental O O
iron O O
is O O
supplemented O O
once O O
in O O
a O O
day O O
only O O
from O O
weeks O O
of O O
pregnancy O O
in O O
form O O
of O O
iron O O
pills O O
which O O
causes O O
multiple O O
side O O
effects O O
but O O
if O O
the O O
amalaki B-Dg B-Dg
emblica O E-Dg
officinalis O O
churna E-Dg E-Dg
is O O
added O O
with O O
these O O
iron O O
pills O O
it O O
increases O O
its O O
absorption O O
and O O
reduces O O
the O O
side O O
effects O O
pregnant O O
women O O
with O O
iron B-Ds B-Ds
deficiency I-Ds I-Ds
anemia E-Ds E-Ds
when O O
treated O O
with O O
the O O
combination O O
of O O
iron O O
tab O O
with O O
amalaki B-Dg B-Dg
churna E-Dg E-Dg
for O O
days O O
showed O O
good O O
response O O

phyto O O
pharmaceutical O O
assay O O
of O O
shilajatu B-Dg B-Dg
rasayana E-Dg E-Dg
a O O
novel O O
compound O O
in O O
the O O
management O O
of O O
diabetic B-Ds B-Ds
polyneuropathy E-Ds E-Ds
diabetes B-Ds B-Ds
mellitus E-Ds E-Ds
is O O
one O O
of O O
the O O
major O O
lifestyle O O
disorders O O
of O O
this O O
century O O
as O O
declared O O
by O O
who O O
diabetic O O
sensorimotor O O
peripheral O I-Ds
polyneuropathy O E-Ds
is O O
manifested O O
as O O
a O O
microvascular O O
complication O O
of O O
diabetes O B-Ds
mellitus O E-Ds
there O O
is O O
no O O
direct O O
reference O O
in O O
ayurvedic O O
classics O O
regarding O O
the O O
nomenclature O O
of O O
this O O
but O O
analyses O O
of O O
the O O
lakshana O B-Dg
samprapti O E-Dg
of O O
the O O
disease O O
exhibits O O
manifestation O O
of O O
vataja O S-Ds
symptoms O O
as O O
individually O O
or O O
as O O
a O O
resultant O O
of O O
anya O S-Dg
or O O
anyonya O O
avarana O O
at O O
this O O
point O O
the O O
wise O O
application O O
of O O
rasayana O S-Dg
and O O
vatahara O O
drugs O O
is O O
best O O
the O O
given O O
combination O O
serves O O
the O O
purpose O O
of O O
both O O
thereby O O
terminating O O
the O O
disease O O
samprapti O O
with O O
an O O
objective O O
to O O
provide O O
considerable O O
relief O O
to O O
this O O
burning O O
health O O
problem O O
the O O
application O O
of O O
shilajatu B-Dg B-Dg
rasayana E-Dg E-Dg
compound O O
was O O
proposed O O
this O O
compound O O
was O O
analyzed O O
and O O
standardized O O
through O O
basic O O
phyto O O
pharmaceutical O O
parameters O O
in O O
an O O
attempt O O
to O O
acquire O O
pure O O
shilajatu S-Dg S-Dg
efforts O O
were O O
made O O
to O O
obtain O O
nepal O B-Dg
shilajatu S-Dg S-Dg
which O O
is O O
generally O O
spoken O O
as O O
the O O
best O O
the O O
quantitative O O
analysis O O
of O O
humic O O
substances O O
in O O
shilajatu B-Dg B-Dg
rasayana E-Dg E-Dg
compound O O
was O O
carried O O
out O O
with O O
reference O O
to O O
fulvic O O
acid O O
as O O
standard O O
by O O
spectrophotometer O O
and O O
gravimetric O O
methods O O
which O O
was O O
specially O O
designed O O
here O O
lignin O O
decomposition O O
logic O O
has O O
been O O
attempted O O
using O O
chromatographic O O
assay O O
chromatography O O
was O O
performed O O
as O O
per O O
certified O O
reference O O
material O O
results O O
showed O O
the O O
shilajatu B-Dg B-Dg
rasayana E-Dg E-Dg
compound O O
contained O O
high O O
purity O O
and O O
greater O O
percentage O O
of O O
fulvic O O
acid O O
along O O
with O O
the O O
other O O
ingredients O O
used O O
for O O
bhavana S-Dg S-Dg
the O O
data O O
may O O
be O O
used O O
as O O
a O O
reference O O
parameter O O
for O O
purity O O
analysis O O
of O O
processed O O
shilajatu S-Dg S-Dg
containing O O
drugs O O

a O O
comparative O O
clincal O O
effect O O
of O O
shatyadi B-Dg B-Dg
churna E-Dg E-Dg
with O O
and O O
without O O
pranayama S-Dg S-Dg
in O O
the O O
management O O
of O O
childhood B-Ds B-Ds
asthma E-Ds E-Ds
the O O
prevalence O O
of O O
childhood B-Ds B-Ds
asthma E-Ds E-Ds
has O O
increased O O
in O O
developing O O
countries O O
like O O
india O O
from O O
last O O
many O O
years O O
symptoms O O
suggestive O O
of O O
childhood B-Ds B-Ds
asthma E-Ds E-Ds
present O O
with O O
the O O
prevalence O O
of O O
the O O
disease O O
are O O
in O O
children O O
under O O
years O O
of O O
age O O
in O O
south O O
india O O
a O O
better O O
and O O
effective O O
therapy O O
is O O
the O O
need O O
of O O
hour O O
with O O
good O O
results O O
without O O
many O O
side O O
effects O O
and O O
at O O
same O O
time O O
within O O
the O O
reach O O
of O O
the O O
masses O O
the O O
present O O
clinical O O
trial O O
was O O
planned O O
to O O
study O O
the O O
effect O O
of O O
an O O
ayurvedic O O
herbal O O
formulation O O
shatyadi B-Dg B-Dg
churna E-Dg E-Dg
with O O
and O O
without O O
pranayama S-Dg S-Dg
in O O
the O O
management O O
of O O
childhood B-Ds B-Ds
asthma E-Ds E-Ds
after O O
reaching O O
to O O
the O O
diagnosis O O
patients O O
were O O
randomly O O
distributed O O
to O O
the O O
three O O
groups O O
viz O O
received O O
shatyadi B-Dg B-Dg
churna E-Dg E-Dg
with O O
warm O O
water O O
received O O
the O O
same O O
with O O
pranayama S-Dg S-Dg
and O O
received O O
the O O
placebo O O
glucose O O
in O O
the O O
dose O O
of O O
in O O
capsule O O
form O O
with O O
pranayama O S-Dg
the O O
duration O O
of O O
the O O
trial O O
was O O
two O O
months O O
and O O
the O O
patients O O
were O O
examined O O
after O O
a O O
gap O O
of O O
days O O
the O O
follow O O
up O O
period O O
was O O
of O O
one O O
month O O
the O O
subjective O O
and O O
objective O O
parameters O O
were O O
measured O O
before O O
and O O
after O O
treatment O O
in O O
each O O
group O O
the O O
result O O
of O O
the O O
shatyadi B-Dg B-Dg
churna E-Dg E-Dg
along O O
with O O
pranayama S-Dg S-Dg
was O O
found O O
to O O
be O O
highly O O
significant O O
in O O
the O O
study O O

kamala S-Ds S-Ds
an O O
ayurvedic O O
perspective O O
ayurveda O O
is O O
not O O
only O O
a O O
medical O O
science O O
but O O
also O O
it O O
is O O
a O O
life O O
science O O
which O O
gives O O
a O O
message O O
of O O
healthy O O
and O O
better O O
living O O
since O O
time O O
immemorial O O
ancients O O
sages O O
like O O
caraka O O
susruta O O
and O O
vagbhata O O
have O O
vividly O O
described O O
kamala B-Ds B-Ds
roga E-Ds E-Ds
the O O
management O O
of O O
kamala S-Ds S-Ds
and O O
its O O
complication O O
with O O
drugs O O
diet O O
and O O
life O O
style O O
have O O
been O O
mentioned O O
in O O
ayurvedic O O
classics O O
caraka O O
has O O
considered O O
it O O
as O O
advance O O
stage O O
of O O
pandu B-Ds B-Ds
roga E-Ds E-Ds
disease O O
and O O
described O O
kamala S-Ds S-Ds
in O O
chapter O O
of O O
cikitsa O O
sthana O O
along O O
with O O
pandu B-Ds B-Ds
roga E-Ds E-Ds
the O O
main O O
dusya O O
causitive O O
factor O O
is O O
rakta O O
blood O O
at O O
the O O
same O O
time O O
both O O
are O O
pitta O O
predominant O O
disease O O
and O O
caraka O S-Ds
has O O
considered O O
it O O
as O O
a O O
advance O O
stage O O
of O O
pandu B-Ds B-Ds
roga E-Ds E-Ds
harita S-Ds E-Ds
has O O
considered O O
it O O
as O O
a O O
type O O
of O O
pandu B-Ds B-Ds
roga E-Ds E-Ds
but O O
susruta O O
has O O
mentioned O O
it O O
as O O
a O O
complication O O
of O O
pandu B-Ds B-Ds
roga E-Ds E-Ds
as O O
well O O
as O O
other O O
disease O O
also O O
where O O
vagbhata O O
also O O
described O O
it O O
as O O
a O O
separate O O
disease O O

antiasthmatic O O
ayurvedic O O
herbs O O
a O O
review O O
asthma S-Ds S-Ds
is O O
amongst O O
the O O
most O O
common O O
chronic O O
diseases O O
worldwide O O
asthma S-Ds S-Ds
is O O
a O O
public O O
health O O
problem O O
and O O
approximately O O
million O O
people O O
worldwide O O
currently O O
suffer O O
from O O
asthma S-Ds S-Ds
with O O
estimates O O
suggesting O O
that O O
asthma S-Ds S-Ds
prevalence O O
increases O O
globally O O
every O O
decade O O
is O O
analogous O O
to O O
bronchial B-Ds B-Ds
asthma E-Ds E-Ds
due O O
to O O
similarity O O
in O O
symptoms O O
onset O O
causes O O
precipitating O O
factors O O
and O O
pathogenesis O O
although O O
asthma S-Ds S-Ds
can O O
not O O
be O O
cured O O
appropriate O O
management O O
can O O
control O O
the O O
disease O O
many O O
synthetic O O
drugs O O
are O O
used O O
to O O
treat O O
acute O O
symptoms O O
of O O
bronchial B-Ds B-Ds
asthma E-Ds E-Ds
but O O
they O O
are O O
not O O
completely O O
safe O O
for O O
long O O
term O O
use O O
because O O
they O O
have O O
various O O
adverse O O
effect O O
many O O
ayurvedic O O
herbs O O
are O O
used O O
as O O
antiasthmatics O O
which O O
have O O
been O O
described O O
in O O
this O O
review O O
paper O O
such O O
as O O
adhatoda B-Dg B-Dg
vasica E-Dg E-Dg
inula B-Dg E-Dg
racemosa E-Dg E-Dg
ocimum O O
sanctum O O
solanum O O
xanthocarpum O O
etc O O
tamaka B-Dg B-Dg
shvasa E-Dg E-Dg
analogous O O
to O O
bronchial B-Ds B-Ds
asthma E-Ds E-Ds

review O O
of O O
agnikarma S-Dg S-Dg
in O O
the O O
management O O
of O O
asthi B-Ds B-Ds
sandhigata I-Ds B-Ds
vata E-Ds E-Ds
sushruta O O
has O O
dedicated O O
a O O
full O O
chapter O O
on O O
agnikarma S-Dg S-Dg
based O O
on O O
the O O
principles O O
of O O
ayurveda O O
and O O
age O O
old O O
experiences O O
to O O
manage O O
many O O
diseases O O
including O O
related O O
to O O
asthi B-Ds B-Ds
sandhigata I-Ds B-Ds
vata E-Ds E-Ds
pain O E-Ds
the O O
result O O
of O O
agnikarma S-Dg S-Dg
are O O
unparallel O O
and O O
the O O
principles O O
lie O O
behind O O
it O O
are O O
still O O
to O O
be O O
explored O O
to O O
establish O O
it O O
as O O
a O O
simple O O
effective O O
and O O
complication O O
free O O
treatment O O
modality O O
for O O
managing O O
musculoskeletal B-Ds B-Ds
pain E-Ds E-Ds
this O O
therapy O O
guides O O
towards O O
the O O
drugless O O
non O O
pharmacological O O
approaches O O
for O O
the O O
management O O
of O O
musculoskeletal B-Ds B-Ds
pain E-Ds E-Ds
where O O
non O O
steroidal O O
anti O O
inflammatory O O
drugs O O
nsaid O S-Ds
and O O
other O O
drugs O O
fail O O
to O O
provide O O
satisfactory O O
and O O
acceptable O O
result O O
this O O
review O O
article O O
attributed O O
to O O
the O O
researches O O
on O O
agnikarma S-Dg S-Dg
carried O O
out O O
at O O
gujarat O O
ayurved O O
university O O
jamnagar O O
gujarat O O

pharmaceutical O O
standardization O O
of O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
prepared O O
by O O
using O O
herbal O O
media O O
in O O
the O O
wake O O
of O O
the O O
present O O
surge O O
of O O
increased O O
global O O
curiosity O O
regarding O O
safety O O
and O O
efficacy O O
of O O
various O O
metallic O O
and O O
mineral O O
preparations O O
in O O
rasashastra O O
there O O
is O O
an O O
imminent O O
need O O
to O O
pay O O
attention O O
towards O O
standardization O O
of O O
each O O
preparation O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
is O O
one O O
of O O
ayurvedic O O
incinerated O O
metallic O O
preparation O O
claimed O O
to O O
possess O O
some O O
extraordinary O O
property O O
some O O
recently O O
published O O
research O O
work O O
emphasized O O
its O O
antidiabetic S-Ds S-Ds
and O O
aphrodisiac S-Ds S-Ds
property O O
different O O
media O O
has O O
been O O
found O O
mentioned O O
for O O
preparation O O
of O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
but O O
till O O
date O O
no O O
work O O
has O O
been O O
published O O
regarding O O
pharmaceutical O O
standardization O O
of O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
prepared O O
by O O
using O O
herbal O O
media O O
pharmaceutical O O
standardization O O
is O O
necessary O O
for O O
batch O O
to O O
batch O O
consistency O O
reproducibility O O
and O O
for O O
good O O
manufacturing O O
practices O O
in O O
present O O
study O O
an O O
attempt O O
has O O
been O O
made O O
to O O
establish O O
standards O O
for O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
prepared O O
by O O
using O O
vasa S-Dg B-Dg
adhatoda B-Dg E-Dg
vasica E-Dg E-Dg
nees O E-Dg
as O O
herbal O O
media O O
present O O
study O O
was O O
planned O O
to O O
standardize O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
prepared O O
by O O
using O O
vasa O S-Dg
as O O
herbal O O
media O O
prepared O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
subjected O O
to O O
tests O O
mentioned O O
in O O
ayurvedic O O
texts O O
varitar O O
rekhapurnatva O O
niruttha O O
apunarbhava O O
tests O O
and O O
physico O O
chemical O O
analysis O O
such O O
as O O
value O O
total O O
ash O O
loss O O
on O O
drying O O
and O O
acid O O
insoluble O O
ash O O
twenty O O
eight O O
days O O
are O O
required O O
to O O
prepare O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
with O O
weight O O
loss O O
jarana O O
is O O
the O O
principal O O
step O O
in O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
preparation O O
as O O
it O O
assist O O
maximum O O
surface O O
of O O
naga O O
for O O
further O O
chemical O O
reaction O O

validation O O
standard O O
manufacturing O O
procedure O O
of O O
guduchi B-Dg B-Dg
ghana E-Dg E-Dg
of O O
miers O O
and O O
its O O
tablets O O
there O O
has O O
been O O
a O O
dramatic O O
surge O O
in O O
popularity O O
of O O
ayurvedic O O
herbal O O
extracts O O
over O O
the O O
past O O
thirty O O
years O O
vast O O
work O O
is O O
needed O O
yet O O
to O O
develop O O
globally O O
accepted O O
standards O O
in O O
the O O
manufacturing O O
process O O
guduchi S-Dg S-Dg
is O O
one O O
of O O
the O O
most O O
versatile O O
rejuvenating O O
herbs O O
possessing O O
numerous O O
therapeutic B-Fn O
attributes E-Fn O
though O O
there O O
is O O
rising O O
continuous O O
demand O O
for O O
its O O
dried O O
aqueous O O
extract O O
called O O
ghana S-Dg S-Dg
in O O
international O O
market O O
its O O
well O O
developed O O
and O O
standard O O
manufacturing O O
procedure O O
smp O O
up O O
to O O
its O O
final O O
tableting O O
are O O
lacking O O
considering O O
this O O
the O O
present O O
study O O
was O O
aimed O O
to O O
develop O O
smp O O
for O O
preparation O O
of O O
guduchi B-Dg B-Dg
ghana E-Dg E-Dg
and O O
its O O
tablet O O
dosage O O
form O O
fifteen O O
batches O O
of O O
guduchi B-Dg B-Dg
ghana E-Dg E-Dg
were O O
prepared O O
by O O
following O O
classical O O
guidelines O O
and O O
compressed O O
into O O
tablets O O
tablets O O
were O O
further O O
subjected O O
to O O
relevant O O
analysis O O
to O O
develop O O
physicochemical O O
profile O O
the O O
average O O
percentage O O
of O O
dried O O
ghana S-Dg S-Dg
obtained O O
was O O
optimum O O
hardness O O
weight O O
of O O
tablets O O
disintegration O O
time O O
and O O
friability O O
of O O
guduchi B-Dg B-Dg
ghana E-Dg E-Dg
tablets O O
were O O
found O O
complying O O
the O O
official O O
standards O O
glycosides O O
alkaloids O O
tannin O O
phenols O O
carbohydrates O O
starch O O
and O O
sterols O O
were O O
found O O
present O O
in O O
guduchi B-Dg B-Dg
ghana E-Dg E-Dg
tablets O O
the O O
datas O O
obtained O O
in O O
present O O
study O O
may O O
prove O O
a O O
torch O O
bearer O O
for O O
future O O
studies O O

dhanyaka B-Dg B-Dg
gokshura I-Dg I-Dg
ghrita I-Dg I-Dg
matra I-Dg I-Dg
basti E-Dg E-Dg
in O O
the O O
management O O
benign O O
prostatic B-Ds B-Ds
hyperplasia E-Ds E-Ds
a O O
case O O
study O O
a O O
case O O
of O O
enlargement O O
of O O
prostate O O
was O O
treated O O
with O O
dhanyaka B-Dg B-Dg
gokshura I-Dg I-Dg
ghrita I-Dg I-Dg
matra I-Dg I-Dg
basti E-Dg E-Dg
of O O
once O O
daily O O
for O O
days O O
the O O
patient O O
was O O
assessed O O
on O O
the O O
basis O O
of O O
international O O
prostate O O
system O O
score O O
and O O
objective O O
parameters O O
after O O
completion O O
of O O
treatment O O
significant O O
relief O O
was O O
observed O O
in O O
signs O O
and O O
symptoms O O
of O O
enlarged O O
prostate O O
this O O
case O O
highlights O O
the O O
fact O O
that O O
it O O
is O O
possible O O
to O O
treat O O
a O O
case O O
of O O
benign B-Ds B-Ds
prostatic I-Ds I-Ds
hyperplasia E-Ds E-Ds
bph O O
with O O
matra B-Dg B-Dg
basti E-Dg E-Dg

role O O
of O O
svedana S-Dg S-Dg
and O O
eranda B-Dg B-Dg
mooladi I-Dg I-Dg
basti E-Dg E-Dg
in O O
the O O
management O O
of O O
ankylosing B-Ds B-Ds
spondilities E-Ds E-Ds
a O O
male O O
patient O O
of O O
age O O
yrs O O
with O O
long O O
history O O
of O O
severe B-Ds B-Ds
pain I-Ds I-Ds
stiffness I-Ds E-Ds
in O O
lowback I-Ds B-Ds
and O O
neck I-Ds B-Ds
region E-Ds O
associated O O
with O O
severe O O
difficulty O O
in O O
movements O O
and O O
diagnosed O O
as O O
ankylosing B-Ds B-Ds
spondilitis E-Ds E-Ds
came O O
for O O
treatment O O
at O O
department O O
of O O
panchakarma O O
national O O
institute O O
of O O
ayurveda O O
jaipur O O
moderate O O
relief O O
was O O
found O O
after O O
panchakarma O O
treatment O O
which O O
includes O O
valuka B-Dg B-Dg
sveda E-Dg E-Dg
patrapinda B-Dg B-Dg
sveda E-Dg B-Dg
kati S-Dg B-Dg
greeva S-Dg E-Dg
prista B-Dg B-Dg
basti E-Dg E-Dg
local O O
oleation O O
over O O
lowback O O
neck O O
and O O
back O O
region O O
and O O
karmabasti S-Dg S-Dg
therapeutic O O
enema O O
along O O
with O O
oral O O
medicines O O

wound O B-Ds
healing O E-Ds
activity O O
of O O
jati B-Dg B-Dg
kalpa I-Dg I-Dg
ghrita E-Dg E-Dg
in O O
albino O O
rats O O
wound B-Ds B-Ds
and O O
healing E-Ds E-Ds
are O O
the O O
two O O
sides O O
of O O
the O O
surgical O O
coin O O
on O O
which O O
an O O
expert O O
surgeon O O
has O O
to O O
play O O
his O O
role O O
very O O
sincerely O O
proper B-Ds O
healing I-Ds O
of O O
wounds E-Ds E-Ds
is O O
essential O O
for O O
the O O
restoration O O
of O O
anatomical O O
continuity O O
and O O
disturbed O O
functional O O
status O O
of O O
the O O
skin O O
a O O
group O O
of O O
herbs O O
having O O
healing O O
property O O
were O O
combined O O
and O O
a O O
ghee O O
based O O
herbal O O
formulation O O
called O O
jati B-Dg B-Dg
kalpa I-Dg I-Dg
ghrita E-Dg E-Dg
was O O
prepared O O
this O O
formulation O O
was O O
evaluated O O
for O O
wound B-Ds B-Ds
healing E-Ds E-Ds
activity O O
in O O
excision O O
wound O O
model O O
parameters O O
like O O
percentage O O
of O O
wound O O
contraction O O
and O O
days O O
taken O O
for O O
complete O O
healing O O
were O O
studied O O
the O O
results O O
showed O O
percentage O O
of O O
wound O O
contraction O O
of O O
trial O O
drug O O
was O O
highly O O
significant O O
when O O
compared O O
to O O
control O O
group O O
the O O
days O O
taken O O
for O O
epithelization O O
was O O
also O O
less O O
when O O
compared O O
to O O
other O O
groups O O
the O O
days O O
taken O O
for O O
complete O O
epithelialization O O
was O O
days O O
for O O
control O O
animals O O
days O O
in O O
vehicle O O
control O O
for O O
jati B-Dg B-Dg
kalpa I-Dg I-Dg
ghrita E-Dg E-Dg
treated O O
animals O O
and O O
days O O
in O O
standard O O
group O O
the O O
results O O
of O O
the O O
present O O
study O O
showed O O
that O O
jati B-Dg B-Dg
kalpa I-Dg I-Dg
ghrita E-Dg E-Dg
has O O
potent O O
wound O O
healing O O
activity O O

pharmacognostical O O
evaluation O O
of O O
taverniera B-Dg B-Dg
nummularia E-Dg E-Dg
baker O O
leaf O O
a O O
preliminary O O
study O O
taverniera B-Dg B-Dg
nummularia E-Dg E-Dg
baker O O
known O O
as O O
jethimala S-Dg S-Dg
is O O
a O O
much O O
branched O O
under O O
shrub O O
that O O
occurs O O
along O O
the O O
banks O O
of O O
small O O
streams O O
leaves O O
of O O
taverniera B-Dg B-Dg
nummularia E-Dg E-Dg
baker O O
are O O
used O O
as O O
poultice S-Fn O
for O O
sloughing B-Ds B-Ds
wounds E-Ds E-Ds
roots O O
are O O
sweet O O
like O O
licorice O O
and O O
used O O
as O O
an O O
expectorant S-Fn S-Ds
in O O
the O O
present O O
study O O
its O O
leaves O O
are O O
evaluated O O
for O O
their O O
morphological O O
microscopical O O
and O O
quantitative O O
microscopic O O
characters O O
following O O
standard O O
procedures O O
the O O
study O O
showed O O
the O O
leaves O O
were O O
in O O
size O O
foliate O O
leaflets O O
very O O
variable O O
in O O
size O O
across O O
microscopic O O
evaluation O O
of O O
leaves O O
showed O O
the O O
presence O O
of O O
pericyclic O O
fibers O O
prismatic O O
crystals O O
single O O
layer O O
of O O
epidermal O O
and O O
endodermal O O
cells O O
surface O O
study O O
of O O
the O O
leaf O O
showed O O
the O O
anomocytic O O
stomata O O
of O O
upper O O
epidermis O O
and O O
anisocytic O O
stomata O O
with O O
cicatrix O O
cells O O
of O O
lower O O
epidermis O O
these O O
observed O O
microscopic O O
characters O O
could O O
serve O O
as O O
a O O
measure O O
for O O
authentication O O
and O O
standardization O O
of O O
the O O
plant O O

scientific O O
basis O O
for O O
using O O
medicated O O
ghrita S-Dg S-Dg
in O O
ayurvedic O O
system O O
of O O
medicine O O
ayurveda O O
is O O
the O O
ancient O O
indian O O
medical O O
science O O
based O O
on O O
herbal O O
remedies O O
in O O
ayurvedic O O
system O O
of O O
medicine O O
some O O
of O O
the O O
drugs O O
are O O
administered O O
as O O
fat O O
soluble O O
preparation O O
this O O
is O O
unique O O
concept O O
of O O
ayurveda O O
to O O
administered O O
drug O O
in O O
fat O O
soluble O O
form O O
in O O
the O O
present O O
scientific O O
world O O
every O O
concept O O
has O O
to O O
be O O
validated O O
scientifically O O
for O O
its O O
global O O
acceptance O O
this O O
article O O
aims O O
to O O
provide O O
probable O O
scientific O O
explanations O O
for O O
using O O
medicated O O
ghrita S-Dg S-Dg
in O O
ayurvedic O O
system O O
of O O
medicine O O
and O O
its O O
clinical O O
importance O O
drug O O
absorption O O
is O O
determined O O
by O O
many O O
important O O
factors O O
among O O
which O O
solubility O O
of O O
the O O
drug O O
is O O
the O O
major O O
determinant O O
regardless O O
of O O
the O O
route O O
of O O
administration O O
drugs O O
must O O
be O O
in O O
solution O O
to O O
be O O
absorbed O O
unless O O
given O O
intravenously O O
a O O
drug O O
must O O
cross O O
several O O
cell O O
membranes O O
before O O
it O O
reaches O O
the O O
systemic O O
circulation O O
cell O O
membranes O O
are O O
biologic O O
barriers O O
that O O
selectively O O
inhibit O O
passage O O
of O O
drug O O
molecules O O
the O O
membranes O O
are O O
composed O O
primarily O O
of O O
a O O
bimolecular O O
lipid O O
matrix O O
which O O
determines O O
membrane O O
permeability O O
characteristics O O
therefore O O
drug O O
in O O
lipid O O
soluble O O
form O O
is O O
more O O
permeable O O
than O O
water O O
soluble O O
form O O
there O O
are O O
many O O
more O O
explanations O O
in O O
the O O
favor O O
of O O
this O O
concept O O
which O O
will O O
be O O
discussed O O
in O O
this O O
article O O
that O O
helps O O
reader O O
to O O
conclude O O
that O O
drug O O
in O O
fat O O
soluble O O
form O O
are O O
more O O
permeable S-Fn O
than O O
water O O
soluble O O
drug O O

physico O O
evaluation O O
of O O
the O O
root O O
of O O
kanoti S-Dg S-Dg
kanoti S-Dg S-Dg
linaria O S-Dg
ramosissima O O
wall O O
janch O S-Dg
from O O
the O O
family O O
scrophulariaceae O O
also O O
known O O
as O O
bhintgilodi S-Dg S-Dg
is O O
a O O
reputed O O
folklore O O
drug O O
the O O
plant O O
is O O
reported O O
for O O
its O O
antidiabetic S-Ds S-Ds
property O O
specially O O
root O O
is O O
used O O
in O O
the O O
management O O
of O O
snake B-Ds B-Ds
and O O
scorpion I-Ds B-Ds
bite E-Ds E-Ds
in O O
the O O
present O O
study O O
root O O
was O O
evaluated O O
following O O
the O O
standard O O
methods O O
for O O
physicochemical O O
parameters O O
flourescence O O
analysis O O
qualitative O O
tests O O
quantitative O O
estimation O O
of O O
alkaloid O O
saponin O O
and O O
hptlc O O
study O O
qualitative O O
tests O O
for O O
root O O
confirms O O
presence O O
of O O
alkaloids O O
glycosides O O
tannins O O
flavonoids O O
and O O
total O O
saponins O O
and O O
alkaloids O O
quantitatively O O
while O O
characteristic O O
colour O O
flourescence O O
in O O
different O O
solvents O O
with O O
different O O
wavelengths O O
was O O
observed O O
hptlc O O
profile O O
shows O O
spots O O
at O O
spots O O
at O O
and O O
spots O O
after O O
spraying O O
the O O
generated O O
information O O
of O O
the O O
present O O
study O O
will O O
provide O O
data O O
which O O
is O O
helpful O O
in O O
the O O
identification O O
and O O
authentification O O
of O O
the O O
drug O O
and O O
also O O
can O O
be O O
used O O
for O O
the O O
further O O
research O O

validation O O
of O O
pharmaceutical O O
parameters O O
for O O
swarna B-Dg B-Dg
shodhana E-Dg E-Dg
standardization O O
is O O
a O O
process O O
that O O
deals O O
with O O
set O O
up O O
of O O
specific O O
parameters O O
ancient O O
sages O O
of O O
rasashastra O O
have O O
made O O
some O O
standard O O
parameters O O
to O O
evaluate O O
the O O
reproducible O O
procedures O O
like O O
shodhana O O
marana O O
etc O O
swarna O B-Dg
bhasma O E-Dg
is O O
one O O
of O O
the O O
most O O
popular O O
medicines O O
of O O
ayurveda O O
and O O
it O O
should O O
be O O
prepared O O
by O O
following O O
shodhana O S-Dg
and O O
marana O O
procedures O O
in O O
however O O
these O O
are O O
variable O O
from O O
text O O
to O O
text O O
and O O
person O O
to O O
person O O
here O O
an O O
attempt O O
has O O
been O O
made O O
to O O
develop O O
and O O
validate O O
standard O O
manufacturing O O
procedure O O
for O O
swarna B-Dg B-Dg
samanya E-Dg E-Dg
general O O
and O O
vishesha B-Dg B-Dg
shodhana E-Dg E-Dg
specific O O
purificatory O O
procedures O O
maximum O O
temperature O O
of O O
kapota O B-Dg
puta O O
ranges O O
in O O
between O O
no O O
loss O O
of O O
weight O O
was O O
observed O O
in O O
gold O O
after O O
both O O
purification O O

care O O
in O O
ayurveda O O
with O O
special O O
reference O O
to O O
sutika B-Dg B-Dg
paricharya E-Dg E-Dg
ayurveda O O
elucidate O O
due O O
importance O O
for O O
the O O
care O O
of O O
mother O O
at O O
every O O
phase O O
of O O
her O O
life O O
especially O O
when O O
it O O
comes O O
to O O
antenatal S-Ds S-Ds
and O O
postnatal S-Ds S-Ds
care O O
post B-Ds O
natal E-Ds E-Ds
care O O
is O O
a O O
period O O
following O O
child O O
birth O O
which O O
can O O
be O O
certainly O O
with O O
sutika B-Dg B-Dg
paricharya E-Dg E-Dg
explained O O
in O O
ayurveda O O
in O O
this O O
stage O O
mother O O
should O O
be O O
educated O O
to O O
take O O
care O O
of O O
herself O O
and O O
the O O
new O O
born O O
baby O O
after O O
delivery O O
woman O O
becomes O O
weedy O O
also O O
empty O O
bodied O O
due O O
to O O
physical B-Ds O
and O O
mental I-Ds B-Ds
stress E-Ds E-Ds
and O O
debility S-Ds S-Ds
at O O
the O O
level O O
of O O
reproductive O O
organs O O
it O O
is O O
essential O O
for O O
a O O
this O O
paper O O
highlights O O
on O O
various O O
major O O
components O O
of O O
sutika B-Dg B-Dg
paricharya E-Dg E-Dg
such O O
as O O
ashwasana S-Dg S-Dg
vihara S-Dg S-Dg
and O O
aahara S-Dg S-Dg
normal O O
diet O O
in O O
puerperium O O
etc O O
ayurveda O O
prescribes O O
numerous O O
herbs O O
to O O
establish O O
healthy O O
status O O
of O O
the O O
woman O O
after O O
delivery O O

therapeutic S-Fn O
importance O O
eranda S-Dg S-Dg
in O O
ayurveda O O
a O O
review O O
ayurveda O O
delinates O O
the O O
use O O
eranda S-Dg S-Dg
for O O
the O O
management O O
different O O
conditions O O
in O O
classical O O
texts O O
in O O
this O O
article O O
an O O
attempt O O
has O O
been O O
made O O
to O O
compile O O
as O O
critically O O
and O O
its O O
informations O O
related O O
to O O
eranda S-Dg S-Dg
from O O
six O O
samhitas O O
seven O O
samgraha O O
granthas O O
nine O O
nighantus O O
and O O
seven O O
other O O
published O O
texts O O
it O O
is O O
observed O O
that O O
root O O
root O O
bark O O
leaves O O
seed O O
oil O O
of O O
eranda S-Dg S-Dg
are O O
used O O
as O O
an O O
ingredient O O
in O O
formulations O O
which O O
are O O
effective O O
in O O
more O O
than O O
conditions O O
the O O
main O O
indications O O
include O O
vatavyadhi S-Ds S-Ds
of O O
aamavata S-Ds S-Ds
vrana S-Ds S-Ds
agnimandya S-Ds S-Ds
of O O
jvara S-Ds S-Ds
grahani S-Ds S-Ds
shiroroga S-Ds S-Ds
disease O O
of O O
shotha S-Ds S-Ds
gandamala S-Ds S-Ds
hikka S-Ds S-Ds
kushtha S-Ds S-Ds
disease O S-Ds
visarpa S-Ds S-Ds
arsha S-Ds S-Ds
etc O O
different O O
parts O O
of O O
eranda S-Dg S-Dg
are O O
used O O
in O O
about O O
dosage O O
forms O O
such O O
as O O
svarasa O O
kvatha O O
decoction O O
lepa O O
paste O O
varti O O
suppository O O
avaleha O O
preparations O O
taila O O
oil O O
rasa O O
mineral O O
preparation O O
rasakriya O O
water O O
extract O O
vati O O
pills O O
kshara O O
alkaline O O
preparations O O
modaka O O
solid O O
dosage O O
form O O
ghrita O O
fat O O
soluble O O
preparations O O
churna O E-Dg
powder O O
dhupa O O
fumigating O O
preparation O O
nasya O O
nasal O O
preparations O O
and O O
aschyotana O O
eye O O
drops O O

pharmacognostic O O
evaluation O O
of O O
stem O O
and O O
root O O
of O O
rivea O O
hypocrateriformis O O
choisy O O
rivea O O
hypocrateriformis O O
choisy O O
convolvulaceae O O
a O O
less O O
silky O O
pubescent O O
climber O O
popular O O
as O O
phang S-Dg S-Dg
or O O
phanji S-Dg S-Dg
in O O
odisha O O
and O O
gujarat O S-Dg
is O O
being O O
consumed O O
as O O
a O O
leafy O O
vegetable O O
and O O
reported O O
for O O
antiimplantation S-Ds S-Ds
antioxidant S-Ds S-Ds
and O O
hepatoprotective S-Ds S-Ds
and O O
anti B-Ds B-Ds
inflammatory E-Ds E-Ds
activities O O
its O O
stem O O
and O O
root O O
were O O
studied O O
for O O
their O O
macroscopic O O
microscopic O O
including O O
powder O O
characters O O
and O O
histochemical O O
tests O O
following O O
standard O O
procedures O O
results O O
showed O O
septate O O
fibers O O
annular O O
border O O
pitted O O
vessels O O
tannin O O
rosette O O
crystals O O
of O O
calcium O O
oxalate O O
and O O
some O O
simple O O
and O O
compound O O
starch O O
grains O O
etc O O
in O O
stem O O
root O O
shows O O
the O O
presence O O
of O O
schlerides O O
pitted O O
stone O O
cells O O
border O O
pitted O O
vessels O O
tannin O O
oil O O
globules O O
rosette O O
crystals O O
of O O
calcium O O
oxalate O O
and O O
some O O
simple O O
and O O
compound O O
starch O O
grains O O

ahara O O
kalpana O O
in O O
charaka O O
samhita O O
a O O
critical O O
review O O
charaka O O
samhita O O
has O O
been O O
considered O O
as O O
the O O
most O O
important O O
classical O O
text O O
for O O
treatment O O
in O O
ayurveda O O
it O O
is O O
in O O
use O O
since O O
for O O
pursuing O O
health O O
among O O
india O O
and O O
worldwide O O
it O O
has O O
narrated O O
many O O
important O O
principles O O
regarding O O
diet O O
ahara O O
kalpana O O
is O O
a O O
unique O O
concept O O
of O O
ayurveda O O
one O O
can O O
alter O O
the O O
properties O O
of O O
a O O
dravya O O
with O O
the O O
help O O
of O O
kalpana O O
this O O
is O O
a O O
very O O
important O O
feature O O
for O O
the O O
ayurvedic O O
science O O
acharya O O
charaka O O
has O O
described O O
ahara O O
kalpana O O
for O O
fulfilling O O
both O O
the O O
aims O O
of O O
ayurveda O O
for O O
swashtha O O
healthy O O
as O O
well O O
as O O
for O O
atura O O
patient O O
ahara O O
kalpana O O
is O O
an O O
important O O
factor O O
in O O
the O O
field O O
of O O
prevention O O
of O O
health O O
where O O
different O O
dravyas O O
are O O
used O O
for O O
maintaining O O
and O O
sustain O O
the O O
living O O
body O O
in O O
therapeutics O O
also O O
many O O
ahara O O
kalpanas O O
are O O
described O O
as O O
vehicle O O
for O O
shodhana O S-Dg
and O O
shamana O O
drugs O O
concept O O
of O O
ahara O O
kalpana O O
is O O
more O O
important O O
to O O
achieve O O
the O O
status O O
of O O
complete O O
health O O
which O O
is O O
said O O
as O O
prakritisthapana O O
establishment O O
of O O
original O O
health O O
status O O
by O O
acharya O O
charaka O O
approximately O O
ahara O O
kalpanas O O
have O O
been O O
described O O
in O O
charaka O O
samhita O O
study O O
of O O
ahara O B-Dg
kalpana O O
in O O
charaka O O
samhita O O
with O O
its O O
placement O O
related O O
to O O
particular O O
adhyaya O S-Dg
and O O
sthana O O
gives O O
a O O
clue O O
in O O
understanding O O
mode O O
of O O
action O O
for O O
ahara O O
kalpana O O
this O O
particular O O
study O O
deals O O
with O O
compilation O O
and O O
classification O O
of O O
ahara O S-Dg
kalpanas O O
of O O
charaka O B-Dg
samhita O E-Dg

development O O
and O O
validation O O
of O O
spectrophotophotometric O O
method O O
for O O
analysis O O
of O O
fulvic O O
acid O O
a O O
decomposition O O
product O O
in O O
shilajith S-Dg S-Dg
fulvic O O
acid O O
is O O
one O O
of O O
the O O
decomposition O O
products O O
of O O
humified O O
material O O
humic O O
acid O O
fulvic O O
acid O O
lignin O O
are O O
the O O
most O O
common O O
products O O
of O O
soil O O
humification O O
the O O
present O O
study O O
was O O
aim O O
to O O
develop O O
a O O
method O O
for O O
determining O O
the O O
purity O O
index O O
of O O
shilajith S-Dg S-Dg
containing O O
fulvic O O
acid O O
the O O
sample O O
extracts O O
were O O
prepared O O
and O O
absorbance O O
was O O
taken O O
at O O
four O O
different O O
wavelengths O O
and O O
from O O
the O O
obtained O O
absorbance O O
results O O
ratio O O
was O O
calculated O O
where O O
shows O O
strongly O O
humified O O
material O O
humification O O
index O O
and O O
proportion O O
between O O
lignin O O
and O O
other O O
material O O
respectively O O
the O O
humification O O
index O O
indicates O O
the O O
presence O O
of O O
fulvic O O
acid O O
the O O
result O O
shows O O
good O O
proportion O O
of O O
fulvic O O
acid O O
in O O
the O O
sample O O
when O O
compared O O
with O O
standard O O
fulvic O O
acid O O
the O O
method O O
can O O
be O O
used O O
to O O
analyze O O
the O O
quality O O
of O O
shilajith S-Dg S-Dg
in O O
context O O
of O O
fulvic O O
acid O O

adharaniya O O
vega O O
inimitable O O
concept O O
in O O
extent O O
of O O
disease O O
manifestation O O
and O O
treatment O O
human O O
body O O
is O O
an O O
amazing O O
machine O O
which O O
has O O
a O O
number O O
of O O
ways O O
to O O
balance O O
the O O
substance O O
which O O
could O O
be O O
useful O O
and O O
harmful O O
to O O
the O O
body O O
to O O
make O O
balance O O
of O O
these O O
substances O O
our O O
body O O
is O O
equipped O O
with O O
vega O O
which O O
appears O O
naturally O O
according O O
to O O
the O O
ancient O O
ayurvedic O O
texts O O
there O O
is O O
one O O
main O O
cause O O
of O O
all O O
type O O
of O O
diseases O O
and O O
that O O
is O O
the O O
suppression O O
of O O
natural O O
vega O O
therefore O O
it O O
should O O
not O O
to O O
be O O
suppressed O O
but O O
still O O
some O O
people O O
use O O
to O O
suppress O O
the O O
vegas O O
ayurveda O O
has O O
described O O
natural O O
vegas O O
which O O
should O O
not O O
be O O
retained O O
at O O
any O O
cost O O
if O O
they O O
are O O
suppressed O O
on O O
a O O
regular O O
basis O O
due O O
to O O
any O O
reason O O
they O O
can O O
lead O O
to O O
various O O
health O O
problems O O
the O O
problem O O
created O O
due O O
to O O
suppressible O O
urges O O
are O O
getting O O
more O O
and O O
more O O
now O O
a O O
day O O
therefore O O
this O O
review O O
article O O
attempts O O
to O O
explain O O
adharaniya O B-Dg
vega O E-Dg
in O O
details O O
as O O
mentioned O O
in O O
ayurvedic O O
literature O O
and O O
also O O
enlists O O
over O O
all O O
hazardous O O
effects O O
on O O
human O O
health O O
and O O
their O O
management O O

concept O O
of O O
jara S-Ds S-Ds
its O O
management O O
in O O
ayurveda O O
the O O
increasing O O
number O O
of O O
the O O
aged O O
in O O
the O O
present O O
scenario O O
signifies O O
a O O
new O O
outlook O O
for O O
our O O
reflection O O
populations O O
worldwide O O
are O O
improvements O O
in O O
environmental O O
and O O
behavioral O O
factors O O
the O O
treatment O O
and O O
prevention O O
of O O
infectious O O
diseases O O
are O O
largely O O
responsible O O
for O O
the O O
increase O O
in O O
life O O
expectancy O O
since O O
is O O
emerging O O
as O O
a O O
main O O
challenging O O
specialty O O
because O O
of O O
ever O O
growing O O
population O O
of O O
aged O O
people O O
all O O
over O O
the O O
world O O
including O O
india O O
in O O
present O O
era O O
medical O O
science O O
deals O O
exclusively O O
with O O
the O O
problem O O
of O O
ageing O S-Ds
and O O
the O O
diseases O O
of O O
the O O
elderly O O
ayurveda O O
is O O
basically O O
the O O
science O O
of O O
life O O
and O O
longevity O O
it O O
presents O O
a O O
good O O
concept O O
of O O
ageing O O
process O O
of O O
delaying O O
the O O
ageingand O O
its O O
management O O
according O O
to O O
the O O
ayurveda O O
ageing O O
is O O
outcome O O
of O O
kalaor O S-Ds
parinama O S-Ds
and O O
describedunder O O
those O O
diseases O O
which O O
produced O O
by O O
the O O
strength O O
of O O
nature O O
such O O
as O O
kshudha S-Ds S-Ds
pipasa S-Ds S-Ds
jara S-Ds S-Ds
ageing S-Ds S-Ds
mrityu S-Ds S-Ds
nidra S-Ds S-Ds
sleep S-Ds S-Ds
etc O O
vatadosha S-Ds S-Ds
the O O
most O O
important O O
factor O O
in O O
the O O
of O O
ageing O O
obviously O O
because O O
of O O
its O O
natural O O
predominance O O
at O O
that O O
stage O O
of O O
life O O
ayurveda O O
advocates O O
an O O
excellent O O
approach O O
for O O
promotion O O
of O O
health O O
and O O
prevention O O
of O O
diseases O O
with O O
number O O
of O O
measures O O
like O O
wholesome O O
diet O O
in O O
proper O O
quantity O O
dincharya S-Dg S-Dg
daily O O
regimen O O
ratricharya S-Dg S-Dg
night O O
regimen O O
ritucharya S-Dg S-Dg
seasonal O O
regimen O O
sadvrittapalan S-Dg S-Dg
behavioral O O
and O O
ethical O O
considerations O O
achara B-Dg B-Dg
rasayana E-Dg E-Dg
rejuvenative O O
healthy O O
dharaniya S-Dg S-Dg
and O O
adharaniyavegas S-Dg S-Dg
suppressible O O
and O O
urges O O
practices O O
of O O
yoga O B-Dg
rasayana S-Dg E-Dg
therapy O O
rejuvenative O O
therapy O O
time O O
to O O
time O O
panchkarma O O
and O O
some O O
herbal O O
drugs O O
the O O
proper O O
practice O O
of O O
these O O
all O O
measures O O
can O O
slow O O
down O O
the O O
process O O
of O O
ageing S-Ds S-Ds
and O O
cure O O
the O O
diseases O O
of O O
ageing S-Ds S-Ds

basti S-Dg S-Dg
an O O
alternative O O
in O O
prevention O O
and O O
management O O
of O O
diabetes S-Ds B-Ds
basti S-Dg E-Dg
is O O
a O O
unique O O
therapy O O
of O O
ayurveda O O
that O O
has O O
wide O O
clinical O O
spectrum O O
its O O
use O O
in O O
metabolic B-Ds B-Ds
disorders E-Ds E-Ds
is O O
being O O
highly O O
recognized O O
in O O
recent O O
days O O
diabetes S-Ds S-Ds
is O O
one O O
such O O
condition O O
that O O
can O O
be O O
managed O O
but O O
it O O
is O O
difficult O O
to O O
control O O
the O O
prognosis O O
with O O
conventional O O
diabetes S-Ds S-Ds
care O O
human O O
gut O E-Ds
is O O
an O O
interesting O O
functional O O
unit O O
that O O
has O O
wide O O
effect O O
on O O
bodily O O
metabolism O O
bacterial O O
extracts O O
of O O
intestinal O B-Ds
microbial O O
flora O O
such O O
as O O
the O O
lipopolysaccharides O O
control O O
the O O
tone O O
of O O
the O O
innate O O
immune O O
system O O
thus O O
regulating O O
the O O
general O O
inflammatory O O
status O O
insulin O O
resistance O O
and O O
adipose O O
tissue O O
plasticity O O
therefore O O
strategies O O
aimed O O
at O O
controlling O O
the O O
ecological O O
mutualism O O
between O O
intestinal O O
microbial O O
flora O O
and O O
the O O
host O O
should O O
lead O O
to O O
a O O
new O O
era O O
of O O
therapeutic O O
and O O
health O O
benefits O O
moreover O O
colon O O
and O O
rectum O O
play O O
a O O
vital O O
role O O
in O O
drug O O
absorption O O
autointoxication O O
and O O
acts O O
on O O
different O O
organs O O
through O O
enteric O O
nervous O O
system O O
this O O
study O O
focuses O O
on O O
action O O
of O O
basti S-Dg S-Dg
in O O
diabetes S-Ds S-Ds
that O O
is O O
evident O O
through O O
the O O
multiple O O
actions O O
like O O
colon O O
cleansing O O
nourishment O O
of O O
microbial O O
flora O O
action O O
through O O
enteric O O
nervous O O
system O O
and O O
improving O O
absorption O O
of O O
drugs O O
etc O O
all O O
these O O
effects O O
on O O
the O O
whole O O
make O O
basti S-Dg S-Dg
an O O
alternative O O
in O O
prevention O O
and O O
management O O
of O O
diabetes S-Ds S-Ds

in O O
vitro O O
antibacterial S-Ds S-Ds
activity O O
of O O
chitrakadi B-Dg B-Dg
vati E-Dg E-Dg
against O O
coli O O
present O O
study O O
was O O
carried O O
out O O
with O O
an O O
objective O O
to O O
investigate O O
the O O
antibacterial S-Ds S-Ds
potentials O O
of O O
chitrakadi B-Dg B-Dg
vati E-Dg E-Dg
a O O
ayurvedic O O
formulation O O
the O O
aim O O
of O O
the O O
study O O
was O O
to O O
assess O O
the O O
antibacterial S-Ds S-Ds
activity O O
and O O
to O O
determine O O
the O O
zone O O
of O O
inhibition O O
of O O
methanol O O
extracts O O
of O O
it O O
for O O
this O O
its O O
methanol O O
extracts O O
were O O
evaluated O O
against O O
medically O O
important O O
bacterial O O
strain O O
using O O
agar O O
cup O O
diffusion O O
method O O
the O O
antibacterial S-Ds S-Ds
activities O O
of O O
extracts O O
of O O
chitrakadi B-Dg B-Dg
vati E-Dg E-Dg
in O O
concentrations O O
were O O
tested O O
against O O
the O O
gram O O
negative O O
escherichia O O
coli O O
human O O
pathogenic O O
bacteria O O
occurring O O
commonly O O
in O O
intestines O O
zone O O
of O O
inhibition O O
of O O
extracts O O
were O O
compared O O
with O O
that O O
of O O
standards O O
of O O
different O O
generations O O
like O O
ampicillin O O
chloramphenicol O O
ciprofloxacin O O
and O O
norfloxacin O O
for O O
antibacterial S-Ds S-Ds
activity O O
the O O
results O O
showed O O
that O O
the O O
remarkable O O
inhibition O O
of O O
the O O
bacterial O O
growth O O
was O O
shown O O
by O O
chitrakadi B-Dg B-Dg
vati E-Dg E-Dg
against O O
the O O
tested O O
organism O O
the O O
antibacterial S-Ds S-Ds
potential O O
of O O
the O O
extracts O O
were O O
found O O
to O O
be O O
dose O O
dependent O O
the O O
total O O
microbial O O
count O O
of O O
the O O
drug O O
was O O
also O O
found O O
within O O
permissible O O
limits O O
the O O
phytochemical O O
analyses O O
of O O
the O O
drug O O
were O O
carried O O
out O O
the O O
antibacterial S-Ds S-Ds
activity O O
of O O
the O O
chitrakadi B-Dg B-Dg
vati E-Dg E-Dg
was O O
due O O
to O O
the O O
presence O O
of O O
various O O
secondary O O
metabolites O O
the O O
study O O
justifies O O
the O O
traditional O O
use O O
of O O
chitrakadi B-Dg B-Dg
vati E-Dg E-Dg
in O O
most O O
of O O
the O O
disorders O O

a O O
clinical O O
study O O
to O O
evaluate O O
the O O
role O O
of O O
shivagutika S-Dg S-Dg
in O O
cystic B-Ds B-Ds
ovarian I-Ds I-Ds
disease E-Ds E-Ds
the O O
human O O
ovary O O
has O O
a O O
striking O O
propensity O O
to O O
develop O O
a O O
wide O O
variety O O
of O O
tumors S-Ds O
the O O
majority O O
of O O
which O O
are O O
benign O O
symptoms O O
like O O
pain S-Ds S-Ds
abdomen O B-Ds
per O O
vaginal B-Ds B-Ds
discharge E-Ds E-Ds
dysmenorrhea S-Ds S-Ds
dyspareunia S-Ds S-Ds
and O O
tenderness S-Ds S-Ds
in O O
fornices S-Ds S-Ds
are O O
common O O
in O O
the O O
different O O
varieties O O
of O O
ovarian B-Ds B-Ds
cysts E-Ds E-Ds
the O O
concept O O
of O O
arbuda O O
and O O
granthi O O
in O O
ayurveda O O
mimics O O
this O O
condition O O
this O O
article O O
reviews O O
the O O
clinical O O
effect O O
of O O
an O O
ayurvedic O O
formulation O O
shivagutika S-Dg S-Dg
on O O
certain O O
symptoms O O
of O O
cystic B-Ds B-Ds
ovaries E-Ds E-Ds
through O O
clinical O O
trials O O
with O O
an O O
intention O O
to O O
maximize O O
its O O
clinical O O
effectiveness O O
and O O
hasten O O
its O O
integration O O
into O O
wider O O
clinical O O
practice O O
shivagutika S-Dg S-Dg
was O O
purchased O O
from O O
nanjangud O B-Dg
sadwidyashala O E-Dg
mysore O O
karnataka O O
it O O
was O O
administered O O
twice O O
daily O O
with O O
honey O O
after O O
food O O
intake O O
for O O
sixty O O
days O O
the O O
signs O O
and O O
symptoms O O
and O O
the O O
size O O
of O O
the O O
cyst O O
in O O
cystic B-Ds B-Ds
ovaries E-Ds E-Ds
were O O
graded O O
before O O
and O O
during O O
the O O
course O O
of O O
treatment O O
in O O
most O O
of O O
the O O
cases O O
there O O
was O O
a O O
progressive O O
reduction O O
in O O
the O O
symptoms O O
and O O
size O O
of O O
the O O
cyst O O
as O O
evident O O
in O O
the O O
usg O O
with O O
time O O
indicating O O
the O O
efficacy O O
of O O
the O O
formulation O O
in O O
cystic B-Ds B-Ds
ovaries E-Ds E-Ds

a O O
clinical O O
study O O
to O O
evaluate O O
the O O
efficacy O O
of O O
chandrakala B-Dg B-Dg
ras E-Dg E-Dg
on O O
madhumeha S-Ds S-Ds
this O O
disease O O
madhumeha S-Ds S-Ds
is O O
a O O
well O O
known O O
since O O
the O O
vedic O O
period O O
madhumeha S-Ds O
is O O
one O O
of O O
the O O
major O O
killers O O
of O O
the O O
modern O O
world O O
it O O
is O O
a O O
disorder O O
which O O
is O O
sharing O O
neither O O
the O O
developing O O
nor O O
the O O
developed O O
nation O O
irregular O O
food O O
habits O O
lack O O
of O O
exercise O O
stress O O
and O O
strains O O
are O O
some O O
causative O O
factors O O
madhumeha S-Ds S-Ds
leads O O
to O O
be O O
a O O
cause O O
for O O
blindness S-Ds S-Ds
renal B-Ds B-Ds
failure E-Ds E-Ds
if O O
it O O
is O O
not O O
controlled O O
in O O
spite O O
of O O
many O O
advances O O
in O O
modern O O
medicine O O
the O O
management O O
of O O
madhumeha S-Ds S-Ds
still O O
remains O O
unsatisfactory O O
madhumeha S-Ds O
may O O
be O O
compared O O
with O O
diabetes B-Ds B-Ds
mellitus E-Ds E-Ds
according O O
to O O
modern O O
medical O O
science O O
the O O
term O O
diabetes S-Ds S-Ds
has O O
much O O
similarity O O
to O O
prameha O O
which O O
is O O
described O O
in O O
ayurveda O O
a O O
type O O
of O O
prameha O O
which O O
is O O
caused O O
by O O
kapha O O
prakopa O O
is O O
called O O
as O O
madhumeha S-Ds S-Ds
a O O
study O O
was O O
done O O
on O O
patients O O
of O O
madhumeha S-Ds S-Ds
for O O
the O O
period O O
of O O
one O O
month O O
and O O
dose O O
chandra B-Dg B-Dg
kala I-Dg I-Dg
ras E-Dg E-Dg
twice O O
a O O
day O O
sign O O
and O O
symptoms O O
were O O
noted O O
and O O
blood O O
examinations O O
were O O
done O O
before O O
and O O
after O O
treatment O O
on O O
the O O
basis O O
of O O
the O O
result O O
observed O O
it O O
may O O
be O O
concluded O O
that O O
the O O
chandra B-Dg B-Dg
kala I-Dg I-Dg
ras E-Dg E-Dg
is O O
having O O
significant O O
effect O O
in O O
ameliorating O O
the O O
disease O O
madhumeha S-Ds S-Ds

pharmaceutical O O
standardization O O
of O O
herbal O O
lozenges O O
vasa S-Dg S-Dg
candy O O
development O O
of O O
new O O
dosage O O
forms O O
without O O
disturbing O O
the O O
basic O O
principles O O
of O O
ayurveda O O
is O O
a O O
need O O
for O O
the O O
global O O
acceptance O O
vasa B-Dg B-Dg
avaleha E-Dg E-Dg
prepared O O
from O O
vasa S-Dg S-Dg
and O O
pippali S-Dg S-Dg
is O O
a O O
well O O
known O O
ayurvedic O O
preparation O O
mentioned O O
in O O
bhavprakasha O B-Dg
avaleha O E-Dg
form O O
has O O
few O O
difficulties O O
in O O
the O O
pharmaceutical O O
processing O O
such O O
as O O
shelf O O
life O O
problems O O
in O O
transportation O O
unit O O
doses O O
administration O O
difficulties O O
etc O O
to O O
overcome O O
these O O
problems O O
and O O
to O O
prepare O O
superior O O
dosage O O
form O O
in O O
present O O
work O O
attempt O O
has O O
been O O
made O O
to O O
develop O O
new O O
dosage O O
form O O
of O O
vasa B-Dg B-Dg
avaleha E-Dg E-Dg
by O O
preparing O O
vasa S-Dg B-Dg
candy O O
aim O O
of O O
the O O
study O O
is O O
to O O
develop O O
new O O
dosage O O
form O O
of O O
vasa B-Dg B-Dg
avaleha E-Dg E-Dg
into O O
candy O O
dosage O O
form O O
and O O
their O O
pharmaceutical O O
standardization O O
three O O
batch O O
of O O
vasa O S-Dg
candy O O
were O O
prepared O O
by O O
using O O
ghana S-Dg S-Dg
of O O
vasa B-Dg B-Dg
kwatha E-Dg E-Dg
leaf O O
solid O O
extract O O
obtained O O
from O O
decoction O O
of O O
adhatoda O B-Dg
vasica O E-Dg
nees O O
and O O
pipalli B-Dg B-Dg
churna E-Dg E-Dg
considering O O
the O O
inconveniencies O O
the O O
formulation O O
composition O O
has O O
been O O
converted O O
into O O
vasa S-Dg S-Dg
candy O O
during O O
developing O O
medicament O O
different O O
concentration O O
in O O
powder O O
form O O
in O O
semisolid O O
form O O
and O O
liquid O O
form O O
were O O
used O O
analytical O O
study O O
was O O
also O O
done O O
to O O
develop O O
the O O
analytical O O
profile O O
vasa S-Dg S-Dg
candy O O
is O O
more O O
stable O O
palatable O O
dosage O O
form O O
superior O O
for O O
commercial O O
purpose O O
and O O
can O O
be O O
administered O O
at O O
fixed O O
unit O O
dose O O
total O O
candies O O
can O O
be O O
prepared O O
from O O
weight O O
of O O
thick O O
mass O O
containing O O
vasa B-Dg B-Dg
ghana E-Dg E-Dg
pippali S-Dg E-Dg
powder O O
sugar O O
and O O
glucose O O
in O O
the O O
ratio O O
respectively O O
with O O
average O O
weight O O
of O O
each O O
candy O O

pharmacognostical O O
and O O
physicochemical O O
analysis O O
of O O
drakshadi B-Dg B-Dg
ghrita E-Dg E-Dg
an O O
ayurvedic O O
polyherbal O O
formulation O O
drakshadi B-Dg B-Dg
ghrita E-Dg E-Dg
is O O
a O O
polyherbal O O
formulation O O
indicated O O
especially O O
in O O
eye B-Ds B-Ds
disorders E-Ds E-Ds
based O O
on O O
its O O
pharmacological O O
properties O O
it O O
is O O
used O O
successfully O O
in O O
treatment O O
of O O
dry B-Ds B-Ds
eye I-Ds I-Ds
syndrome E-Ds E-Ds
present O O
study O O
deals O O
with O O
the O O
pharmacognostical O O
identification O O
of O O
ingredients O O
of O O
drakshadi B-Dg B-Dg
ghrita E-Dg E-Dg
and O O
its O O
analysis O O
pharmacognostical O O
study O O
containing O O
both O O
macroscopic O O
and O O
powder O O
microscopy O O
of O O
raw O O
drug O O
revealed O O
the O O
quality O O
and O O
genuineness O O
of O O
all O O
the O O
constituents O O
of O O
drakshadi B-Dg B-Dg
ghrita E-Dg E-Dg
organoleptic O E-Dg
features O O
of O O
coarse O O
powder O O
made O O
out O O
of O O
the O O
crude O O
drugs O O
were O O
within O O
the O O
standards O O
prescribed O O
specific O O
gravity O O
of O O
drakshadi B-Dg B-Dg
ghrita E-Dg E-Dg
was O O
found O O
to O O
be O O
acid O O
value O O
refractive O O
index O O
at O O
room O O
temperature O O
iodine O O
value O O
and O O
saponification O O
value O O
was O O

research O O
works O O
done O O
on O O
rasasindura S-Dg S-Dg
a O O
critical O O
review O O
rasasindura S-Dg S-Dg
sublimated O O
mercurial O O
preparation O O
often O O
used O O
in O O
diseases O O
like O O
madhumeha S-Ds S-Ds
rajayaksma S-Ds S-Ds
pandu S-Ds S-Ds
sthoulya S-Ds S-Ds
mandagni S-Ds S-Ds
impaired B-Ds B-Ds
digestive I-Ds B-Ds
fire E-Ds E-Ds
etc O O
mercurial O O
preparations O O
are O O
constantly O O
targeted O O
due O O
to O O
lack O O
of O O
documentation O O
and O O
published O O
works O O
till O O
date O O
several O O
research O O
works O O
have O O
been O O
carried O O
out O O
at O O
institutional O O
level O O
on O O
aim O O
of O O
the O O
present O O
work O O
is O O
to O O
compile O O
such O O
research O O
works O O
done O O
on O O
in O O
department O O
of O O
rasashastra O S-Dg
and O O
bhaishajya O B-Dg
kalpana O E-Dg
institute O O
for O O
post O O
graduate O O
teaching O O
and O O
research O O
in O O
ayurveda O O
jamnagar O O
various O O
pharmaceutical O O
experiments O O
revealed O O
yield O O
of O O
ranging O O
from O O
to O O
and O O
was O O
prepared O O
in O O
hrs O O
to O O
hrs O O
is O O
hgs O O
hexagonal O O
cinnabar O O
with O O
percentage O O
of O O
mercury O O
ranging O O
from O O
safety O O
of O O
was O O
established O O
through O O
acute O O
and O O
toxicity O O
studies O O
efficacy O O
of O O
was O O
studied O O
in O O
diseases O O
like O O
shukra B-Ds B-Ds
kshaya E-Ds E-Ds
infertility S-Ds S-Ds
shwasa S-Dg S-Ds
bronchial B-Ds B-Ds
asthma E-Ds E-Ds
madhumeha S-Ds S-Ds
diabetes B-Ds B-Ds
mellitus E-Ds E-Ds
kshudra B-Ds B-Ds
kushta E-Ds E-Ds
skin B-Ds B-Ds
diseases E-Ds E-Ds
shwitra S-Ds S-Ds
leucoderma S-Ds S-Ds
hypertention S-Ds S-Ds
etc O O
in O O
all O O
the O O
studies O O
encouraging O O
results O O
were O O
reported O O
with O O
decrease O O
in O O
signs O O
and O O
symptoms O O
augmenting O O
effect O O
of O O
was O O
established O O
by O O
clinical O O
studies O O

a O O
case O O
report O O
of O O
acute B-Ds B-Ds
lymphoblastic I-Ds B-Ds
leukemia E-Ds E-Ds
an O O
ayurvedic O O
approach O O
leukemia S-Ds S-Ds
is O O
the O O
most O O
common O O
cancer S-Ds O
accounting O O
for O O
all O O
childhood O B-Ds
cancers O E-Ds
in O O
children O O
cancer S-Ds O
in O O
children O O
attracts O O
more O O
attention O O
due O O
to O O
high O O
cost O O
of O O
treatment O O
and O O
emotional O O
psychological O O
trauma O O
to O O
the O O
family O O
leukemic O O
cells O O
rapidly O O
accumulate O O
in O O
the O O
bone O O
marrow O O
cavity O O
replacing O O
most O O
of O O
normal O O
haemopoetic O O
cells O O
resulting O O
in O O
signs O O
and O O
symptoms O O
of O O
disease O O
the O O
rationale O O
for O O
using O O
ayurvedic O O
medicines O O
is O O
to O O
restore O O
homeostasis O O
and O O
reverse O O
the O O
proliferation O O
of O O
neoplastic O O
cells O O
in O O
the O O
bone O O
marrow O O
patient O O
of O O
years O O
old O O
was O O
treated O O
with O O
an O O
ayurvedic O O
formulation O O
and O O
majjabasti S-Dg S-Dg
to O O
get O O
the O O
bone O O
marrow O O
transplant O O
effect O O
the O O
patient O O
got O O
significant O O
result O O
with O O
the O O
help O O
of O O
ayurvedic O O
medicines O O

immunomodulatory B-Fn S-Ds
activity E-Fn O
of O O
vyaghriharitaki B-Dg B-Dg
avaleha E-Dg E-Dg
on O O
humoral O O
formation O O
the O O
aim O O
of O O
the O O
study O O
was O O
to O O
find O O
out O O
the O O
immunomodulatory B-Fn O
effect E-Fn O
on O O
humoral O O
formation O O
of O O
vyaghriharitaki B-Dg B-Dg
avaleha E-Dg E-Dg
standard O O
procedure O O
of O O
doherty O O
was O O
followed O O
wister O O
strain O O
albino O O
rats O O
of O O
either O O
sex O O
weighing O O
between O O
were O O
selected O O
and O O
divided O O
into O O
groups O O
first O O
group O O
received O O
tap O O
water O O
serving O O
as O O
the O O
normal O O
control O O
second O O
group O O
was O O
the O O
srbc O O
control O O
group O O
calculated O O
doses O O
of O O
the O O
sample O O
vyaghriharitaki B-Dg B-Dg
avaleha E-Dg E-Dg
was O O
administered O O
to O O
third O O
group O O
results O O
showed O O
vyaghriharitaki B-Dg B-Dg
avaleha E-Dg E-Dg
is O O
having O O
good O O
immunostimulant B-Fn O
activity E-Fn O

mantra O O
divine B-Fn O
remedial E-Fn O
in O O
ayurveda O O
ayurveda O O
is O O
a O O
complete O O
way O O
of O O
life O O
and O O
this O O
system O O
improves O O
not O O
only O O
a O O
person O O
s O O
health O O
but O O
also O O
their O O
well O O
being O O
behavior O O
and O O
state O O
of O O
mind O O
it O O
is O O
and O O
free O O
from O O
harmful O O
and O O
treats O O
the O O
root O O
cause O O
of O O
a O O
disease O O
rather O O
than O O
just O O
the O O
symptoms O O
as O O
per O O
its O O
views O O
illness O O
areas O O
caused O O
by O O
an O O
imbalance O O
in O O
a O O
person O O
s O O
physical O O
or O O
mental O O
constitution O O
and O O
therefore O O
it O O
gently O O
bring O O
a O O
person O O
s O O
body O O
and O O
mind O O
back O O
into O O
a O O
healthy O O
balance O O
ayurveda O O
can O O
be O O
used O O
to O O
alleviate O O
various O O
conditions O O
it O O
is O O
based O O
on O O
the O O
principles O O
of O O
preventing O O
disorders O O
in O O
the O O
long O O
term O O
rather O O
than O O
waiting O O
for O O
problems O O
to O O
manifest O O
themselves O O
thus O O
it O O
is O O
the O O
ideal O O
way O O
for O O
healthy O O
individuals O O
to O O
maintain O O
good O O
health O O
and O O
general O O
well O O
being O O
in O O
ayurveda O O
apart O O
from O O
herbal O O
remedies O O
for O O
diseases O O
a O O
daivavyapashrayya S-Dg S-Dg
treatment O O
practices O O
is O O
one O O
of O O
the O O
important O O
management O O
measures O O
mantra O O
recitation O O
is O O
the O O
part O O
of O O
it O O
which O O
is O O
cited O O
to O O
enhance O O
the O O
healing O O
it O O
is O O
equally O O
applicable O O
in O O
preventive B-Fn O
and O O
therapeutic I-Fn O
aspects E-Fn O
the O O
rationale O O
of O O
this O O
endeavor O O
is O O
to O O
search O O
and O O
comprehend O O
the O O
basic O O
principles O O
at O O
the O O
rear O O
of O O
mantra O O
therapy O O
though O O
this O O
therapy O O
is O O
not O O
practiced O O
routinely O O
it O O
is O O
a O O
potential O O
area O O
of O O
ayurveda O O
which O O
can O O
be O O
applied O O
so O O
it O O
is O O
a O O
need O O
of O O
hour O O
to O O
explore O O
the O O
fundamental O O
principles O O
of O O
mantra O O
chanting O O

leucorrhoea S-Ds S-Ds
in O O
ayurvedic O O
literature O O
a O O
review O O
leucorrhoea S-Ds S-Ds
the O O
unusual B-Ds B-Ds
vaginal I-Ds I-Ds
discharge E-Ds E-Ds
is O O
a O O
common O O
problem O O
in O O
gynaecological O O
practice O O
it O O
may O O
be O O
physiological O O
but O O
when O O
turn O O
into O O
pathological O O
condition O O
produce O O
associated O O
problems O O
like O O
itching S-Ds S-Ds
vulva S-Ds S-Ds
backache S-Ds S-Ds
and O O
so O O
as O O
to O O
anxiety S-Ds S-Ds
to O O
a O O
female O O
suffering O O
from O O
the O O
entity O O
it O O
is O O
quoted O O
as O O
a O O
symptom O O
in O O
multiple O O
gynaecological O O
problems O O
management O O
of O O
leucorrhoea S-Ds S-Ds
depends O O
upon O O
the O O
causative O O
factor O O
prakriti O O
of O O
the O O
patient O O
s O O
involvement O O
of O O
doshas O O
etc O O
usually O O
leucorrhoea S-Ds S-Ds
is O O
a O O
curable O O
disease O O
but O O
recurrence O O
is O O
common O O
due O O
to O O
causative O O
factors O O
some O O
classical O O
preparations O O
mentioned O O
for O O
the O O
management O O
of O O
leucorrhoea S-Ds S-Ds
in O O
ayurvedic O O
classics O O
oral O O
as O O
well O O
as O O
local O O
like O O
vaginal O O
douche O O
vaginal O O
suppositories O O
dhoopana S-Dg S-Dg
and O O
tampons O O
research O O
works O O
done O O
at O O
various O O
institutions O O
give O O
evidence O O
of O O
effectiveness O O
of O O
such O O
oral O O
and O O
local O O
therapies O O

pattu O E-Dg
used O O
bhagna B-Dg B-Dg
chikitsa E-Dg E-Dg
for O O
in O O
sri O O
lankan O O
traditional O O
medicine O O
a O O
critical O O
review O O
occurrence O O
of O O
fractures S-Ds S-Ds
is O O
very O O
higher O O
incidence O O
at O O
present O O
and O O
this O O
tendency O O
is O O
likely O O
to O O
continue O O
in O O
future O O
too O O
in O O
the O O
present O O
era O O
most O O
of O O
the O O
people O O
are O O
turning O O
towards O O
traditional O O
treatment O O
for O O
fractures O B-Ds
fractures O E-Ds
are O O
called O O
bhagna S-Ds S-Dg
in O O
traditional O O
medicine O O
traditional O O
physicians O O
are O O
in O O
experience O O
with O O
highly O O
effective O O
treatments O O
for O O
fractures O O
and O O
they O O
utilize O O
their O O
knowledge O O
with O O
modern O O
techniques O O
to O O
establish O O
their O O
therapy O O
without O O
any O O
defects O O
so O O
studying O O
this O O
system O O
in O O
depth O O
is O O
a O O
necessity O O
the O O
present O O
study O O
is O O
aims O O
to O O
explore O O
thesecondary O O
data O O
related O O
to O O
the O O
literature O O
about O O
pattu O S-Dg
used O O
for O O
bhagna B-Dg B-Dg
chikitsa E-Dg E-Dg
in O O
traditional O O
medicine O O
and O O
evaluate O O
the O O
pharmacodynamic O O
actions O O
of O O
selected O O
formulations O O
for O O
this O O
study O O
more O O
than O O
formulations O O
of O O
pattu O S-Dg
were O O
collected O O
from O O
reputed O O
traditional O O
physicians O O
and O O
traditional O O
text O O
books O O
and O O
randomly O O
ten O O
formulations O O
were O O
selected O O
to O O
analyze O O
subsequently O O
the O O
pharmacodynamic O O
action O O
based O O
on O O
the O O
properties O O
of O O
the O O
individual O O
drugs O O
in O O
them O O
analysis O O
showed O O
that O O
different O O
pattus O O
produced O O
different O O
results O O
depending O O
on O O
the O O
herbs O O
used O O
in O O
the O O
formulations O O
the O O
main O O
pharmacodynamic O O
actions O O
of O O
these O O
pattus O S-Ds
are O O
shotahara S-Ds S-Ds
vedana B-Ds S-Ds
sthapana E-Ds S-Ds
pradahanashaka S-Ds S-Ds
sandhaneeya S-Ds S-Ds
bone B-Ds B-Ds
healing E-Ds E-Ds
vruna B-Ds B-Ds
shodana E-Ds E-Ds
wound B-Ds B-Ds
purification E-Ds E-Ds
daha B-Ds B-Ds
prashamana E-Ds E-Ds
prevent O B-Ds
burning O E-Ds
sensation O O
of O O
the O O
affected O O
area O O
krimighna S-Ds B-Ds
anti B-Ds B-Ds
microbial I-Ds I-Ds
activity E-Ds E-Ds
vruna B-Ds S-Ds
ropana E-Ds S-Ds
wound B-Ds B-Ds
healing E-Ds E-Ds
and O O
uththejaka O O
stimulating O O
due O O
to O O
these O O
different O O
actions O O
towards O O
the O O
bhagna B-Dg O
these O O
pattu E-Dg O
can O O
be O O
used O O
for O O
different O O
kind O O
of O O
bhagna S-Ds S-Ds
stages O O
with O O
associated O O
symptoms O O

pharmacognostical O O
and O O
pharmaceutical O O
analysis O O
of O O
shatapushpadya B-Dg B-Dg
churna E-Dg E-Dg
ayurveda O O
has O O
given O O
much O O
importance O O
to O O
the O O
agni O O
digestive O O
power O O
agnimandya S-Ds O
is O O
one O O
of O O
most O O
common O O
pathological O O
condition O O
giving O O
rise O O
to O O
appearance O O
of O O
many O O
symptoms O O
like O O
udara B-Ds S-Ds
gaurava E-Ds S-Ds
alasya S-Ds S-Ds
laziness S-Ds S-Ds
etc O O
and O O
also O O
is O O
a O O
root O O
cause O O
for O O
manifestation O O
of O O
many O O
diseases O O
the O O
present O O
study O O
deals O O
with O O
the O O
standardization O O
of O O
shatapushpadya B-Dg B-Dg
churna E-Dg E-Dg
through O O
the O O
pharmacognostical O O
and O O
pharmaceutical O O
standards O O
the O O
presence O O
of O O
bottle O O
neck O O
shaped O O
stone O O
cells O O
aleurone O O
grains O O
of O O
maricha O O
stratified O O
fibres O O
oil O O
globules O O
prysmatic O O
crystals O O
of O O
shatapushpa O O
scleroids O O
stone O O
cells O O
of O O
vidanga O O
were O O
the O O
characteristic O O
features O O
observed O O
in O O
the O O
microscopy O O
of O O
drug O O
combination O O
pharmaceutical O O
analysis O O
showed O O
that O O
loss O O
on O O
drying O O
ash O O
value O O
acid O O
insoluble O O
ash O O
on O O
the O O
basis O O
of O O
observations O O
and O O
experimental O O
results O O
the O O
study O O
may O O
be O O
used O O
as O O
standard O O
protocol O O
in O O
the O O
further O O
quality O O
control O O
researches O O
further O O
studies O O
may O O
be O O
carried O O
out O O
on O O
shatapushpadya B-Dg B-Dg
churna E-Dg E-Dg

understanding O O
hypertension S-Ds S-Ds
on O O
ayurvedic O O
perspective O O
a O O
critical O O
review O O
hypertension S-Ds S-Ds
is O O
a O O
major O O
risk O O
factor O O
for O O
cardiovascular B-Ds B-Ds
diseases E-Ds E-Ds
stroke S-Ds S-Ds
and O O
kidney B-Ds B-Ds
diseases E-Ds E-Ds
high O O
mortality O O
conventional O O
treatment O O
modalities O O
do O O
not O O
have O O
enough O O
efficacies O O
in O O
reducing O O
target O O
organ O O
damage O O
and O O
they O O
have O O
adverse O O
effects O O
as O O
well O O
so O O
it O O
is O O
the O O
need O O
time O O
to O O
get O O
safe O O
effective O O
and O O
remedies O O
in O O
ayurveda O O
formulating O O
ayurvedic O O
therapy O O
for O O
hypertension S-Ds S-Ds
warrants O O
proper O O
understanding O O
of O O
hypertension S-Ds S-Ds
as O O
per O O
the O O
principles O O
of O O
ayurveda O O
this O O
study O O
is O O
made O O
with O O
an O O
aim O O
to O O
understanding O O
the O O
pathogenesis O O
of O O
hypertension S-Ds S-Ds
in O O
terms O O
of O O
ayurveda O O
the O O
various O O
pathological O O
mechanisms O O
contributing O O
the O O
manifestation O O
are O O
compiled O O
by O O
going O O
through O O
texts O O
journals O O
and O O
internet O O
search O O
the O O
obtained O O
data O O
are O O
reviewed O O
critically O O
to O O
understand O O
in O O
terms O O
of O O
ayurveda O O
it O O
is O O
found O O
that O O
the O O
hypertension O S-Ds
is O O
a O O
disorder O O
of O O
vaata O B-Ds
dosha O O
due O O
to O O
aavarana S-Ds O
the O O
causative O O
are O O
santarpanajanya B-Ds S-Ds
nidaana E-Ds S-Ds
factors O O
leading O O
to O O
of O O
the O O
various O O
other O O
factors O O
involved O O
in O O
the O O
manifestation O O
of O O
hypertension S-Ds S-Ds
are O O
rasavaha S-Ds S-Ds
raktavaha S-Ds S-Ds
medovaha S-Ds S-Ds
and O O
manovaha B-Ds O
srotas E-Ds O
the O O
treatment O O
of O O
hypertension S-Ds S-Ds
should O O
be O O
done O O
with O O
targeting O O
these O O
factors O O
with O O
proper O O
assessment O O
of O O
strength O O
of O O
disease O O
and O O
diseased O O

pharmacognostical O O
evaluation O O
of O O
bijapura S-Dg S-Dg
leaves O O
bijapura S-Dg S-Dg
botanically O O
identified O O
as O O
a O O
citrus O O
medica O O
linn O O
is O O
an O O
important O O
plant O O
of O O
ayurvedic O O
material O O
medica O O
its O O
various O O
parts O O
are O O
widely O O
used O O
to O O
treat O O
many O O
ailments O O
in O O
traditional O O
system O O
of O O
medicine O O
leaves O O
are O O
used O O
to O O
treat O O
insomnia S-Ds S-Ds
skin B-Ds B-Ds
diseases E-Ds E-Ds
dyspnoea S-Ds S-Ds
hiccough S-Ds S-Ds
and O O
vomiting S-Ds S-Ds
no O O
reports O O
are O O
available O O
on O O
the O O
pharmacognostic O O
studies O O
of O O
the O O
leaf O O
of O O
medica O O
present O O
study O O
aimed O O
to O O
establish O O
pharmacognostic O O
standards O O
and O O
physicochemical O O
analysis O O
of O O
leaf O O
of O O
citrus O O
medica O O
macroscopic O O
and O O
microscopic O O
characters O O
quantitative O O
microscopy O O
histochemical O O
analysis O O
and O O
physicochemical O O
analysis O O
were O O
carried O O
out O O
to O O
ascertain O O
quality O O
standards O O
for O O
leaf O O
parameters O O
were O O
studied O O
according O O
to O O
pharmacopoeial O O
guidelines O O
study O O
showed O O
that O O
leaf O O
of O O
medica O O
contains O O
lysigenous O O
cavities O O
with O O
the O O
presence O O
of O O
oil O O
globules O O
calcium O O
oxalate O O
crystals O O
paracytic O O
stomata O O
and O O
incomplete O O
ring O O
of O O
sclerenchyma O O
physicochemical O O
analysis O O
revealed O O
loss O O
on O O
drying O O
total O O
ash O O
content O O
water O O
soluble O O
extractive O O
alcohol O O
soluble O O
extractive O O
and O O
aqua O O
solution O O
these O O
parameters O O
will O O
help O O
for O O
establishing O O
identification O O
of O O
this O O
drug O O
for O O
the O O
future O O
references O O

therapeutic B-Fn O
uses E-Fn O
of O O
tamra B-Dg B-Dg
bhasma E-Dg E-Dg
a O O
review O O
through O O
bhaishajya O B-Dg
ratnavali O E-Dg
longer O O
shelf O O
life O O
and O O
efficacy O O
in O O
smaller O O
doses O O
make O O
preparation O O
very O O
popular O O
among O O
ayurvedic O O
physicians O O
though O O
these O O
formulations O O
are O O
being O O
used O O
successfully O O
since O O
centuries O O
serious O O
doubts O O
has O O
been O O
raised O O
from O O
western O O
researchers O O
regarding O O
their O O
safety O O
tamra B-Dg B-Dg
bhasma E-Dg E-Dg
is O O
one O O
of O O
such O O
metallic O O
preparations O O
which O O
are O O
used O O
for O O
the O O
treatment O O
of O O
wide O O
array O O
of O O
diseases O O
like O O
parinamashula S-Ds S-Ds
pandu S-Ds S-Ds
kushtha S-Ds S-Ds
skin B-Ds B-Ds
disorders E-Ds E-Ds
shwasa S-Ds S-Ds
dyspnoea S-Ds S-Ds
etc O O
in O O
the O O
present O O
review O O
various O O
formulations O O
of O O
tamra S-Dg S-Dg
were O O
compiled O O
from O O
bhaishajya O B-Dg
ratnavali O E-Dg
and O O
approximate O O
percentage O O
of O O
copper O O
in O O
them O O
has O O
been O O
calculated O O
in O O
this O O
review O O
total O O
formulations O O
were O O
screened O O
out O O
which O O
directly O O
or O O
indirectly O O
contained O O
tamra B-Dg B-Dg
bhasma E-Dg E-Dg
in O O
them O O
out O O
of O O
them O O
maximum O O
formulations O O
were O O
found O O
in O O
jwara O O
rogadhikara O O
this O O
effort O O
will O O
be O O
helpful O O
to O O
ayurvedic O O
physicians O O
drug O O
manufacturers O O
and O O
research O O
scholars O O
to O O
understand O O
the O O
different O O
uses O O
of O O
tamra B-Dg B-Dg
bhasma E-Dg E-Dg
along O O
with O O
its O O
dose O O
anupana O O
etc O O

clinical O O
evaluation O O
of O O
amavata S-Ds S-Dg
with O O
naturopathy O O
management O O
the O O
clinical O O
study O O
was O O
aimed O O
to O O
evaluate O O
the O O
efficacy O O
of O O
naturopathy O O
management O O
on O O
amavata S-Ds S-Ds
amavata S-Ds S-Ds
rheumatoid B-Ds B-Ds
arthritis E-Ds E-Ds
patients O O
were O O
registered O O
from O O
the O O
and O O
patients O O
discontinued O O
before O O
completion O O
of O O
the O O
treatment O O
certain O O
naturopathy O O
processes O O
mudpack O O
application O O
prayer O O
exercise O O
of O O
stretching O O
rotations O O
breathing O O
exercise O O
relaxation O O
hip O O
bath O O
shiatsu O O
massage O O
acupressure O O
warm O O
sand O O
infrared O O
ray O O
application O O
small O O
mild O O
vibrator O O
and O O
diet O O
planning O O
systemically O O
followed O O
for O O
continuous O O
three O O
weeks O O
days O O
for O O
every O O
day O O
morning O O
in O O
empty O O
stomach O O
and O O
also O O
followed O O
tentative O O
planning O O
of O O
fast O O
for O O
week O O
in O O
the O O
study O O
maximum O O
patient O O
showed O O
major O O
improvement O O
showed O O
minor O O
improvement O O
showed O O
no O O
improvement O O
and O O
complete O O
remission O O
was O O
nil O O
no O O
complication O O
was O O
observed O O
in O O
the O O
clinical O O
study O O

pharmacognostic O O
evaluation O O
pippali B-Dg B-Dg
mula E-Dg E-Dg
to O O
micrometric O O
and O O
isolation O O
techniques O O
pippalimula S-Dg O
of O O
is O O
one O O
of O O
the O O
vital O O
herbs O O
of O O
ayurveda O O
included O O
in O O
panchakola O O
shadushana O S-Dg
etc O O
and O O
attributed O O
dipaniya O O
pachaniya O O
digestive O O
properties O O
it O O
is O O
one O O
of O O
the O O
highly O O
traded O O
species O O
of O O
pharmaceutical O O
industries O O
to O O
meet O O
the O O
increasing O O
demand O O
has O O
resulted O O
in O O
a O O
decline O O
in O O
their O O
quality O O
there O O
is O O
now O O
a O O
need O O
to O O
develop O O
a O O
systematic O O
approach O O
for O O
the O O
authentication O O
of O O
herbal O O
plants O O
and O O
to O O
develop O O
methodologies O O
for O O
their O O
standardization O O
the O O
present O O
paper O O
deals O O
with O O
the O O
macroscopic O O
and O O
microscopic O O
evaluation O O
of O O
the O O
root O O
of O O
piper O O
longum O O
linn O O
along O O
with O O
its O O
micrometric O O
and O O
isolation O O
techniques O O
pharmacognostic O O
study O O
of O O
pippali B-Dg B-Dg
mula E-Dg E-Dg
root O O
of O O
piper O O
longum O O
linn O O
has O O
been O O
carried O O
out O O
as O O
per O O
standard O O
reference O O
procedures O O
paranchymatous O O
cells O O
heavily O O
loaded O O
with O O
starch O O
grains O O
oil O O
globules O O
and O O
fan O O
shaped O O
arrangements O O
of O O
vascular O O
bundle O O
upto O O
centre O O
distinctive O O
the O O
drug O O
from O O
other O O
root O O
morphology O O
powder O O
microscopy O O
along O O
with O O
micrometric O O
and O O
isolation O O
techniques O O
would O O
be O O
of O O
immense O O
value O O
in O O
botanical O O
identification O O
and O O
authentication O O
of O O
plant O O
drug O O
and O O
may O O
help O O
in O O
preventing O O
its O O
adulteration O O

analytical O O
study O O
of O O
balaashwagandha B-Dg B-Dg
taila E-Dg E-Dg
ayurvedic O O
tailas O O
are O O
used O O
for O O
variety O O
of O O
purposes O O
and O O
administered O O
through O O
different O O
routes O O
one O O
such O O
oil O O
is O O
balaashwagandha B-Dg B-Dg
taila E-Dg E-Dg
which O O
contains O O
mainly O O
bala S-Dg S-Dg
ashwagandha S-Dg S-Dg
and O O
laksha S-Dg S-Dg
it O O
has O O
antipyretic S-Ds S-Ds
antispasmodic S-Ds S-Ds
antiseptic S-Ds S-Ds
analgesic S-Ds S-Ds
properties O O
and O O
is O O
indicated O O
fever S-Ds S-Ds
cough S-Ds S-Ds
asthma S-Ds S-Ds
headache S-Ds S-Ds
arthritis S-Ds S-Ds
and O O
to O O
strengthen O O
the O O
muscles O O
in O O
the O O
present O O
study O O
three O O
batches O O
of O O
taila O O
were O O
prepared O O
by O O
referring O O
the O O
method O O
described O O
in O O
the O O
text O O
sahasrayogam O O
these O O
batches O O
were O O
further O O
studied O O
organoleptically O O
as O O
well O O
as O O
chromatographically O O
for O O
developing O O
standards O O

standardisation O O
of O O
a O O
polyherbal O O
ayurvedic O O
medicine O O
diajith S-Dg S-Dg
large O O
number O O
of O O
herbal O O
remedies O O
is O O
available O O
in O O
market O O
for O O
treating O O
diabetes O S-Ds
quality O O
control O O
and O O
standardization O O
of O O
herbal O O
medicines O O
are O O
two O O
urgent O O
needs O O
of O O
time O O
diajith S-Dg S-Dg
a O O
market O O
available O O
anti B-Ds B-Ds
diabetic E-Ds E-Ds
herbal O O
drug O O
is O O
taken O O
for O O
present O O
study O O
this O O
work O O
aims O O
to O O
study O O
quality O O
aspects O O
of O O
diajith S-Dg S-Dg
and O O
an O O
attempt O O
has O O
been O O
made O O
to O O
standardize O O
the O O
product O O
physicochemical O O
and O O
phytochemical O O
analysis O O
was O O
performed O O
on O O
three O O
different O O
batches O O
of O O
ingredient O O
drugs O O
and O O
products O O
using O O
standard O O
procedures O O
quantitative O O
determinations O O
were O O
done O O
for O O
total O O
phenolic O O
content O O
flavonoids O O
and O O
tannin O O
content O O
by O O
spectrophotometric O O
method O O
saponins O O
were O O
estimated O O
by O O
quantitative O O
method O O
thin O O
layer O O
chromatographic O O
profiling O O
was O O
also O O
performed O O
on O O
tlc O O
silica O O
gel O O
aluminum O O
plates O O
for O O
different O O
extracts O O
petroleum O O
ether O O
ethyl O O
acetate O O
and O O
methanol O O
of O O
the O O
product O O
and O O
also O O
with O O
standard O O
curcumin O O
as O O
marker O O
compound O O
results O O
of O O
physicochemical O O
analysis O O
conducted O O
on O O
three O O
batches O O
of O O
raw O O
herbs O O
show O O
slighter O O
variations O O
in O O
all O O
parameters O O
the O O
physicochemical O O
analysis O O
and O O
quantitative O O
estimations O O
of O O
active O O
groups O O
in O O
three O O
batches O O
of O O
diajith S-Dg S-Dg
yielded O O
standardized O O
values O O
the O O
preliminary O O
phytochemical O O
analysis O O
showed O O
presence O O
of O O
similar O O
active O O
phytogroups O O
in O O
all O O
three O O
batches O O
of O O
diajith S-Dg S-Dg
thus O O
by O O
confirming O O
its O O
potency O O
with O O
about O O
phenols O O
flavonoids O O
tannins O O
and O O
saponins O O
thin O O
layer O O
chromatographic O O
profiling O O
of O O
the O O
petroleum O O
ether O O
extracts O O
ethyl O O
acetate O O
extracts O O
and O O
methanol O O
extracts O O
were O O
found O O
similar O O
in O O
three O O
batches O O
of O O
diajith S-Dg S-Dg
the O O
phytochemical O O
finger O O
print O O
profile O O
of O O
the O O
drug O O
can O O
serve O O
as O O
a O O
guideline O O
in O O
ensuring O O
the O O
quality O O
of O O
the O O
drug O O

comparative O O
pharmacognostical O O
evaluation O O
of O O
three O O
source O O
drugs O O
of O O
trivrut S-Dg S-Dg
trivrut S-Dg S-Dg
considered O O
as O O
best O O
among O O
the O O
laxative O O
drug O O
shyama S-Dg S-Dg
aruna S-Dg S-Dg
shukla S-Dg S-Dg
etc O O
are O O
the O O
varieties O O
delineated O O
in O O
different O O
classical O O
texts O O
of O O
ayurveda O O
but O O
clear O O
morphological O O
characters O O
of O O
the O O
varieties O O
are O O
not O O
described O O
ayurvedic O O
pharmacopoeia O O
of O O
india O O
recommends O O
operculina O O
turpethum O O
silva O O
manso O O
as O O
the O O
source O O
drug O O
for O O
trivrut S-Dg S-Dg
in O O
the O O
herbal O O
market O O
roots O O
and O O
stems O O
of O O
marsdenia O O
tenacissima O O
wight O O
arn O O
asclepiadaceae O O
is O O
being O O
sold O O
under O O
the O O
name O O
of O O
shweta B-Dg B-Dg
trivrut E-Dg E-Dg
roots O O
of O O
operculina O O
petaloidea O O
choisy O O
convolvulaceae O O
is O O
also O O
considered O O
as O O
shyama B-Dg B-Dg
trivrut E-Dg E-Dg
present O O
study O O
was O O
carryout O O
to O O
establish O O
certain O O
botanical O O
standards O O
for O O
identification O O
and O O
standardization O O
of O O
three O O
source O O
drugs O O
of O O
trivrut S-Dg S-Dg
roots O O
of O O
the O O
three O O
samples O O
were O O
collected O O
from O O
the O O
natural O O
habitat O O
odisha O O
detailed O O
morphological O O
microscopic O O
and O O
histochemical O O
study O O
was O O
carried O O
out O O
following O O
standard O O
procedure O O
differences O O
in O O
the O O
morphological O O
characters O O
in O O
individual O O
sample O O
were O O
observed O O
diagnostic O O
character O O
of O O
the O O
transverse O O
section O O
of O O
operculina O O
turpethum O O
shows O O
the O O
presence O O
of O O
inter O O
xylary O O
phloem O O
thin O O
cork O O
cells O O
with O O
abundant O O
rosette O O
and O O
cluster O O
crystals O O
were O O
observed O O
in O O
operculina O O
petaloidea O O
whereas O O
marsdenia O O
tenacissima O O
shows O O
thick O O
cork O O
cell O O
with O O
abundant O O
stone O O
cells O O
and O O
starch O O
grains O O
test O O
for O O
lignin O O
calcium O O
oxalate O O
crystal O O
starch O O
grain O O
and O O
tannin O O
showed O O
positive O O
result O O
in O O
all O O
the O O
three O O
samples O O

clinical O O
study O O
of O O
tamraparna S-Dg S-Dg
to O O
swasahara B-Ds B-Dg
karma E-Ds E-Dg
effect O O
properly O O
administered O O
medicine O O
showed O O
good O O
therapeutic O O
effects O O
even O O
though O O
it O O
is O O
a O O
toxic O O
drug O O
thus O O
we O O
can O O
use O O
poisonous O O
in O O
treatment O O
by O O
appropriate O O
work O O
was O O
carried O O
on O O
the O O
plant O O
nicotiana O O
tabacum O O
linn O O
for O O
its O O
swasahara B-Fn O
effect E-Fn O
in O O
tamaka B-Ds B-Dg
swasa E-Ds E-Dg
this O O
plant O O
has O O
well O O
known O O
toxic O O
effect O O
till O O
the O O
work O O
was O O
carried O O
out O O
on O O
this O O
plant O O
to O O
evaluate O O
the O O
classical O O
references O O
based O O
on O O
therapeutic O O
criteria O O
but O O
in O O
classical O O
references O O
the O O
drug O O
delivery O O
system O O
of O O
the O O
drug O O
is O O
not O O
explained O O
as O O
the O O
work O O
is O O
on O O
respiratory O O
track O O
disease O O
the O O
drug O O
administered O O
to O O
the O O
target O O
system O O
in O O
addition O O
the O O
drug O O
has O O
well O O
known O O
toxic O O
drug O O
so O O
it O O
was O O
administered O O
in O O
smaller O O
dose O O
as O O
possible O O
for O O
that O O
purpose O O
the O O
aerosol O O
therapy O O
was O O
selected O O
tamaka B-Ds B-Ds
swasa E-Ds E-Dg
is O O
a O O
life O O
threatening O O
disease O O
and O O
very O O
fast O O
acting O O
drug O O
due O O
to O O
the O O
vyavai S-Dg S-Dg
vikasi S-Dg S-Dg
and O O
tikshna B-Dg B-Dg
guna E-Dg E-Dg
nicotiana O O
tabacum O O
linn O O
can O O
act O O
quickly O O
and O O
by O O
giving O O
it O O
as O O
a O O
inhalation O O
drug O O
can O O
be O O
delivered O O
directly O O
to O O
the O O
respiratory O O
tract O O
in O O
minimal O O
dose O O
and O O
can O O
reduce O O
the O O
adverse O O
effects O O

standard O O
manufacturing O O
procedure O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
by O O
using O O
arka B-Dg B-Dg
dugdha E-Dg E-Dg
of O O
standard O O
manufacturing O O
procedure O O
is O O
the O O
first O O
and O O
basic O O
step O O
towards O O
standardization O O
of O O
any O O
drug O O
in O O
classics O O
many O O
methods O O
are O O
described O O
to O O
prepare O O
a O O
bhasma O O
so O O
there O O
is O O
need O O
to O O
develop O O
smp O O
of O O
some O O
commonly O O
used O O
method O O
of O O
bhasma O O
preparation O O
present O O
work O O
is O O
based O O
on O O
development O O
of O O
smp O O
of O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
by O O
using O O
arka B-Dg B-Dg
dugdha E-Dg E-Dg
as O O
bhavana O E-Dg
media O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
was O O
prepared O O
in O O
three O O
batches O O
of O O
naga O B-Dg
was O O
used O O
in O O
each O O
batch O O
adopting O O
the O O
reference O O
of O O
rasaratna O B-Dg
samuchchaya O E-Dg
freshly O O
collected O O
arka B-Dg B-Dg
dugdha E-Dg E-Dg
was O O
taken O O
as O O
media O O
for O O
levigation O O
equal O O
quantity O O
of O O
manshila S-Dg S-Dg
was O O
added O O
in O O
puta O O
followed O O
by O O
part O O
subsequently O O
up O O
to O O
puta O O
puta O O
was O O
given O O
in O O
electric O O
muffle O O
furnace O O
emf O O
at O O
the O O
temperature O O
of O O
the O O
detail O O
observations O O
like O O
change O O
in O O
weight O O
consistency O O
color O O
characteristic O O
features O O
of O O
bhasma O B-Dg
pariksha O E-Dg
and O O
organoleptic O O
characters O O
after O O
each O O
puta O O
were O O
noted O O
till O O
complete O O
preparation O O
of O O
bhasma O O
grey O O
colored O O
naga B-Dg B-Dg
bhasma E-Dg E-Dg
was O O
obtained O O
after O O
puta O O
in O O
emf O O
average O O
weight O O
gain O O
was O O
observed O O
average O O
arka B-Dg B-Dg
dugdha E-Dg E-Dg
was O O
required O O
for O O
levigation O O
in O O
each O O
puta O O
and O O
from O O
to O O
puta O O

a O O
contemplative O O
study O O
on O O
the O O
clinical O O
evaluation O O
and O O
efficacy O O
of O O
selective O O
formulations O O
in O O
vishama B-Ds B-Dg
jwara E-Ds E-Dg
three O O
clinical O O
studies O O
were O O
conducted O O
on O O
single O O
compound O O
ayurvedic O O
herbal O O
and O O
formulations O O
in O O
various O O
institutes O O
at O O
opd O O
level O O
under O O
central O O
council O O
for O O
research O O
in O O
ayurveda O O
and O O
siddha O O
the O O
objective O O
of O O
the O O
study O O
was O O
to O O
find O O
out O O
the O O
therapeutic O O
efficacy O O
of O O
ayurvedic O O
formulations O O
in O O
the O O
management O O
of O O
vishama B-Ds B-Ds
jwara E-Ds E-Ds
malarial O S-Ds
cases O O
which O O
are O O
positive O O
for O O
plasmodium O O
vivax O O
parasite O O
on O O
peripheral O O
blood O O
smear O O
with O O
the O O
symptoms O O
and O O
signs O O
on O O
vishama B-Ds B-Dg
jwara E-Ds E-Dg
were O O
selected O O
for O O
the O O
study O O
after O O
completion O O
of O O
therapy O O
the O O
results O O
were O O
assessed O O
on O O
the O O
basis O O
of O O
clinical O O
features O O
and O O
pathological O O
investigations O O
different O O
combinations O O
of O O
preparations O O
were O O
evaluated O O
under O O
three O O
studies O O
viz O O
with O O
sphatika B-Dg B-Dg
bhasma E-Dg E-Dg
and O O
guduchi B-Dg B-Dg
ghana I-Dg E-Dg
satwa E-Dg E-Dg
saptaparna B-Dg B-Dg
twak I-Dg I-Dg
ghanavati E-Dg B-Dg
parijata B-Dg B-Dg
patra I-Dg I-Dg
ghanavati E-Dg E-Dg
respectively O O
all O O
the O O
formulations O O
exhibited O O
around O O
therapeutic O O
effect O O
as O O
all O O
the O O
three O O
trial O O
drugs O O
had O O
shown O O
efficacy O O
in O O
curing O O
malaria S-Ds S-Ds
more O O
number O O
of O O
patients O O
were O O
found O O
smear O O
negative O O
after O O
the O O
completion O O
of O O
the O O
therapy O O
with O O
sphatika B-Dg B-Dg
bhasma E-Dg E-Dg
and O O
guduchi B-Dg B-Dg
satwa E-Dg E-Dg
and O O
sapta B-Dg B-Dg
parna I-Dg I-Dg
twak I-Dg I-Dg
ghanavati E-Dg E-Dg
in O O
comparison O O
to O O
parijata B-Dg B-Dg
patra I-Dg I-Dg
ghanavati E-Dg E-Dg
no O O
side O O
effects O O
were O O
observed O O
during O O
the O O
course O O
of O O
the O O
clinical O O
trials O O
thus O O
these O O
studies O O
reveal O O
that O O
the O O
above O O
said O O
trial O O
drugs O O
can O O
be O O
used O O
as O O
a O O
safe O O
and O O
effective O O
treatment O O
for O O
malaria S-Ds S-Ds

a O O
review O O
on O O
marine O O
originated O O
drug O O
tradition O O
in O O
ayurveda O O
ayurveda O O
is O O
a O O
treasure O O
of O O
remedies O O
in O O
which O O
various O O
medicinal O O
preparations O O
are O O
widely O O
prepared O O
by O O
using O O
marine O O
originated O O
drugs O O
these O O
were O O
used O O
by O O
ayurvedic O O
physician O O
in O O
their O O
day O O
to O O
day O O
practice O O
in O O
bone B-Ds B-Ds
structure I-Ds I-Ds
disorders E-Ds E-Ds
muscular B-Ds I-Ds
movements I-Ds E-Ds
and O O
regulation E-Ds O
of O O
secretions O O
majority O O
of O O
such O O
formulation O O
are O O
used O O
for O O
oral O O
administration O O
purpose O O
with O O
negligible O O
ill O O
effect O O
noticed O O
and O O
considerably O O
safe O O
sea O O
is O O
one O O
of O O
the O O
richest O O
natural O O
sources O O
of O O
minerals O O
like O O
calcium O O
phosphorus O O
iron O O
and O O
also O O
some O O
others O O
trace O O
elements O O
in O O
the O O
form O O
of O O
pravala S-Dg S-Dg
mukta S-Dg S-Dg
pearl S-Dg S-Dg
shankha S-Dg S-Dg
conch S-Dg S-Dg
marine O O
organisms O O
which O O
contribute O O
the O O
bioactive O O
products O O
are O O
having O O
profound O O
applications O O
in O O
pharmaceuticals O O
cosmeceuticals O O
all O O
the O O
marine O O
originated O O
drugs O O
used O O
in O O
ayurveda O O
are O O
to O O
be O O
kept O O
under O O
one O O
specific O O
group O O
as O O
per O O
occurrence O O
utpattisthana S-Dg S-Dg
with O O
special O O
reference O O
to O O
their O O
uses O O
and O O
other O O
details O O
of O O
calibration O O
and O O
validation O O
measure O O
such O O
as O O
chemical O O
constituents O O
structures O O
and O O
analytical O O
techniques O O
are O O
also O O
been O O
discussed O O
this O O
attempt O O
has O O
been O O
made O O
to O O
accumulate O O
all O O
scattered O O
literature O O
in O O
one O O
place O O
for O O
easy O O
and O O
better O O
understanding O O
of O O
all O O
marine O O
drugs O O
of O O
ayurveda O O

understanding O O
the O O
concept O O
of O O
diabetic B-Ds B-Ds
peripheral I-Ds I-Ds
neuropathy E-Ds E-Ds
in O O
ayurveda O O
diabetic B-Ds B-Ds
peripheral I-Ds I-Ds
neuropathy E-Ds E-Ds
is O O
one O O
of O O
the O O
most O O
troublesome O O
micro O O
vascular O O
complications O O
of O O
diabetes B-Ds B-Ds
mellitus E-Ds E-Ds
and O O
present O O
in O O
of O O
all O O
diabetics O O
hence O O
it O O
needs O O
an O O
hour O O
to O O
understand O O
the O O
concept O O
of O O
dpn O O
in O O
ayurveda O O
so O O
as O O
to O O
form O O
an O O
effective O O
management O O
protocol O O
madhumeha S-Ds S-Ds
is O O
one O O
among O O
the O O
four O O
varieties O O
of O O
vataja B-Ds B-Ds
prameha E-Ds E-Ds
which O O
has O O
similarity O O
with O O
dpn O O
is O O
one O O
of O O
the O O
complication O O
of O O
madhumeha S-Ds S-Ds
being O O
one O O
of O O
maharoga O O
due O O
to O O
chronicity O O
it O O
attains O O
complication O O
stage O O
dpn O O
is O O
understood O O
in O O
ayurveda O O
on O O
its O O
symptoms O O
such O O
as O O
daha O S-Ds
harsha S-Ds S-Ds
suptata S-Ds S-Ds
numbness S-Ds S-Ds
shosha S-Ds S-Ds
wasting S-Ds S-Ds
mamsopachaya S-Ds S-Ds
muscle B-Ds B-Ds
wasting E-Ds E-Ds
dourbalya S-Ds S-Ds
weakness S-Ds S-Ds
anga B-Ds B-Ds
sada E-Ds E-Ds
lethargy S-Ds S-Ds
etc O O
which O O
are O O
attributed O O
to O O
madhumehajanya O B-Dg
dhatukshayaja O S-Ds
stage O O
thus O O
in O O
this O O
review O O
article O O
an O O
effort O O
has O O
been O O
made O O
to O O
understand O O
the O O
concept O O
of O O
dpn O O
explained O O
in O O
ayurveda O O

efficacy O O
dhatri B-Dg B-Dg
avaleha E-Dg E-Dg
in O O
pandu S-Ds S-Ds
an O O
open O O
end O O
randomized O O
clinical O O
trial O O
pandu B-Ds B-Ds
roga E-Ds E-Ds
is O O
characterized O O
by O O
panduta B-Ds O
of O O
nayana I-Ds B-Ds
nakha I-Ds B-Ds
twak E-Ds E-Ds
associated O O
with O O
mandagni S-Ds S-Ds
daurbalya S-Ds S-Ds
arohanayasa S-Ds S-Ds
in O O
severe O O
conditions O O
it O O
results O O
in O O
deterioration O O
of O O
asta O O
vidha O O
sara O O
of O O
alpa B-Ds B-Dg
rakta E-Ds I-Dg
alpa B-Ds B-Ds
medas E-Ds E-Ds
less O O
fat O O
etc O O
dhatri B-Dg B-Dg
avaleha E-Dg E-Dg
is O O
an O O
ayurvedic O O
formulation O O
mentioned O O
in O O
charaka O O
samhita O O
for O O
the O O
treatment O O
of O O
pandu S-Ds B-Ds
roga O E-Ds
current O O
study O O
was O O
carried O O
out O O
with O O
the O O
objective O O
of O O
assessing O O
the O O
efficacy O O
of O O
amapachana S-Dg S-Dg
and O O
dhatri B-Dg B-Dg
avaleha E-Dg E-Dg
on O O
patients O O
of O O
pandu B-Ds B-Ds
roga E-Ds E-Ds
nutritional O O
anaemia S-Ds S-Ds
patients O O
were O O
selected O O
by O O
random O O
sampling O O
method O O
patients O O
were O O
administered O O
panchakola O B-Dg
phanta O E-Dg
for O O
ama O B-Dg
pachana O E-Dg
metabolism O O
of O O
improperly O O
metabolized O O
products O O
followed O O
by O O
dhatri B-Dg B-Dg
avaleha E-Dg E-Dg
for O O
days O O
assessment O O
parameters O O
such O O
as O O
haemoglobin O O
subjective O O
parameters O O
arohanayasa S-Ds S-Ds
dyspnoea S-Ds S-Ds
on O O
exertion S-Ds S-Ds
shrama S-Ds S-Ds
tiredness S-Ds S-Ds
daurbalya S-Ds S-Ds
weakness S-Ds S-Ds
and O O
observational O O
parameters O O
aruchi S-Ds S-Ds
anorexia S-Ds S-Ds
hatanala S-Ds S-Ds
reduced B-Ds S-Ds
appetite E-Ds S-Ds
bhrama S-Ds S-Ds
giddiness S-Ds S-Ds
and O O
so O O
on O O
were O O
assessed O O
before O O
treatment O O
after O O
treatment O O
and O O
after O O
follow O O
up O O
of O O
days O O
the O O
results O O
were O O
analyzed O O
statistically O O
mean O O
haemoglobin O O
percentage O O
was O O
raised O O
by O O
after O O
treatment O O
for O O
days O O
statistically O O
significant O O
result O O
was O O
also O O
observed O O
in O O
terms O O
of O O
subjective O O
and O O
objective O O
parameters O O
the O O
result O O
was O O
maintained O O
even O O
during O O
the O O
follow O O
up O O
period O O

an O O
observational O O
clinical O O
study O O
on O O
the O O
management O O
of O O
mutrakrichchra S-Ds S-Ds
mutrakrichchra S-Ds S-Ds
is O O
one O O
of O O
the O O
prime O O
disease O O
affecting O O
mutravaha O O
srotas O O
involving O O
the O O
basti O O
marma O O
the O O
symptoms O O
of O O
different O O
types O O
of O O
mutrakrichchra S-Ds S-Ds
particularly O O
pittaja B-Ds B-Ds
mutrakrichchra E-Ds E-Ds
are O O
similar O O
to O O
signs O O
and O O
symptoms O O
of O O
lower B-Ds B-Ds
urinary I-Ds B-Ds
tract I-Ds I-Ds
infection E-Ds E-Ds
urinary B-Ds B-Ds
tract I-Ds I-Ds
infections E-Ds E-Ds
uti S-Ds S-Ds
are O O
serious O O
health O O
problems O O
affecting O O
millions O O
of O O
people O O
each O O
year O O
among O O
all O O
infections O O
infection O O
of O O
the O O
urinary O B-Ds
tract O E-Ds
is O O
most O O
common O O
type O O
of O O
infections O O
it O O
is O O
estimated O O
that O O
about O O
million O O
people O O
are O O
seeking O O
medical O O
advice O O
each O O
year O O
for O O
the O O
same O O
problem O O
women O O
are O O
especially O O
prone O O
to O O
uti S-Ds S-Ds
the O O
management O O
of O O
uti S-Ds S-Ds
is O O
by O O
antibiotics O O
even O O
though O O
they O O
are O O
useful O O
they O O
involve O O
considerable O O
amount O O
of O O
risk O O
and O O
at O O
the O O
same O O
time O O
the O O
infective O O
organism O O
develops O O
resistance O O
to O O
drugs O O
considering O O
this O O
situation O O
it O O
is O O
relevant O O
to O O
search O O
for O O
an O O
alternative O O
management O O
which O O
is O O
both O O
effective O O
and O O
economical O O
various O O
measures O O
are O O
described O O
in O O
ayurveda O O
for O O
the O O
management O O
of O O
mutrakrichchra S-Ds S-Ds
hence O O
this O O
study O O
was O O
taken O O
up O O
for O O
the O O
effective O O
management O O
of O O
mutrakrichchra S-Ds S-Ds
luti O S-Ds
present O O
study O O
was O O
conducted O O
on O O
patients O O
who O O
were O O
administered O O
with O O
the O O
combination O O
of O O
gokshura B-Dg B-Dg
churna E-Dg E-Dg
pashanabhedadi B-Dg B-Dg
kashaya E-Dg E-Dg
and O O
shweta B-Dg B-Dg
parpati E-Dg E-Dg
for O O
the O O
duration O O
of O O
days O O
out O O
of O O
patients O O
got O O
complete O O
relief O O
and O O
got O O
marked O O
relief O O
from O O
the O O
parameters O O
considered O O
for O O
the O O
assessment O O
of O O
result O O
which O O
was O O
statistically O O
highly O O
significant O O
with O O
value O O

analysis O O
concept O O
of O O
raktaashaya O B-Dg
raktaashaya O E-Dg
refers O O
to O O
the O O
pratyanga O O
of O O
of O O
the O O
body O O
which O O
serves O O
as O O
main O O
seat O O
of O O
the O O
rakta O O
literary O O
meaning O O
of O O
ashaya O S-Dg
is O O
the O O
place O O
which O O
provides O O
shelter O O
to O O
a O O
substance O O
or O O
any O O
constituent O O
pertaining O O
to O O
the O O
body O O
similar O O
is O O
the O O
raktaashaya O O
the O O
concept O O
of O O
raktaashaya O O
blood O O
reservoirs O O
is O O
more O O
than O O
its O O
literary O O
meaning O O
it O O
has O O
vital O O
importance O O
in O O
the O O
prakrita O O
normal O O
vaikrata O O
altered O O
karma O O
and O O
pathology O O
of O O
certain O O
raktaja B-Ds B-Ds
vikara E-Ds E-Ds
diseases O O
of O O
blood O O
or O O
in O O
the O O
diseases O O
where O O
the O O
rakta O O
blood O O
is O O
involved O O
this O O
article O O
focuses O O
on O O
the O O
concept O O
of O O
raktaashaya O O
blood O O
reservoirs O O

anatomical O O
consideration O O
on O O
dhamani O O
in O O
ayurveda O O
with O O
special O O
reference O O
to O O
susruta O O
samhita O O
the O O
term O O
siras O O
and O O
dhamanis O O
are O O
as O O
old O O
as O O
vedas O O
they O O
have O O
been O O
generally O O
used O O
in O O
the O O
same O O
sense O O
but O O
these O O
are O O
not O O
synonymous O O
in O O
general O O
siras O O
and O O
dhamanis O O
means O O
blood O O
vessels O O
but O O
on O O
the O O
basis O O
of O O
interpretation O O
of O O
commentators O O
dhamani O O
is O O
a O O
channel O O
connected O O
to O O
the O O
heart O O
which O O
is O O
thick O O
whereas O O
sira O O
is O O
a O O
thin O O
blood O O
vessel O O
sira O O
and O O
dhamani O O
both O O
are O O
related O O
to O O
heart O O
but O O
their O O
relations O O
are O O
different O O
in O O
relation O O
to O O
dhamani O O
hridaya O O
is O O
ashraya O O
ashraya O O
is O O
those O O
structures O O
which O O
provide O O
base O O
nutrition O O
and O O
protection O O
to O O
their O O
ashrayi O O
heart O O
is O O
place O O
of O O
ojus O O
so O O
dhamani O O
which O O
carry O O
ojus O O
are O O
called O O
as O O
ojovaha O O
dhamani O S-Ds
heart O O
is O O
also O O
place O O
of O O
prana O O
so O O
dhamani O O
are O O
also O O
pranavaha O O
due O O
to O O
place O O
of O O
rasa O O
dhamanis O O
are O O
rasavahini O O
heart O O
is O O
the O O
place O O
of O O
contraction O O
and O O
relaxation O O
so O O
contraction O O
and O O
relaxation O O
also O O
received O O
by O O
dhamani O O
thus O O
dhamanis O O
are O O
ashrita O O
depends O O
on O O
heart O O
for O O
ojus O O
prana O O
rasa O O
spandana O O
etc O O
although O O
siras O O
are O O
also O O
related O O
to O O
heart O O
but O O
they O O
do O O
not O O
receive O O
any O O
significant O O
things O O
from O O
heart O O
sira O O
only O O
drain O O
their O O
blood O O
into O O
the O O
heart O O

critical O O
analysis O O
care O O
in O O
brihat O B-Ds
trayi O E-Ds
care B-Ds O
new I-Ds O
born E-Ds O
right O O
from O O
just O O
after O O
birth O O
till O O
first O O
feeding O O
has O O
been O O
described O O
by O O
three O O
major O O
treatise O O
of O O
ayurveda O O
the O O
brihattrayi O O
it O O
includes O O
charaka O O
samhita O O
sushruta O O
samhita O O
and O O
astanga O B-Dg
hridaya O E-Dg
the O O
steps O O
included O O
in O O
care O O
or O O
navjata B-Dg B-Dg
shishu I-Dg B-Dg
paricharya E-Dg E-Dg
are O O
prana B-Dg B-Dg
pratyagamana E-Dg E-Dg
neonatal O O
ulva B-Dg B-Dg
parimarjana E-Dg E-Dg
of O O
the O O
naalchedan S-Dg O
of O O
snana S-Dg B-Dg
neonatal O O
mukh B-Dg B-Dg
vishodhan E-Dg E-Dg
cleaning O O
of O O
oral O O
cavity O O
garbhodak B-Dg B-Dg
vamana E-Dg E-Dg
clearing O O
of O O
neonate O O
s O O
stomach O O
jata B-Dg B-Dg
karma E-Dg E-Dg
birth O O
rite O O
and O O
raksha B-Dg B-Dg
karma E-Dg E-Dg
protection O O
of O O
baby O O
this O O
article O O
presents O O
a O O
critical O O
study O O
of O O
the O O
procedures O O
included O O
in O O
navjata B-Dg B-Dg
shishu I-Dg B-Dg
paricharya E-Dg E-Dg
revealing O O
their O O
scientific O O
relevance O O
and O O
utility O O
in O O
adequate O O
care O O
of O O
new O O
born O O
the O O
materials O O
were O O
collected O O
from O O
the O O
classical O O
ayurvedic O O
literatures O O
pediatric O O
textbooks O O
magazines O O
and O O
research O O
journals O O
the O O
measures O O
of O O
care O O
of O O
new O O
born O O
described O O
in O O
our O O
ancient O O
texts O O
indicate O O
their O O
wisdom O O
regarding O O
resuscitation S-Ds O
prevention B-Ds O
of O O
hypothermia E-Ds S-Ds
aspiration S-Ds S-Ds
and O O
infections S-Ds O
and O O
promotion O O
of O O
rooming O O
in O O
and O O
early O O
initiation O O
of O O
breast O O
feeding O O

a O O
concept O O
of O O
udavartayoni B-Ds B-Dg
vyapat E-Ds E-Dg
an O O
ayurvedic O O
perspective O O
classics O O
of O O
ayurveda O O
have O O
described O O
most O O
of O O
the O O
problems O O
as O O
yoni B-Ds B-Ds
vyapat E-Ds E-Ds
some O O
of O O
the O O
menstrual O O
such O O
as O O
asrigdara S-Ds S-Ds
etc O O
have O O
been O O
described O O
individually O O
although O O
to O O
get O O
thorough O O
knowledge O O
regarding O O
menstrual O O
the O O
understanding O O
of O O
yoni B-Ds B-Ds
vyapat E-Ds E-Ds
disorders O O
concept O O
is O O
necessary O O
ayurveda O O
classics O O
have O O
described O O
twenty O O
kinds O O
of O O
yoni B-Ds B-Ds
vyapat E-Ds E-Ds
gynaecological B-Ds B-Ds
disorders E-Ds E-Ds
by O O
reviewing O O
concerned O O
quotes O O
from O O
classics O O
it O O
reveals O O
that O O
udavarta B-Ds B-Ds
yoni I-Ds I-Ds
vyapat E-Ds E-Ds
dysmenorrhoea S-Ds S-Ds
is O O
caused O O
by O O
vitiated O O
vata O O
dosha O O
classically O O
described O O
udavarta B-Ds B-Ds
yoni I-Ds I-Ds
vyapat E-Ds E-Ds
dysmenorrhoea S-Ds S-Ds
matches O O
with O O
the O O
all O O
types O O
of O O
dysmenorrhoea S-Ds S-Ds
on O O
the O O
grounds O O
of O O
explanation O O
of O O
charaka O S-Ds
that O O
the O O
pain O O
symptom O O
is O O
immediately O O
relieved O O
after O O
discharge O O
of O O
menstrual O O
blood O O
it O O
can O O
be O O
concluded O O
that O O
udavarta B-Ds B-Ds
yoni I-Ds I-Ds
vyapat E-Ds E-Ds
gynaecological O B-Ds
disorders O E-Ds
is O O
close O O
to O O
spasmodic O O
or O O
true O O
dysmenorrhoea S-Ds S-Ds

brief O O
review O O
of O O
bakuchi S-Dg S-Dg
and O O
its O O
therapeutic O O
uses O O
bakuchi S-Dg S-Dg
psoralea O O
corylifolia O O
linn O O
is O O
belongs O O
to O O
fabaceae O O
family O O
it O O
is O O
an O O
endangered O O
and O O
medicinally O O
important O O
plant O O
grows O O
throughout O O
india O O
it O O
has O O
multifarious O O
uses O O
as O O
it O O
is O O
an O O
important O O
component O O
of O O
ayurvedic O O
as O O
well O O
as O O
allopathic O O
system O O
of O O
medicines O O
bakuchi S-Dg S-Dg
is O O
one O O
of O O
the O O
main O O
herbs O O
in O O
traditional O O
indian O O
and O O
chinese O O
herbal O O
medicine O O
for O O
the O O
treatment O O
of O O
skin B-Ds B-Ds
disorders E-Ds E-Ds
it O O
has O O
been O O
used O O
in O O
the O O
treatment O O
of O O
eczema S-Ds S-Ds
and O O
hair B-Ds B-Ds
loss E-Ds E-Ds
roots O O
of O O
the O O
plant O O
are O O
useful O O
in O O
dental B-Ds B-Ds
caries E-Ds E-Ds
fruits O O
are O O
laxative O O
aphrodisiac O O
and O O
are O O
used O O
for O O
the O O
treatment O O
of O O
leucoderma S-Ds S-Ds
leprosy S-Ds S-Ds
and O O
in O O
inflammatory B-Ds B-Ds
diseases E-Ds E-Ds
of O O
the O O
skin O O
and O O
leaves O O
are O O
good O O
for O O
the O O
treatment O O
of O O
diarrhoea S-Ds S-Ds
the O O
plant O O
has O O
been O O
used O O
in O O
ayurvedic O O
medicinal O O
system O O
as O O
a O O
cardiac O O
tonic O O
vasodilator O O
and O O
pigmentor O O
it O O
possesses O O
important O O
activities O O
like O O
antibacterial S-Ds S-Ds
inflammatory O S-Ds
antiplatelet S-Ds S-Ds
antitumor S-Ds S-Ds
immunomodulatory S-Ds S-Ds
various O O
other O O
activities O O
like O O
hepatoprotective S-Ds S-Ds
antioxidants S-Ds S-Ds
and O O
antihelmentic S-Ds O
have O O
also O O
been O O
reported O O
this O O
article O O
reviews O O
the O O
various O O
references O O
of O O
bakuchi S-Dg S-Dg
in O O
ayurvedic O O
texts O O
regarding O O
its O O
therapeutic O O
uses O O
and O O
different O O
formulations O O
the O O
review O O
also O O
encompasses O O
the O O
pharmacological O O
activities O O
and O O
various O O
folklore O O
uses O O
of O O
this O O
plant O O

effect O O
of O O
the O O
vachadi B-Dg B-Dg
yoga E-Dg E-Dg
based O O
on O O
the O O
relative O O
predominance O O
of O O
doshika O O
characteristics O O
in O O
diarrheal B-Ds B-Ds
stool E-Ds E-Ds
of O O
infants O B-Ds
atisara S-Ds E-Ds
is O O
a O O
very O O
common O O
and O O
disease O O
in O O
almost O O
all O O
textbooks O O
of O O
ayurveda O O
however O O
very O O
little O O
description O O
is O O
available O O
for O O
balatisara S-Ds B-Ds
infantile B-Ds B-Ds
diarrhea E-Ds E-Ds
which O O
occurs O O
during O O
infantile O O
period O O
or O O
in O O
spite O O
of O O
its O O
high O O
incidence O O
during O O
this O O
period O O
however O O
a O O
number O O
of O O
in O O
different O O
books O O
are O O
mentioned O O
for O O
the O O
treatment O O
of O O
diarrhea S-Ds S-Ds
but O O
it O O
is O O
very O O
difficult O O
to O O
decide O O
which O O
one O O
recipe O O
is O O
more O O
effective O O
in O O
particular O O
dosha O O
specific O O
diarrhea S-Ds S-Ds
having O O
predominant O O
suppressive O O
doshika O O
stool O O
characteristics O O
hence O O
this O O
study O O
was O O
ensued O O
to O O
know O O
the O O
effect O O
of O O
syrup O O
vachadi B-Dg B-Dg
yoga E-Dg E-Dg
in O O
dosha O O
specific O O
atisara S-Ds O
of O O
bala O O
based O O
on O O
the O O
tartam O O
of O O
doshika O O
characteristics O O
after O O
getting O O
approval O O
from O O
the O O
ethical O O
committee O O
all O O
the O O
registered O O
infants O O
were O O
categorized O O
into O O
doshaja B-Ds B-Ds
atisara E-Ds E-Ds
groups O O
based O O
on O O
dosha O O
specific O O
stool O O
characteristics O O
and O O
associated O O
features O O
all O O
the O O
gathered O O
data O O
were O O
analyzed O O
by O O
applying O O
paired O O
t O O
statistical O O
test O O
overall O O
effect O O
of O O
vachadi B-Dg B-Dg
yoga E-Dg E-Dg
suggest O O
its O O
significant O O
effect O O
in O O
various O O
types O O
of O O
doshajanya B-Ds B-Ds
atisara E-Ds E-Ds
mainly O O
on O O
the O O
vatapradhana B-Ds B-Ds
pittajatisara E-Ds E-Ds
and O O
pittapradhana B-Ds B-Ds
vatajatisara E-Ds E-Ds

a O O
clinical O O
observational O O
study O O
in O O
management O O
diabetic B-Ds B-Ds
peripheral I-Ds I-Ds
neuropathy E-Ds E-Ds
diabetic B-Ds B-Ds
peripheral I-Ds I-Ds
neuropathy E-Ds E-Ds
is O O
one O O
of O O
the O O
most O O
troublesome O O
micro O O
vascular O O
complications O O
of O O
diabetes B-Ds B-Ds
mellitus E-Ds E-Ds
and O O
which O O
is O O
the O O
major O O
cause O O
for O O
lower B-Ds B-Ds
limb I-Ds I-Ds
amputation E-Ds E-Ds
to O O
manage O O
dpn S-Ds B-Dg
takradhara S-Dg E-Dg
and O O
pushyanuga B-Dg B-Dg
churna E-Dg E-Dg
were O O
planned O O
in O O
order O O
to O O
have O O
an O O
effective O O
and O O
safe O O
result O O
objective O O
of O O
the O O
study O O
is O O
to O O
evaluate O O
the O O
combined O O
effect O O
of O O
takradhara S-Dg S-Dg
and O O
pushyanuga B-Dg B-Dg
curna E-Dg E-Dg
in O O
dpn S-Ds S-Ds
it O O
is O O
an O O
observational O O
clinical O O
study O O
with O O
pre O O
mid O O
and O O
posttest O O
design O O
where O O
patients O O
of O O
dpn S-Ds S-Ds
were O O
randomly O O
selected O O
and O O
subjected O O
to O O
takradhara S-Dg S-Dg
procedure O O
for O O
days O O
pushyanuga B-Dg B-Dg
churna E-Dg E-Dg
was O O
administered O O
with O O
a O O
dose O O
of O O
before O O
food O O
with O O
warm O O
water O O
for O O
days O O
the O O
of O O
result O O
obtained O O
with O O
respect O O
to O O
the O O
parameter O O
daha O S-Ds
cumcumayana S-Ds S-Ds
tingling B-Ds S-Ds
sensation E-Ds S-Ds
had O O
showed O O
statistically O O
highly O O
significant O O
result O O
with O O
value O O
suptata S-Ds S-Ds
numbness S-Ds S-Ds
showed O O
significant O O
result O O
with O O
value O O
dourbalya S-Ds S-Ds
weakness S-Ds S-Ds
in O O
extremities O O
showed O O
insignificant O O
result O O
with O O
value O O
hence O O
the O O
combination O O
of O O
takradhara S-Dg S-Dg
and O O
pushyanuga B-Dg B-Dg
churna E-Dg E-Dg
are O O
found O O
to O O
be O O
effective O O
in O O
management O O
of O O
dpn S-Ds S-Ds

a O O
study O O
on O O
role O O
of O O
bhastrika B-Dg B-Dg
pranayama E-Dg E-Dg
in O O
premature O O
process O O
is O O
a O O
universal O O
and O O
phenomenon O O
that O O
affects O O
each O O
and O O
everyone O O
in O O
a O O
certain O O
way O O
according O O
to O O
ayurveda O O
the O O
ageing S-Ds O
is O O
a O O
natural O O
phenomenon O O
like O O
hunger O O
thirst O S-Ds
and O O
sleep O O
the O O
ageing S-Ds S-Ds
jara S-Ds S-Ds
is O O
described O O
as O O
of O O
two O O
types O O
kalaja O S-Ds
natural O S-Ds
ageing O S-Ds
and O O
akalaja S-Ds B-Ds
premature B-Ds E-Ds
ageing E-Ds E-Ds
the O O
bhastrika B-Dg B-Dg
yogic I-Dg I-Dg
kriya E-Dg E-Dg
is O O
a O O
well O O
known O O
breathing O O
exercise O O
pranayama S-Dg S-Dg
which O O
is O O
effective O O
in O O
premature B-Ds B-Ds
ageing E-Ds E-Ds
phenomenon O O
the O O
study O O
was O O
conducted O O
on O O
clinically O O
diagnosed O O
and O O
confirmed O O
cases O O
of O O
akalaja B-Ds B-Ds
jara E-Ds E-Ds
premature B-Ds E-Ds
ageing E-Ds E-Ds
and O O
was O O
asked O O
to O O
perform O O
bhastrika B-Dg B-Dg
pranayama E-Dg E-Dg
these O O
registered O O
patients O O
were O O
recommended O O
to O O
do O O
bhastrika B-Dg B-Dg
kriya E-Dg E-Dg
for O O
min O O
after O O
performing O O
sukshma B-Dg B-Dg
vyayama E-Dg E-Dg
for O O
days O O
it O O
was O O
observed O O
that O O
bhastrika B-Dg B-Dg
pranayama E-Dg E-Dg
not O O
only O O
provides O O
better O O
relief O O
in O O
symptoms O O
of O O
akalaja B-Ds B-Ds
jara E-Ds E-Ds
but O O
also O O
increases O O
the O O
antioxidant O O
potential O O
of O O
body O O

clinical O O
evaluation O O
of O O
role O O
of O O
shirodhara S-Dg S-Dg
and O O
aspirin O O
in O O
the O O
management O O
of O O
headache S-Ds S-Ds
headache S-Ds S-Ds
represents O O
one O O
of O O
the O O
most O O
frequent O O
human O O
discomforts O O
its O O
significance O O
is O O
often O O
abstruse O O
for O O
it O O
may O O
signal O O
serious O O
disease O O
or O O
represent O O
only O O
tension S-Ds O
of O O
fatigue S-Ds S-Ds
the O O
term O O
headache S-Ds S-Ds
should O O
encompass O O
the O O
aches S-Ds S-Ds
and O O
pain S-Ds S-Ds
located O O
in O O
the O O
region O O
of O O
head O O
in O O
ayurvedic O O
text O O
headache O S-Ds
is O O
described O O
under O O
the O O
head O O
diseases O O
approximately O O
of O O
people O O
have O O
a O O
headache S-Ds S-Ds
at O O
some O O
point O O
of O O
their O O
lives O O
during O O
each O O
year O O
an O O
average O O
of O O
people O O
have O O
headache S-Ds S-Ds
the O O
treatment O O
of O O
headache S-Ds S-Ds
depends O O
on O O
the O O
cause O O
but O O
commonly O O
involves O O
pain O O
killer O O
and O O
antidepressant O O
but O O
they O O
have O O
serious O O
side O O
effect O O
in O O
ayurveda O O
there O O
is O O
wide O O
scope O O
to O O
find O O
out O O
safe O O
remedy O O
for O O
the O O
management O O
of O O
headache O S-Ds
for O O
clinical O O
study O O
clinically O O
diagnosed O O
patients O O
of O O
headache O S-Ds
were O O
selected O O
from O O
the O O
opd O O
of O O
kayachikitsa O O
and O O
panchkarma O O
of O O
jamc O O
nagpur O O
selected O O
patients O O
were O O
randomly O O
divided O O
into O O
two O O
groups O O
each O O
of O O
patients O O
group O O
a O O
was O O
again O O
divided O O
into O O
three O O
sub O O
group O O
each O O
of O O
patients O O
in O O
group O O
a O O
patients O O
of O O
vataja B-Ds B-Ds
shiroshoola E-Ds E-Ds
were O O
treated O O
with O O
shirodhara S-Dg S-Dg
of O O
bala B-Dg B-Dg
tailaa E-Dg E-Dg
patient O O
of O O
pittaja B-Ds B-Dg
shiroshoola E-Ds E-Ds
were O O
treated O O
with O O
shirodhara S-Dg S-Dg
of O O
godudgha S-Dg S-Dg
cow O O
s O O
milk O O
and O O
patient O O
of O O
kaphaja B-Ds B-Dg
shiroshoola E-Ds E-Dg
were O O
treated O O
with O O
shirodhara S-Dg S-Dg
of O O
koshna B-Dg B-Dg
jaal E-Dg E-Dg
warm O O
water O O
for O O
days O O
group O O
was O O
administered O O
with O O
tab O O
for O O
days O O
although O O
satisfactory O O
result O O
obtained O O
on O O
various O O
parameter O O
with O O
tab O O
aspirin O O
but O O
shirodhara S-Dg S-Dg
is O O
more O O
significant O O

pharmacognostical O O
review O O
on O O
substitutes O O
for O O
tejapatra S-Dg S-Dg
in O O
sri O O
lankan O O
herbal O O
medicine O O
tejapatra S-Dg S-Dg
or O O
patra S-Dg S-Dg
is O O
a O O
herbal O O
ingredient O O
which O O
is O O
included O O
in O O
numerous O O
ayurvedic O O
and O O
indigenous O O
medicinal O O
preparations O O
most O O
books O O
revealed O O
tejapatra S-Dg S-Dg
patra S-Dg S-Dg
is O O
a O O
leaves O O
of O O
tamalapatra S-Dg S-Dg
and O O
this O O
plant O O
is O O
grown O O
in O O
india O O
and O O
does O O
not O O
grow O O
in O O
sri O O
lanka O O
however O O
some O O
texts O O
state O O
that O O
leaves O O
of O O
kurudu S-Dg S-Dg
take O O
as O O
a O O
tejapatra S-Dg S-Dg
patra S-Dg S-Dg
whereas O O
certain O O
other O O
books O O
mentioned O O
kollankola S-Dg S-Dg
pogostemon O O
heyneanus O O
used O O
as O O
a O O
tejapatra S-Dg S-Dg
patra S-Dg S-Dg
practically O O
for O O
the O O
preparation O O
of O O
herbal O O
medicine O O
in O O
sri O O
lanka O S-Dg
these O O
both O O
varieties O O
kurudukola S-Dg S-Dg
and O O
kollankola S-Dg S-Dg
are O O
taken O O
as O O
a O O
substitute O O
to O O
tejapatra S-Dg S-Dg
patra S-Dg S-Dg
therefore O O
this O O
literary O O
study O O
was O O
carried O O
out O O
to O O
analyze O O
ayurvedic O O
pharmacodynamic O O
and O O
modern O O
morphological O O
microscopical O O
physiochemical O O
chemical O O
and O O
biological O O
characteristics O O
of O O
kurudukola S-Dg S-Dg
kollankola S-Dg S-Dg
and O O
tamalapatra S-Dg S-Dg
to O O
find O O
out O O
most O O
appropriate O O
leaves O O
could O O
be O O
used O O
as O O
a O O
substitute O O
to O O
the O O
classical O O
tamalapatra S-Dg S-Dg
literature O O
found O O
out O O
both O O
kurudukola S-Dg S-Dg
and O O
kollankola S-Dg S-Dg
have O O
similar O O
and O O
dissimilar O O
characteristics O O
compare O O
to O O
the O O
tamalapatra S-Dg S-Dg
and O O
hence O O
these O O
two O O
plants O O
could O O
be O O
used O O
in O O
place O O
of O O
tamalapatra S-Dg S-Dg

role O O
of O O
punarnava B-Dg B-Dg
amrita I-Dg I-Dg
guggulu E-Dg E-Dg
in O O
the O O
management O O
of O O
vatarakta S-Ds S-Ds
a O O
clinical O O
trial O O
in O O
the O O
present O O
revolutionary O O
era O O
the O O
life O O
of O O
a O O
person O O
is O O
hectic O O
and O O
materialistic O O
and O O
is O O
quite O O
difficult O O
due O O
to O O
the O O
various O O
obstacles O O
which O O
are O O
experienced O O
during O O
the O O
routine O O
life O O
the O O
disease O O
vatarakta S-Ds S-Ds
is O O
one O O
of O O
them O O
vatarakta S-Ds S-Ds
is O O
an O O
ailment O O
where O O
both O O
vata O O
and O O
rakta O O
are O O
responsible O O
to O O
lead O O
a O O
complex O O
effect O O
on O O
the O O
joints O O
its O O
clinical O O
onset O O
is O O
from O O
great O O
toe O O
which O O
later O O
spreads O O
over O O
other O O
joints O O
of O O
the O O
body O O
in O O
chakradutta O O
vatavyadhi O O
rogaadhikaar O O
chapter O O
amrita B-Dg B-Dg
guggulu I-Dg I-Dg
dwitiya E-Dg I-Dg
punarnava B-Dg B-Dg
amrita I-Dg I-Dg
guggulu E-Dg E-Dg
is O O
described O O
which O O
is O O
taken O O
here O O
for O O
the O O
treatment O O
of O O
vatarakta S-Ds S-Ds
this O O
is O O
a O O
single O O
blind O O
clinical O O
study O O
with O O
a O O
pre O O
and O O
design O O
wherein O O
patients O O
of O O
both O O
sex O O
suffering O O
from O O
vatarakta S-Ds S-Dg
in O O
an O O
age O O
limit O O
of O O
to O O
years O O
were O O
selected O O
randomly O O
and O O
given O O
punarnava B-Dg B-Dg
amrita I-Dg I-Dg
guggulu E-Dg E-Dg
with O O
an O O
anupana O O
of O O
amritaadi B-Dg B-Dg
kashaya E-Dg E-Dg
with O O
each O O
dose O O
the O O
therapeutic O O
effect O O
of O O
the O O
treatment O O
was O O
assessed O O
based O O
on O O
specific O O
subjective O O
and O O
objective O O
parameters O O
the O O
results O O
obtained O O
were O O
analyzed O O
statistically O O
using O O
student O O
paired O O
test O O
and O O
a O O
significant O O
improvement O O
was O O
observed O O
in O O
all O O
the O O
criteria O O
of O O
assessment O O
the O O
use O O
of O O
punarnava B-Dg B-Dg
amrita I-Dg I-Dg
guggulu E-Dg E-Dg
was O O
a O O
perfect O O
selection O O
in O O
the O O
management O O
of O O
vatarakta S-Ds S-Ds
it O O
needs O O
further O O
study O O
with O O
bigger O O
sample O O
size O O
in O O
the O O
management O O
of O O
vatarakta S-Ds S-Ds

impact O O
of O O
erratic O O
lifestyles O O
on O O
hospital O O
attending O O
patients O O
of O O
amlapitta S-Ds S-Ds
a O O
survey O O
a O O
survey O O
over O O
a O O
large O O
population O O
of O O
a O O
particular O O
area O O
can O O
help O O
to O O
collect O O
epidemiological O O
data O O
and O O
find O O
out O O
probable O O
etiological O O
factors O O
of O O
a O O
disease O O
amlapitta S-Ds S-Ds
is O O
a O O
chronic O O
lifestyle O O
disorder O O
which O O
has O O
great O O
impact O O
on O O
the O O
quality O O
of O O
life O O
the O O
objective O O
of O O
this O O
study O O
was O O
to O O
assess O O
the O O
impact O O
of O O
foods O O
and O O
food O O
habits O O
as O O
well O O
as O O
their O O
lifestyles O O
on O O
severity O O
and O O
frequency O O
of O O
amlapitta S-Ds S-Ds
symptoms O O
a O O
survey O O
study O O
was O O
conducted O O
on O O
hospital O O
attending O O
patients O O
affected O O
with O O
various O O
types O O
of O O
problems O O
on O O
the O O
basis O O
of O O
a O O
out O O
of O O
respondents O O
with O O
mean O O
age O O
of O O
years O O
were O O
diagnosed O O
of O O
having O O
amlapitta S-Ds O
according O O
to O O
cardinal O O
signs O O
and O O
symptoms O O
maximum O O
participants O O
were O O
from O O
the O O
age O O
group O O
of O O
to O O
years O O
hindu O O
male O O
vegetarian O O
and O O
educated O O
most O O
of O O
them O O
were O O
habituated O O
in O O
taking O O
heavy O O
and O O
contrary O O
foods O O
at O O
irregular O O
intervals O O
maximum O O
patients O O
were O O
addicted O O
with O O
tea O O
followed O O
by O O
tobacco O O
and O O
adopted O O
sedentary O O
lifestyle O O
previous O O
medication O O
was O O
taken O O
by O O
of O O
patients O O
and O O
out O O
of O O
them O O
preferred O O
allopathic O O
medicine O O
whereas O O
had O O
chosen O O
ayurveda O O
it O O
was O O
found O O
that O O
amlapitta S-Ds S-Ds
is O O
the O O
most O O
prevalent O O
disease O O
among O O
the O O
participants O O
who O O
had O O
adopted O O
unhealthy O O
food O O
habits O O
and O O
erratic O O
lifestyles O O

outcome O O
of O O
bilwa B-Dg B-Dg
phala I-Dg I-Dg
majja I-Dg I-Dg
churna E-Dg E-Dg
on O O
intestinal B-Ds B-Ds
transit E-Ds E-Ds
intestinal B-Ds B-Ds
transit E-Ds E-Ds
is O O
define O O
as O O
length O O
of O O
the O O
intestine O O
travelled O O
by O O
chyme O O
per O O
unit O O
time O O
an O O
important O O
factor O O
for O O
determination O O
of O O
intestinal O B-Ds
mobility O O
as O O
well O O
as O O
bacterial O O
growth O O
which O O
is O O
important O O
factor O O
for O O
development O O
of O O
gastrointestinal B-Ds B-Ds
disorders E-Ds E-Ds
aegle O O
marmelos O O
commonly O O
known O O
as O O
bilwa S-Dg S-Dg
its O O
fruit O O
has O O
been O O
used O O
for O O
treatment O O
of O O
gastrointestinal B-Ds B-Ds
disorders E-Ds E-Ds
like O O
chronic B-Ds B-Ds
diarrhoea E-Ds S-Ds
dysentery S-Ds S-Ds
peptic B-Ds B-Ds
ulcers E-Ds E-Ds
as O O
a O O
laxative O O
in O O
traditional O O
system O O
of O O
indian O O
medicine O O
and O O
possesses O O
antioxidant S-Ds S-Ds
hepatoprotective S-Ds S-Ds
properties O O
the O O
main O O
aim O O
of O O
the O O
study O O
is O O
to O O
assess O O
the O O
effect O O
of O O
bilwa B-Dg B-Dg
phala I-Dg I-Dg
majja I-Dg I-Dg
churna E-Dg E-Dg
on O O
intestinal B-Ds B-Ds
transit E-Ds E-Ds
study O O
was O O
conducted O O
on O O
eight O O
inbreed O O
albino O O
rats O O
having O O
body O O
weight O O
and O O
these O O
animals O O
were O O
divided O O
in O O
to O O
two O O
groups O O
four O O
animals O O
in O O
each O O
group O O
of O O
either O O
sex O O
bilwa B-Dg B-Dg
phala I-Dg I-Dg
majja I-Dg I-Dg
churna E-Dg E-Dg
was O O
administered O O
in O O
the O O
dose O O
of O O
body O O
weight O O
of O O
animals O O
twice O O
a O O
day O O
in O O
drug O O
treated O O
group O O
along O O
with O O
food O O
water O O
and O O
only O O
food O O
and O O
water O O
was O O
administered O O
in O O
control O O
group O O
animals O O
after O O
six O O
days O O
treatment O O
effect O O
of O O
body O O
weight O O
diet O O
consumption O O
intestinal O B-Ds
transit O O
was O O
recorded O O
of O O
both O O
groups O O
body O O
weight O O
and O O
diet O O
consumption O O
did O O
not O O
show O O
any O O
significant O O
changes O O
in O O
between O O
group O O
there O O
was O O
increased O O
intestinal B-Ds B-Ds
transit E-Ds E-Ds
and O O
decrease O O
length O O
of O O
small O O
intestine O O
but O O
these O O
changes O O
were O O
not O O
significant O O
large O O
intestine O O
did O O
not O O
show O O
any O O
changes O O
in O O
their O O
length O O
where O O
as O O
its O O
weight O O
content O O
was O O
increased O O
in O O
drug O O
treated O O
group O O
bilwa B-Dg B-Dg
phala I-Dg I-Dg
majja I-Dg I-Dg
churna E-Dg E-Dg
increase O O
intestinal B-Ds B-Ds
transit E-Ds E-Ds
but O O
did O O
not O O
affect O O
body O O
weight O O
and O O
diet O O
consumption O O

a O O
review O O
on O O
trividha B-Ds B-Dg
rogamarga E-Ds E-Dg
its O O
role O O
in O O
manifestation O O
of O O
ayurveda O O
is O O
science O O
of O O
life O O
it O O
emphasizes O O
on O O
preventive B-Fn O
aspect E-Fn O
rather O O
than O O
curative O O
treatment O O
the O O
subject O O
rogamarga O O
disease O O
indicates O O
relationship O O
between O O
different O O
tissue O O
and O O
organ O O
in O O
a O O
unique O O
way O O
morbid O O
state O O
of O O
dosha O O
which O O
is O O
motivates O O
in O O
a O O
specific O O
way O O
with O O
a O O
specific O O
affinity O O
towards O O
the O O
selected O O
tissue O O
and O O
organ O O
the O O
concept O O
is O O
traced O O
in O O
ancient O O
ayurveda O O
books O O
this O O
is O O
an O O
objective O O
approach O O
of O O
ancient O O
scientist O O
helping O O
for O O
the O O
clinical O O
practice O O
the O O
subject O O
is O O
vast O O
but O O
it O O
is O O
traced O O
in O O
short O O
present O O
day O O
student O O
can O O
not O O
study O O
and O O
learned O O
the O O
vast O O
subject O O
in O O
a O O
time O O
based O O
period O O
so O O
through O O
this O O
article O O
we O O
have O O
made O O
an O O
attempt O O
to O O
highlight O O
its O O
importance O O
in O O
clinical O O
practice O O
some O O
of O O
the O O
important O O
sanskrit O O
shloka O O
verse O O
are O O
presented O O
in O O
picture O O
form O O
this O O
article O O
highlight O O
the O O
summery O O
based O O
on O O
the O O
concept O O
of O O
trividha B-Ds B-Ds
rogamarga E-Ds O
three O O
disease O O
pathway O O

rationale O O
behind O O
three O O
days O O
rest O O
period O O
before O O
virechana B-Dg B-Dg
karma E-Dg E-Dg
vamana O E-Dg
and O O
virechana O O
processes O O
amongst O O
panchakarma O O
have O O
the O O
fixed O O
time O O
bound O O
procedural O O
format O O
both O O
are O O
having O O
almost O O
same O O
at O O
first O O
internal O O
oleation O O
till O O
the O O
occurrence O O
of O O
symptoms O O
of O O
complete O O
oleation O O
then O O
gap O O
and O O
then O O
the O O
main O O
procedure O O
the O O
main O O
difference O O
lies O O
in O O
duration O O
of O O
gap O O
between O O
their O O
vamana O O
has O O
one O O
gap O O
day O O
while O O
virechana O O
has O O
the O O
gap O O
of O O
three O O
there O O
is O O
no O O
clear O O
cut O O
reason O O
mentioned O O
in O O
texs O O
anywhere O O
one O O
has O O
to O O
extract O O
the O O
rationale O O
behind O O
it O O
from O O
their O O
purposes O O
and O O
modes O O
of O O
action O O
surprisingly O O
the O O
quantity O O
of O O
kapha O B-Dg
dosha O O
inside O O
gastro B-Ds B-Ds
intestinal I-Ds B-Ds
tract E-Ds I-Ds
koshtha S-Ds E-Ds
plays O O
a O O
major O O
role O O
in O O
both O O
these O O
different O O
procedures O O
so O O
evaluation O O
of O O
virechana O O
process O O
out O O
of O O
these O O
two O O
on O O
the O O
basis O O
of O O
presence O O
of O O
doshas O O
in O O
git O O
before O O
the O O
procedure O O
relevance O O
of O O
keeping O O
certain O O
rest O O
period O O
rationale O O
behind O O
the O O
specific O O
diet O O
regimes O O
before O O
it O O
needs O O
attention O O

understanding O O
hypertension S-Ds S-Ds
on O O
ayurvedic O O
perspective O O
a O O
critical O O
review O O
hypertension S-Ds S-Ds
is O O
a O O
major O O
risk O O
factor O O
for O O
cardiovascular B-Ds B-Ds
diseases E-Ds E-Ds
stroke S-Ds S-Ds
and O O
kidney B-Ds B-Ds
diseases E-Ds E-Ds
high O O
mortality O O
conventional O O
treatment O O
modalities O O
do O O
not O O
have O O
enough O O
efficacies O O
in O O
reducing O O
target O O
organ O O
damage O O
and O O
they O O
have O O
adverse O O
effects O O
as O O
well O O
so O O
it O O
is O O
the O O
need O O
time O O
to O O
get O O
safe O O
effective O O
and O O
remedies O O
in O O
ayurveda O O
formulating O O
ayurvedic O O
therapy O O
for O O
hypertension S-Ds S-Ds
warrants O O
proper O O
understanding O O
of O O
hypertension S-Ds S-Ds
as O O
per O O
the O O
principles O O
of O O
ayurveda O O
this O O
study O O
is O O
made O O
with O O
an O O
aim O O
to O O
understanding O O
the O O
pathogenesis O O
of O O
hypertension O S-Ds
in O O
terms O O
of O O
ayurveda O O
the O O
various O O
pathological O O
mechanisms O O
contributing O O
the O O
manifestation O O
are O O
compiled O O
by O O
going O O
through O O
texts O O
journals O O
and O O
internet O O
search O O
the O O
obtained O O
data O O
are O O
reviewed O O
critically O O
to O O
understand O O
in O O
terms O O
of O O
ayurveda O O
it O O
is O O
found O O
that O O
the O O
hypertension S-Ds S-Ds
is O O
a O O
disorder O O
of O O
vaata O B-Ds
dosha O O
due O O
to O O
aavarana O O
the O O
causative O O
are O O
santarpanajanya O S-Ds
nidaana O S-Ds
factors O O
leading O O
to O O
of O O
the O O
various O O
other O O
factors O O
involved O O
in O O
the O O
manifestation O O
of O O
hypertension S-Ds S-Ds
are O O
rasavaha O S-Ds
raktavaha O S-Ds
medovaha O S-Ds
and O O
manovaha O O
srotas O O
the O O
treatment O O
of O O
hypertension O S-Ds
should O O
be O O
done O O
with O O
targeting O O
these O O
factors O O
with O O
proper O O
assessment O O
of O O
strength O O
of O O
disease O O
and O O
diseased O O

role O O
ksheerbala B-Dg B-Dg
taila I-Dg I-Dg
nasya E-Dg E-Dg
and O O
ksheerdhooma S-Dg O
in O O
management O O
of O O
ardita S-Ds S-Ds
a O O
review O O
ardita S-Ds S-Ds
is O O
a O O
vatika O O
disorder O O
mentioned O O
in O O
ayurvedic O O
classics O O
which O O
is O O
included O O
amongst O O
the O O
eighty O O
nanatmaja O O
vata O O
disorders O O
by O O
acharya O O
charaka O O
acharya O O
vagbhatta O O
describes O O
it O O
as O O
ekayam S-Ds O
acharya O O
sushruta O O
mentions O O
the O O
involvement O O
of O O
face O O
whereas O O
acharya O O
charaka O O
the O O
whole O O
of O O
sharirardha O O
of O O
the O O
both O O
acharya O O
charaka O O
and O O
sushruta O O
described O O
nasya S-Dg S-Dg
and O O
as O O
the O O
prime O O
treatment O O
modalities O O
for O O
ardita O B-Dg
sneha S-Dg S-Dg
is O O
considered O O
to O O
be O O
the O O
best O O
and O O
also O O
the O O
substances O O
have O O
greater O O
affinity O O
for O O
passive O O
absorption O O
through O O
nasal O O
mucosa O O
and O O
crossing O O
blood O O
brain O O
barrier O O
bbb O O
hence O O
navana B-Dg B-Dg
nasya E-Dg E-Dg
is O O
considered O O
the O O
best O O
nasya O O
drug O O
enters O O
the O O
brain O O
through O O
shringataka O B-Dg
marma O O
which O O
is O O
a O O
congruence O O
of O O
the O O
nerve O O
fibers O O
for O O
smell O O
taste O O
speech O O
vision O O
and O O
hearing O O
sensations O O
ksheerdhooma S-Dg S-Dg
in O O
the O O
form O O
of O O
sweda S-Dg S-Dg
a O O
decoction O O
of O O
cow O O
milk O O
and O O
vatahara S-Dg S-Dg
drugs O O
not O O
only O O
serves O O
the O O
purpose O O
of O O
swedana S-Dg S-Dg
helping O O
in O O
better O O
absorption O O
of O O
the O O
drug O O
administered O O
through O O
nasya S-Dg S-Dg
but O O
also O O
helps O O
to O O
reduce O O
the O O
symptoms O O
thus O O
this O O
whole O O
treatment O O
can O O
prove O O
to O O
be O O
a O O
promising O O
management O O
of O O
ardita S-Ds S-Ds
by O O
reducing O O
the O O
symptoms O O
and O O
correcting O O
the O O
pathophysiology O O

arka S-Dg S-Dg
and O O
its O O
botanical O O
equivalents O O
a O O
critical O O
analysis O O
herbal O O
medicines O O
are O O
an O O
integral O O
part O O
of O O
treatment O O
in O O
ayurveda O O
for O O
their O O
proper O O
clinical O O
usage O O
correct O O
botanical O O
identification O O
becomes O O
first O O
and O O
foremost O O
necessity O O
ancient O O
classical O O
literature O O
reports O O
types O O
of O O
various O O
plants O O
based O O
upon O O
its O O
floral O O
colours O O
size O O
and O O
shape O O
etc O O
in O O
this O O
way O O
arka O S-Dg
has O O
also O O
been O O
classified O O
into O O
various O O
types O O
by O O
different O O
authors O O
of O O
treatise O O
and O O
lexicons O O
texts O O
related O O
to O O
medicinal O O
plants O O
in O O
general O O
and O O
dravyaguna S-Dg S-Dg
in O O
particular O O
have O O
attributed O O
different O O
botanical O O
sources O O
to O O
arka S-Dg S-Dg
and O O
its O O
variety O O
thus O O
a O O
controversy O O
stills O O
persists O O
among O O
the O O
botanical O O
and O O
classical O O
identities O O
of O O
arka S-Dg S-Dg
till O O
date O O
this O O
present O O
work O O
attempts O O
to O O
critically O O
analyse O O
the O O
classical O O
types O O
of O O
arka S-Dg S-Dg
from O O
available O O
literature O O
and O O
correlate O O
them O O
with O O
the O O
available O O
botanical O O
sources O O
from O O
different O O
floras O O
thus O O
it O O
could O O
be O O
said O O
that O O
rajarka S-Dg S-Dg
is O O
the O O
white O O
and O O
purple O O
variety O O
of O O
calotropis O S-Dg
gigantea O S-Dg
whereas O O
the O O
synonym O O
alarka O S-Dg
shwetarka O S-Dg
corresponds O O
to O O
white O O
variety O O
of O O
exclusively O O
arka O S-Dg
can O O
be O O
taken O O
as O O
calotropis O O
procera O O
ait O O
and O O
calotropis O O
acia O O
well O O
the O O
pharmacological O O
potential O O
for O O
acia O O
which O O
resembles O O
procera O O
is O O
yet O O
to O O
be O O
explored O O
in O O
detail O O

an O O
observational O O
study O O
on O O
the O O
effecacy O O
of O O
tagaradi B-Dg B-Dg
churna E-Dg E-Dg
in O O
the O O
management O O
of O O
essential O O
hypertension S-Ds S-Ds
hypertension S-Ds S-Ds
has O O
become O O
worldwide O O
problem O O
effecting O O
of O O
adult O O
population O O
million O O
indians O O
are O O
believed O O
to O O
be O O
suffering O O
with O O
the O O
disease O O
which O O
is O O
a O O
key O O
risk O O
factor O O
for O O
coronary O O
artery O O
disease O O
and O O
renal O O
failure O O
today O O
approximately O O
one O O
billion O O
people O O
worldwide O O
are O O
suffering O O
from O O
high B-Ds O
blood I-Ds O
pressure E-Ds O
and O O
its O O
number O O
is O O
expected O O
to O O
increase O O
to O O
billion O O
by O O
the O O
year O O
of O O
hypertension S-Ds S-Ds
is O O
identified O O
as O O
single O O
most O O
important O O
risk O O
factor O O
in O O
both O O
coronary O O
heart O O
disease O O
and O O
cerebrovascular O B-Ds
accidents O E-Ds
it O O
may O O
also O O
lead O O
to O O
congestive O S-Ds
cardiac B-Ds B-Ds
failure E-Ds E-Ds
and O O
renal B-Ds B-Ds
failure E-Ds E-Ds
the O O
treatment O O
of O O
hypertension S-Ds S-Ds
in O O
contemporary O O
science O O
includes O O
administration O O
of O O
beta O O
blockers O O
calcium O O
channel O O
blockers O O
ace O O
inhibitors O O
and O O
other O O
different O O
modalities O O
in O O
spite O O
of O O
such O O
a O O
comprehensive O O
approach O O
the O O
treatment O O
of O O
hypertension O S-Ds
has O O
still O O
many O O
limitations O O
the O O
major O O
drawback O O
is O O
the O O
probable O O
adverse O O
effects O O
and O O
cost O O
of O O
medicine O O
hence O O
there O O
is O O
always O O
a O O
scope O O
for O O
management O O
of O O
hypertension S-Ds S-Ds
with O O
alternative O O
approach O O
making O O
use O O
of O O
cost O O
effective O O
safer O O
management O O
present O O
study O O
was O O
conducted O O
on O O
patients O O
of O O
essential O O
hypertension S-Ds S-Ds
with O O
tagaradi B-Dg B-Dg
churna E-Dg E-Dg
shankhapushpi S-Dg S-Dg
jyotishmati S-Dg S-Dg
celastrus O O
paniculata O O
ashwagandha S-Dg S-Dg
withania O O
somnifera O O
brahmi S-Dg S-Dg
bacopa O O
monnieri O O
churnas S-Dg O
with O O
water O O
as O O
anupana O S-Dg
for O O
a O O
period O O
of O O
days O O
observation O O
was O O
done O O
before O O
intervention O O
mid O O
test O O
assessments O O
were O O
done O O
on O O
and O O
day O O
and O O
assessment O O
was O O
done O O
on O O
day O O
intervention O O
revealed O O
that O O
patients O O
had O O
marked O O
improvement O O
had O O
moderate O O
improvement O O
and O O
had O O
mild O O
relief O O
while O O
insignificant O O
relief O O
was O O
noticed O O
in O O
patients O O

a O O
review O O
of O O
gridhrasi B-Ds B-Dg
hetu E-Ds E-Ds
according O O
to O O
bruhatrayi O O
acharya O O
charaka O O
stated O O
that O O
for O O
treating O O
any O O
disease O O
a O O
thorough O O
history O O
has O O
to O O
be O O
taken O O
with O O
a O O
stress O O
given O O
on O O
nidana O O
samprapti O O
pathogenesis O O
the O O
disorders O O
of O O
locomotor O O
system O O
are O O
increasingly O O
seen O O
in O O
present O O
era O O
that O O
reduces O O
the O O
human O O
activity O O
in O O
terms O O
of O O
social O O
and O O
professional O O
life O O
among O O
these O O
disorders O O
gridhrasi S-Ds S-Ds
is O O
one O O
of O O
the O O
severe O O
debilitating O O
diseases O O
its O O
causes O O
are O O
mentioned O O
in O O
ayurveda O O
for O O
the O O
awareness O O
of O O
common O O
man O O
about O O
this O O
vyadhi O O
aetiology O O
aetiology O O
given O O
in O O
various O O
references O O
are O O
collected O O
and O O
classified O O
according O O
to O O
nature O O
of O O
aetiology O O
acharya O O
sushruta O O
mentioned O O
most O O
of O O
the O O
hetu O O
for O O
gridhrasi O S-Ds
from O O
which O O
vata B-Ds O
vaigunya E-Ds O
is O O
very O O
important O O
to O O
cause O O
pain S-Ds B-Ds
vata O E-Ds
is O O
the O O
main O O
factor O O
producing O O
the O O
disease O O
gridhrasi S-Ds O
other O O
doshas O O
may O O
be O O
involved O O
it O O
essentially O O
plays O O
a O O
role O O
in O O
the O O
over O O
stimulation O O
of O O
the O O
nerve O O
as O O
experienced O O
by O O
severe O O
pain O O
in O O
the O O
course O O
of O O
affected O O
part O O
according O O
to O O
various O O
samhita O O
hetu O O
of O O
gridhrasi S-Ds O
is O O
studied O O
and O O
concluded O O
that O O
acharya O O
sushruta O O
mentioned O O
most O O
of O O
the O O
nidanas O O
of O O
vatavyadhis O S-Ds
such O O
as O O
abhighata S-Ds S-Ds
bharaharana S-Ds S-Ds
vegavidharana S-Ds S-Ds
gajaturanrathapadaticharya S-Ds S-Ds
which O O
are O O
viharaja O S-Ds
and O O
these O O
are O O
the O O
most O O
occurring O O
causes O O
of O O
gridhrasi S-Ds S-Ds

review O O
on O O
shwasaaghna S-Dg S-Dg
plants O O
of O O
various O O
nighantus O B-Ds
asthma S-Ds E-Ds
is O O
a O O
global O O
problem O O
with O O
an O O
estimated O O
million O O
affected O O
individuals O O
asthma S-Ds S-Ds
accounts O O
for O O
about O O
one O O
out O O
of O O
every O O
deaths O O
worldwide O O
in O O
india O O
it O O
is O O
estimated O O
that O O
million O O
asthmatics O O
report O O
to O O
the O O
hospital O O
every O O
year O O
the O O
available O O
treatment O O
options O O
have O O
major O O
limitations O O
owing O O
to O O
low O O
efficacy O O
associated O O
adverse O O
events O O
and O O
compliance O O
issues O O
this O O
led O O
to O O
an O O
intense O O
search O O
for O O
potent O O
and O O
safe O O
drugs O O
ayurveda O O
has O O
a O O
long O O
tradition O O
of O O
using O O
herbal O O
medicines O O
in O O
the O O
maintenance O O
of O O
health O O
and O O
management O O
of O O
diseases O O
the O O
plenty O O
of O O
plants O O
with O O
properties O O
are O O
mentioned O O
in O O
classical O O
texts O O
of O O
ayurveda O O
mainly O O
in O O
various O O
nighantus O O
ayurvedic O O
materia O O
medica O O
just O O
by O O
glorifying O O
the O O
past O O
we O O
survive O O
or O O
develop O O
further O O
the O O
validation O O
of O O
their O O
therapeutic O O
attributes O O
has O O
to O O
be O O
made O O
evidence O O
based O O
by O O
using O O
modern O O
scientific O O
methods O O
but O O
we O O
are O O
still O O
lacking O O
in O O
having O O
quantitative O O
data O O
of O O
shwasaghna S-Dg S-Dg
plants O O
which O O
will O O
serve O O
as O O
a O O
ready O O
reckoner O O
for O O
researchers O O
as O O
well O O
as O O
physicians O O
thus O O
there O O
is O O
a O O
need O O
for O O
generation O O
of O O
quantitative O O
scientific O O
data O O
from O O
various O O
nighantus O O
the O O
study O O
reveals O O
plants O O
described O O
in O O
various O O
nighantus O O

ayurvedic O O
management O O
of O O
ulcerative B-Ds B-Ds
colitis E-Ds E-Ds
a O O
case O O
study O O
ulcerative B-Ds B-Ds
colitis E-Ds E-Ds
is O O
an O O
idiopathic O B-Ds
chronic B-Ds E-Ds
inflammatory I-Ds B-Ds
bowel I-Ds I-Ds
disease E-Ds E-Ds
involving O O
the O O
colon B-Ds B-Ds
the O O
inflammation E-Ds E-Ds
usually O O
involves O O
the O O
rectum O O
but O O
may O O
spread O O
to O O
sigmoid O O
colon O O
or O O
whole O O
colon O O
pancolitis O O
it O O
is O O
manifested O O
as O O
rectal B-Ds O
bleeding E-Ds O
mucus O O
discharge O O
frequent O O
stool O O
weight O O
loss O O
anemia S-Ds S-Ds
fever S-Ds S-Ds
malaise S-Ds S-Ds
abdominal B-Ds B-Ds
pain E-Ds E-Ds
bloody B-Ds B-Ds
diarrhoea E-Ds E-Ds
etc O O
in O O
allopathic O O
medical O O
science O O
no O O
significant O O
treatment O O
is O O
there O O
for O O
corticosteroid O O
agents O O
etc O O
are O O
used O O
which O O
results O O
in O O
other O O
complications O O
too O O
a O O
chronic O O
patient O O
of O O
ulcerative B-Ds B-Ds
colitis E-Ds E-Ds
came O O
to O O
consult O O
in O O
ayurveda O O
to O O
take O O
better O O
management O O
for O O
him O O
the O O
features O O
like O O
blood O O
in O O
stool O O
frequent O O
stool O O
and O O
general O O
debility O S-Ds
was O O
treated O O
with O O
concept O O
of O O
in O O
ayurveda O O
pitta B-Dg B-Dg
shamaka I-Dg I-Dg
chikitsa E-Dg O
and O O
rakta B-Dg B-Dg
prasadana I-Dg I-Dg
chikitsa E-Dg E-Dg
was O O
adopted O O
as O O
line O O
of O O
treatment O O
and O O
the O O
patient O O
responded O O
well O O
with O O
much O O
improvement O O
in O O
his O O
general O O
condition O O

